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ABSTRACT 
In vertebrates, haematopoiesis is maintained by self-renewing 
multipotent haematopoietic stem cells (HSCs) in the adult bone 
marrow. HSCs are speciﬁed and generated during early embryonic 
development from arterial endothelial cells in the ventral wall of the 
dorsal aorta (vDA) that become haemogenic. Examination of mib 
mutants and rbpja/b morphants zebrafish embryos, that have defects 
in Notch signalling show that both arterial specification and HSCs 
development require an intact Notch signalling pathway. Utilizing in-
house generated zebrafish Notch reporter lines, we show that Notch 
signalling initiates in the migrating hEC progenitors before their 
arrival to the midline to form the DA. Following arterial specification, 
Notch activity rapidly increases in the DA cells and persists at high 
levels until the time point of HSC emergence from the vDA, then 
sharply falls to hardly detectable levels. Embryos treated with the γ-
secretase inhibitor DAPT or DAPM lose HSC development but retain 
arterial specification. Quantification of the residual Notch activity in 
our reporter lines by RT-PCR, revealed that low levels of Notch 
signalling retained in treated embryos are sufficient for arterial gene 
expression, while high levels of Notch signalling are required for hECs 
induction. Additional to these loss of function experiments, our 
endothelial specific gain of function studies suggested that continuous 
expression of nicd in the ECs in stable transgenic lines prevent cells 
from differentiation into mature HSCs that can leave the vDA to seed 
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the CHT. By contrast, transient expression of nicd in ECs appeared to 
expand HSC fate and allow cells to seed the CHT, suggesting that 
down-regulation of Notch signalling is essential to enable cells 
committed to the blood lineage to leave the vDA and seed the CHT. 
These data represent the first demonstration, to our knowledge, that 
cell autonomous Notch induction in ECs in vivo is sufficient to expand 
HSC formation in vertebrates. 
 
Ten-Eleven-Translocation (Tet) proteins are a family of enzymes 
known to be actively involved in DNA de-methylation by 5-mC 
oxidation. This process is essential for proper development and cell 
lineage specification. Here, we used zebrafish tet1/2/3 morpholinos 
to study the role of Tet enzymes in zebrafish development and 
organogenesis. Our results showed that individual depletion of Tet1 
or Tet3 enzymes is sufficient to arrest zebrafish development at the 
onset of somitogenesis, whereas tet2 morphants appear normal. 
Moreover, analysis of mildly affected morphants shows that Tet1 
knockdown leads to atypical neurogenesis in zebrafish embryos. 
Global 5hmC levels are dramatically reduced in both tet1 and tet3 
morphants, indicating the importance of Tet proteins in vertebrate 
organogenesis.  
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CHAPTER 1 
1 Introduction 
1.1 Haematopoiesis  
Blood is among the tissues that have the highest cell turnover in the 
body. Every day, it is estimated that one trillion blood cells are 
produced in the bone marrow to replenish old ones. More than a 
century ago, it was proposed that all blood cells derive from one 
common precursor, the haematopoietic stem cells (HSC), and that 
the cells derived from these precursors are organized in a hierarchy 
(Maximow, 1908). 
This hypothesis was supported by establishing that the lethal 
consequences following radiation were due to bone marrow failure, 
and that those patients could actually be rescued by injection of 
spleen or marrow from non-irradiated donors (Lorenz et al., 1951). 
Remarkably, lymphohaematopoietic cells from donor bone marrow 
were also shown to repopulate the recipient haematopoietic tissues 
(Ford et al., 1956, Makinodan, 1956, Nowell et al., 1956). Despite 
the establishment of bone marrow transplantation in the early 1950s, 
it was still not known whether blood is derived from multiple lineage 
restricted stem cells or single multipotent stem cells that have the 
ability to give rise to all blood lineages (HSC).   
In the early 1960s, Till and McCulloch (1961) injected bone marrow 
into irradiated mice and noticed the presence of gross nodules in their 
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spleens that are proportional to number of bone marrow cells 
injected. To demonstrate that each colony was truly derived from a 
single bone marrow cell, they further exposed bone marrow recipient 
mice to sub-lethal doses of radiation sufficient to induce karyotipic 
variation among the injected cells. They then noticed that each colony 
has a unique karyotipic pattern compared to other neighbouring 
nodules, and so provided  the first  evidence  for  the existence  of  
single multipotent stem cells in  the  bone marrow, the 
haematopoietic stem cells (HSCs) that have the  potential  for 
proliferation,  differentiation  and  self-renewal. This definition was 
then updated when Jones et al. (1989) discovered that cells forming 
colonies in the spleen were in fact progenitor cells with only short-
term repopulating ability while the haematopoietic cells seeding the 
bone marrow are the cells that provide long-term repopulation 
(Figure 1.1 shows the classical haematopoietic hierarchy). 
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Figure 1.1: Lineage Hierarchy of blood cell progenitors. 
Diagram showing the classical model for the haematopoietic 
development. HSCs develop from haemogenic endothelial 
progenitors derived from mesodermal cells that have the potential to 
give rise to primitive blood cells and the haemogenic endothelial 
progenitors that form the axial vessels' endothelium.  HSCs  reside 
at the top of the haematopoietic hierarchy, where they 
asymmetrically divide to give rise to committed progenitor cells that 
pass through several levels of differentiation to finally give rise to all 
mature cells of all blood lineages.  
    
Soon after their discovery, HSCs were used in bone marrow 
transplantation for patients with blood system failure to restore 
normal blood formation and their use is now established as a standard 
therapy for several malignant and non-malignant diseases (Cambier 
et al., 2015). However, HSC transplantation has not achieved its full 
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potential due to the scarcity of HSCs in bone marrow and the shortage 
of suitable donors. The use of improperly matched donor HSCs can 
lead to graft rejection or graft-versus-host disease, common serious 
complications in the clinic (Slukvin, 2013). Despite substantial efforts 
by the research community, HSC derivation from human pluripotent 
stem cells or from reprogrammed  somitic cells has not been fully 
accomplished yet. Knowledge about the molecular programming of 
HSCs during embryogenesis is an important prerequisite for achieving 
this goal. We study HSC formation in the zebrafish embryo to reveal 
the molecular programming HSC precursors undergo as they develop 
from haemogenic endothelium in the ventral wall of the dorsal aorta, 
one of the major arteries in the vertebrate embryo.  
 
1.2 Embryonic Haematopoiesis in Vertebrates 
In vertebrates, haematopoiesis occurs in two major waves. The first 
transient (embryonic) wave, which takes place during early 
development to provide oxygen and innate immunity to the rapidly 
growing tissue, occurs in the mammalian and avian embryos in the 
extra-embryonic yolk sac. The second permanent (definitive) wave, 
which follows the embryonic wave, and provides all blood cell lineages 
from multipotent self-renewing HSCs that maintain the blood system 
throughout life. 
 
22 | P a g e  
 
1.2.1 Embryonic Haematopoiesis  
Embryonic haematopoiesis is the process that leads to the production 
of all primitive blood cells in early embryogenesis, as well as some of 
definitive-like blood cells. Primitive blood cells are the erythrocytes, 
macrophages and megakaryocytes that form during the transient 
wave of haematopoiesis. These blood cells are required to provide 
nutrient, oxygen and innate immunity to the rapidly growing tissues 
during early development. 
Primitive blood cells are termed primitive due to the fact that they 
are closer in shape and characteristics to lower vertebrates' blood 
cells than their adult type counterparts. For instance, primitive 
erythrocytes are generally large in size, nucleated and they express 
embryonic haemoglobins (Palis and Yoder, 2001). Primitive 
macrophages are also functionally immature and have less 
phagocytic activity compared to their adult counterpart, and they lack 
certain markers such as F40/80 antigen and Lysozyme M (Lichanska 
and Hume, 2000). On the other hand primitive megakaryocytes are 
indistinguishable from   their adult types, as they are both 
morphologically similar, express the same surface markers and both 
have the ability to produce platelets (Xu et al., 2001).   
Primitive blood cells originate in the extra-embryonic yolk sac directly 
from mesodermal precursors that form blood islands, and are 
detectable in mouse embryos by embryonic day (E) 7-7.5 (reviewed 
in Medvinsky et al., 2011). This is at least half a day earlier than the 
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establishment of the yolk sac circulation, and one day  earlier than 
the embryonic circulation initiating at E8 and E8.5 respectively (Walls 
et al., 2008). Towards the end of the embryonic wave, it is also now 
accepted that some definitive-like blood cells also being produced in 
the murine yolk sac  (Palis and Yoder, 2001) and in the zebrafish CHT 
(Bertrand et al., 2010b). These cells develop under a different genetic 
control than that of primitive and true definitive blood cells, as 
discussed later in this chapter. Even though produced blood cells are 
morphologically and functionally similar to the blood cells generated 
in the definitive wave. Because the progenitor that these cells arise 
from does not have the full characteristics of the HSCs, including the 
ability to reconstitute haematopoiesis of irradiated mouse, and due 
to their disappearance later in development, they are still classified 
under embryonic haematopoietic stem cells.  
   
1.2.2 Definitive Haematopoiesis  
A short time after the establishment of blood circulation in the yolk 
sac and before its connection to the embryo proper (around E8), 
another wave of haematopoiesis is detected intra-embryonically. The 
intra-embryonic origin was first confirmed experimentally by 
(Dieterlen-Lievre, 1975) to correct the previous theory of the yolk sac 
being the origin of HSCs (Moore and Metcalf, 1970), which was based 
on culturing murine embryo bodies harvested on day 7 in the 
presence or absence of their yolk sac, and then dissecting their foetal 
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liver to explore colony formation. Even though only embryos cultured 
in presence of their yolk sac produce foetal liver colonies, this 
experiment does not exclude possible cell migration and the 
repopulating capability of the later identified AGM region.  Unlike the 
first wave, which is only transient and mainly forms primitive blood 
cells, this wave leads to formation of all blood lineages throughout 
the life of the organism, and so it is called the definitive wave. In this 
wave, haematopoietic progenitors develop in an area called the para-
aorta  splanchnopleura  (P-Sp/PAS), which later forms the aorta, 
gonads, and mesonephros (AGM) (reviewed in Golub and Cumano, 
2013). These progenitors are the founders of the first long term 
haematopoietic stem cells. They gain their full self-renewal activity 
and autonomous ability to reconstitute haematopoiesis of adult 
recipient (HSCs characteristics) two days after their first appearance 
in the AGM with a potency like those found in the adult HSCs 
(Medvinsky and Dzierzak, 1996).  
In the mouse embryo proper, hemangioblasts differentiate from 
mesodermal origin during early development and are found dispersed 
throughout the head mesenchyme and other areas of the embryo 
(Herbert et al., 2009). Based on molecular signals coming from other 
cells and from the microenvironment, they aggregate to form arterial 
and venous angioblasts, including the dorsal aorta DA and cardinal 
vein CV (Coultas et al., 2005). They then slowly remodel and refine 
into endothelial cells (ECs).  A subset of the DA endothelium 
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“haemogenic endothelium” in the AGM region then further 
differentiate to generate the definitive haematopoietic stem cells that 
were found to form clusters that contain progenitors with the ability 
to reconstitute the HSC system from E10 (Medvinsky and Dzierzak, 
1996). 
  Several other vascular tissues were also found to produce blood 
progenitor clusters at the same time point, including placenta, yolk 
sac, vetelline and umbilical arteries (Alvarez-Silva et al., 2003, Gekas 
et al., 2005, Ottersbach and Dzierzak, 2005, de Bruijn et al., 2002) 
however, only the AGM derived progenitors have the ability to 
reconstitute adult blood system by day 10.5 (Kumaravelu et al., 
2002). A few days later, blood progenitors derived from these 
vascular tissues also gain the ability to reconstitute haematopoiesis 
in irradiated mouse, but as blood circulation has already established 
in the embryo at this time point, it is difficult to exclude the possibility 
that these cells were originating from the AGM region. As all current 
lines of evidence point to the AGM region as the first and major site 
for HSC development, in this study we are mainly focusing on 
definitive haematopoiesis originating in this area and the molecular 
programming involved in AGM derived haematopoiesis. 
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1.3 HSCs are derived from a sub population of 
endothelial cells (haemogenic endothelium) in the 
AGM region 
Soon after the chick quil chimera experiment by Dieterlen-Lievre 
(1975) that provided evidence for the intra-embryonic origin of HSCs, 
intensive morphological and lineage tracing studies  were carried out 
to determine the origin and nature of cells that give rise to HSCs. 
These studies led to identification of intra-aortic haematopoietic 
clusters (IAHCs) associated with the aorta in the AGM region that 
contain cells capable of engrafting adult recipients. The close 
association between these clusters and the endothelial cells lining of 
the DA also suggested that HSCs might be derived from endothelial 
origin, giving rise to the theory of haemogenic endothelium. To 
investigate this theory, Jaffredo et al. (1998) injected the endothelial 
and macrophage specific marker DiI-labelled AcLDL into chick 
embryos and noticed that the HSCs clusters budding from ventral wall 
of the DA were positive for the injected endothelial marker, thus 
demonstrating for the first time that HSCs are derived from 
endothelial origin.  
The other confirmation came from the use of inducible Cre/loxP 
system, in which the promoter of the endothelial gene VE-cadherin 
was used to initiate recombination of a Cre reporter gene, and so 
label endothelial cells at E9 of mouse embryogenesis.  Because the 
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induction is only done for a short period of time, it only labels cells 
positive for VE-Cadhirin at that time point. The labelled cells and their 
progenies were then traced throughout development and into 
adulthood, and result was that at least 10% of adult HSCs were 
labelled, and so were derived from cells expressing VE-cadherin 
during early embryogenesis (Zovein et al., 2008, Oberlin et al., 
2002). Additional evidence also emerged from the experiment of 
Chen et al. (2009) in which they used the Cre/loxP system to 
specifically delete the runx1 gene flanked by two loxPs with a cre 
expressed under the control of the VE-cadherin gene promoter. This 
resulted in the absence of intra-aortic cluster formation and of HSCs, 
which confirmed that all adult HSCs were derived from endothelial 
cells. 
In vitro experiments carried out by two independent research groups 
also showed the formation of endothelial cells from hemangioblasts. 
Likewise, both groups showed expression of the endothelial specific 
markers tie-2 and c-kit, but not CD41, VE-cadherin expression and 
DiI-Ac-LDL uptake. Subsequently these cells differentiated into blood 
cells expressing c-kit, CD41 and then CD45, but not tie-2 (Lancrin et 
al., 2009, Eilken et al., 2009).  
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1.4 Zebrafish as a model to study haematopoiesis 
Historically several vertebrate models have been used to study the 
development of haematopoietic stem cells, including mouse, chick, 
frog and fish. This has been possible because of the high genetic and 
phenotypic conservation of this system across vertebrates (Amatruda 
and Zon, 1999). Today, the mouse is still considered the gold 
standard model for studying haematopoietic development, however   
exploring the early haematopoietic events in mice are hampered  by 
the small size of embryos and intra uterine development, added to 
the high costs of maintaining and breeding the animals themselves. 
In contrast, invertebrate models such as the fruit fly and C.elegans 
lack number of blood and vascular structures and organs found in 
vertebrates such as the multi-chambered heart and the multi-lineage 
haematopoietic system (Haffter et al., 1996).  
 In this context, the zebrafish has emerged during the last two 
decades as one of the preeminent complements to the study of 
haematopoietic stem cells development. Apart from zebrafish 
similarity to mammalian cardiovascular system, the zebrafish also 
has multi-lineage blood cells that are regulated by vascular and 
haematopoietic markers homologous to their mammalian 
counterparts  such as Gata, Lmo2, Scl, c-Myb, Ikaros, Lck, c-Fms, c-
Kit, Globins, Tie1, Tek, Flk1 and Flt (Paw and Zon, 2000). 
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 These added to their external fertilization, embryo transparency 
during development, which makes it easy to manipulate and monitor 
in real time.   Moreover, the short generation time and high number 
of embryos produced even in weekly crosses, makes it possible to get 
strong statistical data from experiments. Another advantage of 
zebrafish is the ease of introducing germ-line mutations, which make 
them suitable for forward genetics (Paw and Zon, 2000).  
Additionally, one of the unique features of the zebrafish embryo is 
that blood circulation is not essential for oxygen delivery, 
consequently, it can live on oxygen diffusion from water for days with 
no blood circulation (Pelster and Burggren, 1996). This feature allows 
tolerating and assessing conditions that compromise cardiovascular 
function, which opens the door for a wide range of experiments that 
are impossible to carryout in mice due to complications resulting from 
cardiovascular abnormalities under such conditions.  
 
1.5 Haematopoietic Development in Zebrafish 
In zebrafish, as in mammals, haematopoiesis occurs through two 
major waves, the embryonic and the definitive waves; however, 
unlike in mammals, both waves occur intra-embryonically in zebrafish 
(Detrich et al., 1995, Gering et al., 1998, Thompson et al., 1998). 
During the embryonic wave, haematopoiesis occurs in two places: 
the anterior lateral mesoderm (ALM) in which primitive myeloid cells 
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and head ECs form, and the posterior lateral mesoderm (PLM) in 
which sub-populations of cells are specified as blood and endothelial 
progenitors. These specified cells then migrate to the midline to form 
the intermediate cell mass (ICM) (Detrich et al., 1995, Gering et al., 
1998, Fouquet et al., 1997, Sumoy et al., 1997). By 18hpf all these 
migrating cells will have arrived in the ICM and started to further 
differentiate into arterial angioblasts that form the dorsal aorta (DA), 
venous angioblasts that form the posterior cardinal vein (PCV), and 
erythroblasts that form primitive red blood cells. Soon after the 
formation of major axial vessels, primary inter-somitic vessels start 
to sprout from the DA, followed by similar sprouting from the PCV 
that then connects to half of the ISV sprouting from the DA to form 
a functional circulatory loop (Isogai et al., 2003). 
 Before the onset of blood circulation, a sub population of the arterial 
angioblasts present in the ventral wall of the DA are specified to form 
the first HSCs indicated by the consecutive expression of the 
transcription factors such as Runx1 and c-Myb (Lam et al., 2010, 
Kissa et al., 2008, Murayama et al., 2006). These markers are 
homologous to the markers expressed in the ventral wall of the DA 
in the mouse AGM. However, confocal time-lapse studies in zebrafish 
have shown that, unlike mammalian HSCs that bud into the lumen of 
the DA and eventually join circulation, zebrafish HSCs leave the DA 
lining and join the mesenchyme underneath the ventral wall of the 
DA. They then  squeeze through in between the venous ECs and leave 
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through the cardinal vein (Bertrand et al., 2010a, Lam et al., 2010, 
Kissa and Herbomel, 2010). They are then carried by the circulation 
to an area in the ventral tail mesenchyme that develops into the 
caudal haematopoietic tissue (CHT), which is an intermediate 
haematopoietic organ equivalent to the foetal liver in mammals 
(Murayama et al., 2006). At this stage, some of these cells further 
differentiate into erythrocytes and myeloid cells, whereas others 
proliferate and then the T cells migrate through the circulation to seed 
the thymus, whereas HSCs seed the kidney, to provide all blood cell 
types throughout life (Murayama et al., 2006, Jin et al., 2007)(Figure 
1.2). 
 
Figure 1.2: Comparison of the spatiotemporal haematopoietic 
ontogeny in different vertebrates.  
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Diagram showing the haematopoietic development and migratory 
root in zebrafish, compared to human and mouse. Embryonic wave 
that takes place in zebrafish ICM and in human and mouse yolk sac. 
HSCs in the three vertebrates emerge from DA endothelium in the 
AGM region. They then migrate to the haematopoietic intermediate 
tissue, which is the CHT in zebrafish and foetal liver in human and 
mouse. After several rounds of proliferation and differentiation, HSCs 
migrate to the adult site of haematopoiesis, which is the kidney and 
thymus in zebrafish or the bone marrow in human and mouse 
(Adapted from Detrich et al., 2011, Orkin and Zon, 2008, Baron et 
al., 2012). 
 
 
Studies on runx1 mutants and runx1 morphants have shown that 
Runx1 protein depletion completely blocks definitive haematopoiesis, 
indicated by absence of c-Myb positive haematopoietic progenitors in 
all haematopoietic tissues, whereas embryonic haematopoiesis is 
completely unaffected. The loss of HSC formation in Runx1 depleted 
cells greatly support the theory that the Runx1 positive cells present 
in the AGM region contain HSCs (Gering and Patient, 2005, Burns et 
al., 2005, Jin et al., 2009).  
 
 
1.6 Notch signalling distinguishes Erythroid/myeloid 
progenitors (EMPs) from true HSCs  
In zebrafish, as in the mouse, the emergence of HSCs is preceded by 
specification of definitive-like progenitor cells with limited multi-
lineage differentiation potential, termed Erythroid/myeloid 
progenitors (EMPs). These cells arise in the posterior blood island 
between 24-30 hpf and are first identified by co-expression of 
fluorescent transgenes driven by the lmo2 and gata1a promoters 
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(Bertrand et al., 2007).  In vitro assays and cellular transplantation 
experiments showed that these cells are only capable of 
differentiation into erythroid and and myeloid cells (Bertrand et al., 
2007). Interestingly, it was also shown that blocking Notch signalling 
chemically or with mind bomb mutation (mib) does not affect  the 
specification and differentiation of these cells while blocking 
expression of HSCs markers such as Runx1 and c-Myb in the vDA 
(Bertrand et al., 2010b). Fate mapping and transplantation assays 
also showed that EMPs remain in the CHT and do not have the ability 
to migrate and seed the thymus or kidney (Bertrand et al., 2007).   
 
1.7 Notch signalling in definitive HSC  
Three signalling molecules were found to work in a cascade required 
for proper vascular and HSC formation: Hedgehog (Hh), Vascular 
endothelial growth factor a (Vegfa) and Notch (Gering and Patient, 
2005).  This cascade is initiated by the release of Hh from the 
notochord and floor plate into the nearby somites. Upon receiving the 
signal, somitic cells start expressing and secreting Vegfa. The 
secreted VegfA protein then diffuses to the DA angioblasts in the 
midline, where it interacts with the Vegfa receptor Flk1. This 
interaction induces these cells to express Notch receptors and 
ligands, leading to subsequent activation of the Notch pathway 
(Gering and Patient, 2005). Activation of the Notch pathway involves 
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interaction of the Notch ligands delta and jagged with the Notch 
receptor extracellular domain (NECD) on adjacent cells (Figure 1.3). 
Upon binding, the NECD is cleaved and endocytosed by the signal 
sending cell in the presence of functioning ubiquitin ligase (Itoh et 
al., 2003). The remaining part of Notch receptor in signal receiving 
cell then becomes susceptible to γ-secretase, which cleaves it and 
releases the Notch intracellular domain (Nicd). Nicd then enter the 
nucleus where it forms a complex with Rbpj (Csl) and co-activators. 
The complex then binds Rbpj binding sites in enhancer and promoter 
sequences of Notch target genes.  
 
 
Figure 1.3: Representation of the Notch signalling pathway. 
Activation of the Notch pathway is triggered by the interaction of the 
Notch ligands (blue) with the NECD (red) on an adjacent cell. Upon 
binding, the NECD get cleaved and endocytosed by the signal sending 
cell in presence of functioning ubiquitin ligase (the blue circle on the 
left). The stump of Notch receptor in signal receiving cell then 
becomes susceptible to γ-secretase, which cleaves the stump and 
releases the Nicd. Nicd then enters the nucleus where it forms a 
complex with Rbpj and co-activators. The complex binds Rbpj (Csl) 
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binding sites in enhancer and promoter sequences and so activates 
Notch target genes.  
 
Notch is an evolutionary conserved pathway that plays essential roles 
in normal embryonic development in most multicellular organisms 
including vertebrates. It performs this role through regulating cell 
fate decisions during development through a process called lateral 
inhibition. In this process, Notch signals to neighbouring cells to 
prevent them from adopting equivalent identity (Kopan and Ilagan, 
2009). The pathway was first discovered in Drosophila, where 
mutations were found to be linked with indentations (Notches) in the 
fly wings (Morgan, 1917). Soon after its discovery, the pathway 
became a target for extensive studies. It is now known that the 
pathway is involved in a wide variety of cell fate decisions during 
development, including neurogenesis, somitogenesis, angiogenesis 
and haematopoiesis. In haematopoiesis Notch was shown to be 
involved in the regulation of HSC differentiation, proliferation, 
survival and apoptosis (Penton et al., 2012).  
The link between Notch signalling and haematopoiesis was first 
discovered in the early 1990s, when defected Notch1 signalling was 
linked with certain types of chromosomal translocation lymphoid 
leukaemia (Ellisen et al., 1991). Cloning the truncated human Notch1 
from this translocation leukaemia into retrovirus constructs, then 
injecting the construct to mice, was also shown to lead to similar 
lymphoid leukaemia in 50% of injected mice.  Abnormal  Notch 
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signalling was also found in myeloid leukaemia, and several studies 
suggested a Notch-induced suppression in myeloid progenitors 
differentiation (reviewed in Weber and Calvi, 2010).  
Additionally, in vivo and in vitro studies in the mouse that involved 
blocking and over-activating the Notch pathway also confirmed the 
requirement for Notch in endothelial and HSCs development. For 
instance, when Varnum-Finney et al. (2000) infected murine bone 
marrow cells with a retrovirus containing a constitutive active form of 
notch1 gene, they succeeded in establishing immortalized cell lines 
that generate progeny with either lymphoid or myeloid characteristics 
both in vitro and in vivo. Kawamata et al. (2002) also reported that 
over-activating Notch with constitutively active Nicd  in mouse 
embryos,  suppresses the B cell lineage development and increases 
development of thymus cells T-cells. On the other hand when 
(Kumano et al., 2003) surgically removed the AGM region  from 
notch1-/- mutant mice and grew it in culture they showed that the 
AGM-derived cells from notch1-/- mutants were unable to produce 
colony forming cell (CFC) units in vitro or reconstitute the blood 
system of irradiated adult mice. In consistence with these early 
studies, Notch involvement in HSCs specification during early 
embryogenesis was confirmed in all studied vertebrate models 
including chick, frog and fish (Drevon and Jaffredo, 2014, Clements 
and Traver, 2013, Medvinsky et al., 2011).   
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In zebrafish, some of the earliest evidence on Notch involvement in 
HSC development came with the identification of the zebrafish mib 
mutants. These mutants were first identified in large scale zebrafish 
mutagenesis projects due to their neurological  and somitogenic 
abnormalities (Jiang et al., 1996, Schier et al., 1996). Apart from 
their neurological and somitogenic defects, these mutants were also 
found to lack both arterial ECs and definitive haematopoiesis (Lawson 
et al., 2001, Gering and Patient, 2005). Itoh et al. (2003) then 
showed that these mutants lack functioning Notch due to mutations 
in the enzyme E3 ubiquitin ligase,  required for the ubiquitination of 
the Notch ligands, and eventually the release of Nicd.  
In zebrafish there are four Notch receptor genes that are homologous 
to Drosophila notch and nine Notch ligands genes, five deltas and 4 
jaggeds that are homologous to Drosophila delta and serrate genes 
respectively (Espin-Palazon et al., 2014, Janicke et al., 2007).  
Table1.1 shows the zebrafish Notch receptor and ligand genes and 
their ortholog in Drosophila and mammals. 
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Table1.1: Notch ligand and receptor genes in Drosophila and 
their homologues in mammals and zebrafish. 
 
 
Drosophila 
Homologous  
References 
Mammals Zebrafish 
 
 
Ligands 
 
 
delta 
 
delta-like1 dla (deltaA) 
dld (deltaD) 
(Haddon et al., 1998) 
delta-like3 dlb (deltaB) 
dlc (deltaC) 
(Haddon et al., 1998) 
delta-like4 dll4 (delta-like4) (Leslie et al., 2007) 
 
serrate 
jagged1  jag1a (jagged1A) 
jag1b (jagged1B) 
(Zecchin et al., 2005) 
jagged2 jag2a (jagged2A) (Zecchin et al., 2005) 
jag2b (Jagged2B) (Janicke et al., 2007) 
 
Receptors 
notch notch1 notch1a (Bierkamp and Campos-
Ortega, 1993) 
notch2 notch2 (notch6) (Westin and Lardelli, 1997) 
notch3 notch3 (notch5) (Westin and Lardelli, 1997) 
notch4  notch1b (Westin and Lardelli, 1997) 
 
 
In support of mib mutant data, Notch whole embryo gain of function 
and loss of function studies in zebrafish embryos as well as 
expression of Notch ligands and receptors in the AGM region at the 
time of HSCs formation, further confirmed the essential role for Notch 
in embryonic haematopoiesis. Notch whole embryo loss of function 
experiments involved blocking the γ-secretase enzyme with DAPT and 
DAPM, the use of rbpja/b morpholinos that prevent formation of Nicd-
containing transcription complex, or the expression of the dominant 
negative form of rbpj gene (dnrbpj) to compete with the endogenous 
Rbpj protein (see Figure 1.4).  
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Figure 1.4: Approaches used to block Notch pathway.  
(a) Deletion of the ubiquitin ligase enzyme in mib mutants, (B) 
inhibition of γ-secretase by γ-secretase inhibitors, (c) blocking Rbpj  
protein production with rbpja/b morpholinos, (D) blocking Rbpj 
function by occupying the binding site by the non-functioning Rbpj 
(DnRbpj).  
 
Blocking Notch signalling in the whole zebrafish embryo with any of 
these approaches leads to phenotypes that are generally similar to 
those in mib mutants (Rowlinson and Gering, 2010). The common 
phenotypes observed in these embryos were somite defects, 
neuronal defects, and absence of HSCs. From data generated in the 
lab, we also showed that blocking Notch signalling with different 
a 
b 
c 
d 
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approaches leads to loss of the haematopoietic marker runx1 mRNA 
(Figure 1.5).   
 
Figure 1.5: blocking the Notch pathway with different 
approaches blocks HSCs formation.  
The Figure shows great reduction or absence of HSCs in the three 
approaches indicated by absence of runx1 expression in the AGM 
region (the darkness in rbpja/b morphants in C is a stain deposition 
resulting from over-staining). Adapted from (Rowlinson, 2010, 
Rowlinson and Gering, 2010). 
 
We also previously produced gain of function data showing that using 
the Gal4-Uas system to over-express the zebrafish notch1a intra-
cellular domain (nicd) over-activates Notch pathway in the whole 
embryo, leading to ectopic expression of both arterial endothelial and 
HSCs markers in the cardinal vein (see Figures 1.6 and 1.7).  
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Figure 1.6: Diagram showing the heat shock over-activation 
of Notch pathway with the Gal4-Uas system.  
Crossing the tg(hsp:gal4) with the tg(uas:nicd) lead to generation of 
double transgenic embryos, which when heat shocked initiated 
expression of the gal4 gene. The Gal4 protein then interacts with the 
UAS and so activate expression of the nicd in the whole embryo. 
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Figure 1.7: The effects of Notch over-activation on arterial and 
HSCs specification. 
Embryos from crossing tg(hsp:gal4) with the tg(uas:nicd)  transgenic 
fish were heat shocked at 17hpf for 30 min. the results showed 
increased expression of both arterial ECs and HSCs indicated by 
elevated expression of the endothelial marker efnb2a and HSCs 
marker runx1. The figure also shows that with forced activation of 
Notch pathway even veins become positive for these markers. 
Adapted from (Rowlinson and Gering, 2010, Rowlinson, 2010). 
 
1.8 Is the requirement for Notch in definitive HSCs 
formation cell autonomous? 
Establishment of the essential role for Notch signalling in definitive 
haematopoiesis by whole embryo Notch gain/loss of function studies 
opened up a new question, which is whether this requirement was 
cell autonomous or non-cell-autonomous. A first indication that the 
requirement was cell autonomous came from studies on chimeras 
that showed the in-ability of the notch1-/- mouse ES cells to contribute 
to definitive haematopoiesis in chimeric animals, which suggests a 
cell autonomous requirement for Notch in definitive haematopoiesis.   
However, this study does not identify the time point or developmental 
window at which Notch is required.  
Other efforts to study the cell autonomous requirements for Notch in 
HSCs development, like those utilizating endothelial promoters to 
mis-express Notch signalling either directly or with the help of Cre-
loxP recombinase system were also explored in mice, but these 
experiments were hampered by the severe impairment in the foetal 
vascular system and embryonic arrest shortly after E9 (Krebs et al., 
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2004, Venkatesh et al., 2008, Uyttendaele et al., 2001, Kim et al., 
2008), which is well before the time point when HSCs can be reliably 
detected. On the other hand, zebrafish provide an attractive animal 
model to study the cell autonomous requirements for Notch in 
definitive haematopoiesis due to their ability to survive in the absence 
of intact blood circulation by diffusion of oxygen and nutrients from 
water. However, at the time of starting this project, no published data 
were available about the cell autonomous requirements for Notch in 
zebrafish definitive haematopoiesis. This was mainly due to lack of 
several molecular manipulation and lineage tracing tools homologous 
to those available in the mouse, such as the lack of a reliable 
ubiquitous transgene promoter like the rosa26 promoter which leads 
to ubiquitous and efficient expression of downstream genes both in 
embryonic and adult mouse tissues (Mosimann et al., 2011). 
 
1.9 Recently reported non-cell autonomous 
requirements for Notch in definitive haematopoiesis  
Despite the fact that Notch signalling was known to be active in the 
muscular and neural tissues in close association to the developing 
AGM, until recently Notch was assumed to be only required cell 
autonomously in HSCs formation.  This assumption was based mainly 
on the mouse chimera experiments conducted by Hadland et al. 
(2004), which demonstrated failure of notch1-/- cells in contribution 
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to haematopoiesis. Recently, an additional non-cell autonomous 
Notch requirement for Notch in HSC specification was also reported 
(Clements et al., 2011). The reported requirement for Notch involves 
Wnt16/Dlc/Dld in the developing sclerotomal somites. The 
requirement for Notch through this pathway seems to occur earlier 
and in a form distinct from the previously described Hh/Vegf/Notch 
pathway.  
Targeted deletion of wnt16 gene with morpholinos was shown to 
cause severe reduction in the number of Runx1 positive cells without 
affecting Notch ligands and receptors in the DA (Clements et al., 
2011). wnt16 knock down was also shown to have no effect on 
expression of Notch components in the DA (Figure 1.8). The fact that 
blocking this non-cell autonomous signalling only blocks HSCs 
specification without affecting arterial identity, added to the early 
timing of signalling, raises the possibility that this signalling may 
interact with other signalling pathways to initiate HSC formation 
(Figure 1.8). Interestingly, Bmp4 signalling from the mesenchyme 
below the DA was also shown to be required non-cell autonomously, 
to polarize HSC formation in the vDA (Wilkinson et al., 2009). Similar 
to the Wnt16/Dlc/Dld pathway, loss of Bmp4 protein was shown to 
block HSC emergence without affecting the arterial fate.  However, 
initially it was not known whether there is an interaction between the 
non-cell autonomous Notch and Bmp pathways to initiate 
haematopoiesis. 
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Figure 1.8: Diagram showing signalling pathways involved in 
HSC formation. 
The diagram shows the established Hh/Vegf/Notch signalling and the 
non-cell autonomous signalling from the sclerotomal somites 
surrounding the DA, and the Bmp4 signal from the mesenchyme 
below the DA.  
 
Complementary to Clements et al. (2011) work, in an efforts to 
understand how an early Notch signalling in the somites contributes 
to HSCs,  Kim et al. (2014) provided data showing that this early non-
cell autonomous Notch signalling is mediated by the Notch3 receptor, 
to promote HSCs specification. They also showed that early somite-
specific Notch induction is sufficient to rescue runx1 and c-myb 
expression in notch3 morphants. The fact that dlc/dld were expressed 
normally in notch3 morphants, and also the fact that dlc/dld mRNA 
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injection to the notch3 morphants did not rescue runx1 expression, 
were also used to postulate that the somitic Notch3 act downstream 
of the wnt16/dlc/dld (Kim et al., 2014). 
 The other addition to this Notch non-cell autonomous signalling came 
from the study of  Lee et al. (2014), which showed early involvement 
for FGF signalling in HSCs specification downstream of the Wnt16, 
and demonstrated that  the FGF receptor 4 (Fgfr4) mediates a signal 
between Wnt16 and Dlc, but not Dld, to regulate HSC speciﬁcation. 
It also appears from their findings that the somitic Dlc/Dld can also 
interact with Notch receptors expressed on the surface of the HSC 
progenitors, while they are migrating to the midline along the ventral 
face of the somite, in a process facilitated by adhesion of the somitic 
Jam2a, with the HSCs progenitors' Jam1a (Kobayashi et al., 2014).  
This early somitic haemogenic Notch signalling is possibly required to 
prime these progenitor cells in a process that involves activation of 
the recently identified Gata2b (Butko et al., 2015).  
Unlike gata2a, which is expressed throughout the endothelium, 
gata2b expression is restricted to the haemogenic subpopulation of 
the endothelium forming the DA, and this expression initiates in these 
cells as early as 18hpf in a Notch dependent manner (Butko et al., 
2015). In birds, a later somitic contribution to haematopoiesis was 
also described (Pardanaud et al., 1996). In this process, the 
endothelial cells forming the roof of the DA were shown to originate 
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from a somitic mesodermal origin, then they migrate to the DA in a 
process regulated by Notch signalling (Pardanaud et al., 1996). Even 
though these cells do not appear to directly contribute to the HSCs 
population, their Notch activity may be essential in regulating the DA 
floor endothelial to haematopoietic transition. Somitic derived 
endothelium was also shown to restrict endothelial to haematopoietic 
transition to a limited developmental window by replacing the DA 
floor splanchnic endothelium, giving rise to haematopoietic cells 
(Pouget et al., 2006).  
A similar somitic contribution to the DA was also recently proposed in 
zebrafish; as Nguyen et al. (2014) also showed that the zebrafish 
meox1 mutants have an expansion in HSCs markers, and showed 
that this expansion resulted from an increase in somitic cells 
contribution to the DA in these mutants. Even though the authors 
were not be able to establish a link between these migrating cells and 
the somitic Wnt16/Dlc;Dld/Notch3 pathway, it appears from their in 
situ data that these migrating cells were Notch3 active, as indicated 
by the increase in the DA Notch3 activity in these meox1 mutants. 
There is also now evidence in the zebrafish model that early Notch 
signalling in the somites also contributes to the polarization of HSC 
emergence. This is particularly true because appropriate Notch 
signalling is essential for somite formation and patterning, which is a 
prerequisite for somitic FGF signalling. In addition to FGF involvement 
in the Wnt16/Dlc;Dld Notch3 pathway discussed earlier (Lee et al., 
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2014), the Patient lab recently reported a late FGF requirement 
(Pouget et al., 2014). In this newly reported signalling pathway, it 
was revealed that FGF acts upstream of the BMP4 localized in the 
sub-aortic mesenchyme, and was shown to be responsible for 
polarizing HSCs formation to the ventral wall of the DA (Wilkinson et 
al., 2009). 
1.10 Reporting Notch activity in zebrafish 
Notch signalling pathway is among the most widely studied pathways 
in most animal models. This is due to Notch involvement in various 
developmental roles such as neurogenesis, somitogenesis, 
vasculogenisis and haematopoiesis. Consequently, it is essential to 
precisely determine cells and tissues with Notch activity at given time 
point to study its involvement in these tissues development. These 
studies can be achieved with Notch reporter genes that highlight 
tissues with reporter gene activity in the experimental model of 
interest. However, the generation of such reporter lines for Notch 
signalling was hampered by the fact that Notch signalling is mediated 
by several Notch receptors and ligands that have various degrees of 
overlap in their expression pattern and redundant functions (Espin-
Palazon et al., 2014).  
Notch signalling also involves several other intracellular and 
extracellular proteins in the process of pathway activation such as 
Mindbomb, Tace and γ-secretase (Itoh et al., 2003). Notch signalling 
49 | P a g e  
 
is also modulated by other pathways such as Wnt, FGF and Bmp 
(Bigas et al., 2013). Moreover, Notch target genes are also large 
families with complex expression patterns such as the Her gene 
family (Takke and Campos-Ortega, 1999, Takke et al., 1999). As a 
result, it is impossible to simply report Notch activity through utilizing 
the regulatory elements of any of its components or downstream 
targets. However, activation of the Notch pathway only occurs when 
Notch intra cellular domain makes a complex with Csl/Rbpj, that then 
binds specific DNA sequences called csl/rbpj binding sites. This makes 
using reporter lines with this binding sequence an optimal alternative. 
Several Notch reporter lines were generated in mice in recent years 
(Souilhol et al., 2006, Nowotschin et al., 2013). Despite the 
difference in the reporting proteins and the methodologies used to 
generate these lines, all these lines were similar in their utilization of 
the Epstein Barr Virus terminal protein 1 tp1 promoter. This promoter 
due to its containment of two Csl/Rbpj-like binding sites with the 
binding  sequence "GTGGGAAA", which enables expression of the 
reporting proteins in cells with Notch activity. Despite the difference 
in origins of the Epstein-Barr virus and Notch cellular components, 
the similarity in their sequences, both were found to be 
interchangeable (Henkel et al., 1994). For instance the EBV tp1 
promoter natively contains two binding sites for the complex of 
Epstein Barr Virus C-promoter binding factor 1 (CBF1) and the 
Epstein-Barr virus nuclear antigen 2 (EBNA2). As CBF1 and Csl/Rbpj 
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binding sites are identical, these binding sites also act as binding sites 
for Csl/Rbpj (see Figure 1.9).  
 
EBV component  Notch signalling counterpart 
   
Ebna2  Nicd 
   
Cbf1  Csl/Rbpj 
   
EBV tp1 binding sites  csl/rbpj binding sites 
 
Figure 1.9 EBV components and their cellular counterparts 
The first row shows the Epstein-Barr virus nuclear antigen 2 (EBNA2) 
that shares great similarity and interchangeability with Notch 
Intracellular Domain (Nicd). The second row shows the Epstein Barr 
Virus C-promoter binding factor 1 (CBF1) that was shown to be 
identical to the cellular Csl/Rbpj. The third row shows the Epstein-
Barr virus EBV TP1 binding sites that were also shown to serve as 
binding sites for the cellular Csl/Rbpj (Henkel et al., 1994, Hsieh et 
al., 1996).  
 
Henkel et al. (1994) showed that Epstein Barr Virus CBF1 is identical 
to Rbpj, and due to the great similarity between EBNA2 and Notch 
intra cellular domain (Nicd), both have the ability to bind Rbpj to 
activate Notch target genes (Hsieh et al., 1996).     
Utilizing Csl protein binding ability to tp1 promoter, Kato et al. (1997) 
generated a Notch reporter cell line using six repeats of the EVB tp1 
promoter sequence and a minimal promoter upstream of fluorescent 
protein gene (luciferase), and showed that that they reliably report 
Notch activity. 
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1.10.1 Notch reporter transgenic lines as tools to 
monitor and lineage trace cells with Notch activity  
Several mammalian Notch reporter lines were established ex vivo and 
in vivo in the last few years (Gupta-Rossi et al., 2001, Joutel et al., 
2004, Kohyama et al., 2005, Souilhol et al., 2006). All generated lines 
utilized repeats of the well characterized tp1 promoter, to drive the 
reporter genes expression in Notch-active tissues. Due to the un-
availability of similar lines in zebrafish at the time of starting this 
work, the decision was taken in our lab to establish in-house zebrafish 
Notch reporter lines utilizing the same promoter. To achieve this, the 
former technicians in our lab. (A. Haase and K. McMahon) used the 
tp1-luc construct PGa981-6 (Kato et al., 1997) to get the csl/rbpj like 
cassette and the minimal βglobin promoter. They then cloned this 
cassette and promoter sequence (we will refer to this fragment as csl 
for short) upstream of the venus gene. The csl:cerulean and 
csl:mCherry constructs were also generated by former PhD students 
in the lab (R. Thambyrajah and S. Modhara) by replacing the venus 
gene with either cerulean or mCherry within tol2 backbone plasmids 
(Appendix 1). These plasmids were then co-injected with transposase 
mRNA to zebrafish embryos at one cell stage, as previously published 
(Kawakami et al., 2004), and embryos with mosaic fluorescent 
expression were grown to adulthood. Progenies of these fish were 
then screened for inheritance of the fluorescent protein, and positive 
embryos with decent expression were grown to establish stable Notch 
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reporter lines. This has led to establishment of three stable transgenic 
lines for reporting Notch activity, each with different fluorescent 
protein, the Tg(csl:venus)qmc61, Tg(csl:cerulean)qmc63 and the 
Tg(csl:mCherry)qmc97.  
 
1.11 flk1 promoter drives endothelial specific gene 
expression during early zebrafish development 
Tissue-specific promoters are powerful tools, commonly used for 
tissue specific genetic manipulation in mice and zebrafish animal 
models. To enable studying the cell autonomous requirements for 
Notch in definitive haematopoiesis we decided to use the flk1 
promoter to specifically manipulate the Notch pathway in the 
endothelial cells, which includes the endothelial cells from which HSCs 
first emerge in the vDA. The following is an introduction about the 
expression pattern of the endogenous flk1 gene and identification and 
utilization of its promoter to label, lineage trace and also to 
specifically genetically manipulate  flk1 active tissues. 
The mammalian receptor tyrosine kinase Flk1 (also known as 
Kdr,Nyk, Vegfr2) is a receptor for the vascular endothelial growth 
factor receptor 2 Vegfr2. flk1 is first expressed in the early lateral 
mesoderm on the surface of cells committed to form both the vascular 
and haematopoietic systems, then during later stages of embryonic 
development. flk1 expression then persists in the endothelial cells, 
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while is lost in most cells committed to the haematopoietic lineage 
(Yamaguchi et al., 1993). Genetic studies showed that Flk1 plays an 
essential role in the establishment of the  vascular and 
haematopoietic systems, and its deletion in the flk1-/- mutant mice 
leads to failure in vascular and haematopoietic development and  
mice death by E 9.5,  (Shalaby et al., 1995). Moreover, flk1-/- ESCs 
were shown to be in-capable of contribution to   the chimeric mouse 
endothelial or haematopoietic system (Shalaby et al., 1995).  
The early expression and specificity of flk1 makes it an ideal marker 
for the vascular and blood progenitors and endothelium through 
detection of its mRNA (Yamaguchi et al., 1993) as well as protein with 
antibodies that specifically bind and label these populations of cells 
(Kataoka et al., 1997). flk1 promoter was also used to follow 
expression of reporter genes in live embryos through lacz or gfp 
knock-in down-stream of the flk1 promoter (Shalaby et al., 1995, 
Ishitobi et al., 2010). flk1 promoter was also used to specifically mis-
express other genes, specifically in the flk1 active cells and their 
progenies, such as expression of activated Notch directly under the 
flk1 promoter by Uyttendaele et al. (2001). flk1 promoter was also 
integrated with the recombinase system to enable conditional 
knockout, and also  for  genetic switching (Motoike et al., 2003).  This 
system was shown to be useful in the mouse model to drive 
expression of recombinase genes such as the cre recombinase, with 
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presence of floxed genes to enable conditional knockout of target 
genes, specifically in flk1 active cells. 
Soon after identification of the mouse flk1 gene, three independent 
groups simultaneously identified a DNA sequence with close 
homology in zebrafish (Fouquet et al., 1997, Sumoy et al., 1997, Liao 
et al., 1997). The identified zebrafish gene was found to share an 
overall of 60% cDNA sequence identity with the mouse flk1. The 
identified gene was initially named flk1/kdr by the zebrafish 
community. However and due to identification of a duplicate gene 
(discussed in flk1 knockout) with high similarity in structure and 
function to the initially identified flk1 gene (Bahary et al., 2007), the 
flk1 name was changed initially to kdra and then to kdrl (Bussmann 
et al., 2008). This thesis still uses the term flk1 to refer to the firstly 
identified zebrafish flk1 on chromosome 4 due to the wide use of this 
term in the literature and the great similarity in its expression pattern 
to the mouse flk1 gene. 
Although the zebrafish flk1 is expressed in the axial and ISV during 
early development, its knockdown was shown to be milder than that 
seen in mouse and it does not affect vasculogenesis or 
haematopoiesis (Habeck et al., 2002). Other cytoplasmic or kinase 
domain mutations  identified in the same gene were shown to cause 
vascular development defects (Covassin et al., 2006) but still milder 
than that seen with the deletion of the Vegf   signalling mediator plcg1 
55 | P a g e  
 
(Lawson et al., 2003) or treatment with the Vegf receptors inhibitor 
(SU5416), suggesting a compensation from other genes. 
 To resolve this issue, Covassin et al. (2006) searched the zebrafish 
genome for a gene with homology to the previously identified flk1 
gene, and found an orthologues gene (kdrb/kdr) on chromosome 20 
that has a marked overlap with the previously identified flk1.  Over-
expression of the newly identified gene was found to partially rescue 
flk1, and the combined knockdown of the two genes with 
morpholinos, leading to more severe vascular defects, including 
partial loss of the main axial vessels and complete loss of ISV, but 
with apparently un-affected haematopoiesis (Bahary et al., 2007). 
Because newly identified flk1 homologue (kdrb/kdr) was found to 
exhibit a pan mesodermal expression pattern (Bussmann et al., 
2008), which makes it un-suitable for endothelial specific gene mis-
expression or lineage tracing, in this thesis I am only focusing on the 
firstly identified flk1 gene and its promoter. 
In situ hybridization was performed by the three labs in which 
zebrafish flk1 gene was first identified to analyse its expression 
pattern (Fouquet et al., 1997, Sumoy et al., 1997, Liao et al., 1997). 
All three studies showed that flk1 specifically marks cells that follow 
the distribution and migration of the endothelial cells, as previously 
described by Al-Adhami and Kunz (1977). flk1 expression was 
detectable in zebrafish embryos between 5-7 somites (about 12hpf) 
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in the form of two bilateral lines located in the lateral mesoderm both 
in the trunk and the head regions. These cells then migrate medially 
to form the main trunk and head vasculature, including the 
haemogenic endothelium in the vDA that initiates the haematopoietic 
system (Figure 1.10, A-C). At 15 somites two waves of migrating flk1 
expressing cells become evident, the medial flk1 high expressing cells 
that mainly form the DA angioblasts followed by the flk1 low 
expressing cells that mainly form the CV angioblasts (Sumoy et al., 
1997, Kohli et al., 2013). At the 24 somites stage (20hpf) all 
migrating cells reach the midline to form the DA and the CV. Some 
flk1 positive cells are now also visible between the somites and they 
are the early ISV forming endothelium. At 24hpf flk1 mRNA become 
visible in all vascular tissues, with arterial preferability of flk1, unlike 
what is observed with the other tyrosine kinase receptor flt4 that 
becomes restricted to the veins (Thompson et al., 1998, Fouquet et 
al., 1997). The developing vascular tissues continue to express flk1 
until at least 36hpf, then Flk1 activity is greatly reduced and becomes 
hardly detectable. Apart from blood and endothelial progenitors and 
endothelial expression of flk1, both Liao et al. (1997) and Sumoy et 
al. (1997) also reported flk1 expression in the hindbrain and the 
endocardium (Figure 1.10 A), however flk1 expression in these non-
endothelial tissues only exists for a short period of time then becomes 
undetectable. 
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Figure 1.10: flk1 expression pattern during zebrafish early 
development. 
Whole mount in situ hybridization of flk1 expression at the six somite 
(A), 15 somite (B-C), 22 somite (D), 21 hpf (E), 24hpf (F), 48hpf (G), 
4 days (H). (A) flk1 is expressed in two lateral lines along the 
intermediate cell mass (icm) and other bilateral lines of endothelial 
precursor cells anteriorly (arrowhead). A weak expression of flk1 is 
also seen in the lower part of the central nervous system (CNS). (B-
C) flk1 expression expand both anteriorly and posteriorly. (C) Two 
waves of migrating cells become distinguishable (1º and 2º waves 
cells). (D) At 22 somites, all migrating cells in the trunk and tail arrive 
to the midline and the head and trunk positive cells connect at the 
level of the root of the aorta (ra); flk1 positive cells also become 
detectable at the position of the ducts of Cuvier (dc). (D-H) Lateral 
view with (D) showing 21 hpf old embryo; at this stage the developing 
axial vessels, DA and CV become distinguishable with a higher level 
of expression in the DA (a) compared to that of the CV (v). (F) At 
24hpf flk1 expression is visible in all head and trunk vasculature, 
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including the DA, CV and ISV. (G) At 48hpf flk1 expression  is down-
regulated after the vasculature is established and by 4 days it is 
barely detectable by in situ hybridization (H). Sources: (images A-D 
adapted from (Sumoy et al., 1997), image E adapted from (Fouquet 
et al., 1997), images F-G adapted from (Bertrand et al., 2010a), 
image H adapted from (Bahary et al., 2007). 
 
 
Until recently, it was not easily possible to knock reporter genes into 
endogenous genes, which created the need to identify the flk1 
promoter and utilizes it in generating endothelial specific fluorescent 
reporter or recombinase lines. To achieve this, Cross et al. (2003) 
used a 6.5kb genome fragment 5' to the zebrafish flk1 gene start 
codon to drive the green-red coral ﬂuorescent protein (G-RCFP) 
expression specifically in zebrafish blood vessels. With this approach 
they acquired an expression pattern almost identical to that of the 
endogenous flk1 gene. Following the findings of Cross et al. (2003), 
similar transgenic lines were independently generated in several labs 
with the same fragment. All labs reported expression pattern 
recapitulating endogenous flk1 expression (see Appendix 2) (Beis et 
al., 2005, Jin et al., 2005, Choi et al., 2007, Bertrand et al., 2010a). 
To enable lineage tracing of ECs, Bertrand et al. (2010a) have also 
generated a transgenic line with the same promoter driving 
expression of cre recombinase gene Tg(kdrl:cre)s898 and showed a 
tight restriction of cre gene expression to the endothelium (appendix 
3). With this approach, they were able to permanently label the ECs 
and show that the ECs can give rise to HSCs that seeded the adult 
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kidney. However, it was also found by the same group that the used 
flk1 promoter also labels the primitive blood cells (Bertrand et al., 
2009). 
To further characterise the original 6.5 kb flk1 promoter fragment, 
Choi et al. (2007) generated a series of deletion variants of the 6.5kb 
fragment. These were cloned upstream of a gfp reporter gene and 
injected in zebrafish embryos. Analysis of transient gfp expression in 
the injected F0 embryos  showed that a 0.8kb (−4.3,−3.5) enhancer 
and a 1.5kb minimal promoter  (−1.5) were sufficient to drive gfp 
expression specifically in the endothelium of injected embryos (see 
Appendix 4).  
Based on Choi et al. (2007) findings, we cloned the (−4.3,−3.5) 
enhancer and 1.5kb minimal promoter  (−1.5) upstream of gfp into 
a tol2 plasmid backbone, then co-injected the construct with 
transposase mRNA into WT embryos at one cell stage, as previously 
described (Kawakami et al., 2004). The injected embryos were raised 
to adulthood, and then screened for potential founders. This led to 
identification of founders whose progeny express gfp in a spatial and 
temporal expression pattern indistinguishable from the previously 
published line with the full 6.5kb flk1 promoter fragment (Jin et al., 
2005), (see Appendix 5) . Identified embryos were grown to establish 
our in-house generated line  Tg(flk1:gfp)qmc67. 
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Figure 1.11: Minimal and flk1 promoter drive cre expression 
in the endothelium. 
Whole mount in situ hybridization for cre mRNA. (A) cre mRNA was 
undetectable at 8 somite stage. (B) at 18s cre mRNA become 
detectable in the endothelial progenitors in the ALM (black 
arrowheads) and the PLM (black arrows). (C-D) at 24hpf, cre mRNA 
is expressed in the developing DA (black arrow), and also in the 
posterior end of the ICM (blue arrowhead). cre mRNA is also present 
in the posterior blood island (PBI; black arrowhead) and the 
endocardium (red arrowhead). (E) cre mRNA persists in the dorsal 
aorta (black arrow), CHT (black arrowhead) and the branchial arteries 
(red arrow) (adapted from Drew, 2010). 
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To enable endothelial specific mis-expression of other genes, we then 
modified the flk1:gfp construct used to generate the Tg(flk1:gfp)qmc67 
line by replacing the gfp gene with the cre gene. The generated 
construct was then co-injected with transposase mRNA into WT 
embryos at one cell stage as previously described by Kawakami et al. 
(2004). The injected embryos were then raised to adulthood, and 
screened for potential founders by PCR with the primers DB143 and 
DB144, which recognise and amplify a 592 bp fragment of an area 
made of part of the flk1 promoter and part of the cre gene. This has 
led to the identification of founders whose progeny have the cre gene 
integrated into their genome, and establishment of the flk1:cre 
transgenic line Tg(flk1:cre)qmc101. To analyse the expression pattern 
of the cre gene in this line, in situ hybridization analysis was 
performed by the former student in our lab (Drew, 2010), and the 
results showed an endothelial specific expression of the cre gene (as 
shown in Figure 1.11). 
As in situ analysis confirmed presence of the cre mRNA in the 
endothelial tissues, we wanted to know if this mRNA leads to 
production of an active Cre protein, that is able to induce endothelial 
specific Cre recombination. To achieve this, we utilized the Cre 
reporter line Tg(ef1α:loxP-gfp-loxP-dsRed2), which was a kind gift 
from Dr. Bally-Cuif’s lab (Sinha et al., 2010). In the Cre reporter 
transgenic line, dsRed gene was cloned downstream a floxed gfp-pA 
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cassette under the ef1α promoter (Figure 1.12 B). This leads to 
ubiquitous expression of the floxed gfp gene, however in the presence 
of the Cre protein, the  loxP  sites  get recombined and the gfp-pA 
cassette get deleted. This then makes the dsRed gene fall directly 
downstream of the ef1α promoter in the tissues were cre gene is 
expressed (Figure 1.12 A-C).  
With this genetic reporting tool, we were able to label all cells that 
were flk1 active or derived from flk1 active progenitor, through 
detection of the DsRed protein with fluorescent microscopy by 
crossing the flk1:cre transgenic,  Tg(flk1:Cre)qmc101 to the Cre 
reporter line Tg(ef1α:loxP-gfp-loxP-dsRed2). This led to endothelial 
specific cre induced recombination and expression of dsRed, that was 
detectable starting from day 4. At this time point dsRed gene was 
expressed in the vascular endothelium as well as cells that are located 
in the CHT in the area where the HSCs are located (Figure 1.12 D), 
whereas un-recombined tissues were negative for dsRed, and still 
expressing gfp under the control of the ef1α promoter (Figure 1.12 
E). Unlike in situ results that showed the presence of flk1 mRNA  
starting from 18 somite stage, DsRed fluorescent protein was only 
detectable on day 4. This might be resulting from the slow maturation 
of the DsRed protein or the low level of produced DsRed due to down 
regulation of ef1α promoter activity, as previously reported (Hans et 
al., 2009).    
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Figure 1.12: Cre-mediated endothelial specific deletion of the 
floxed gfp and expression of dsRed in recombined cells. 
(A) Schematic diagram showing the flk1 activator line with the 
minimal flk1 promoter, Tg(flk1:cre)qmc101 that drives cre expression 
specifically in the endothelium. (B) Crossing the Cre reporter line 
Tg(ef1α:loxP-gfp-loxP-dsRed2) to the activator line enables reporting 
the cre active tissues through Cre induced removal of the floxed gfp 
and allow expression of the dsRed gene under the ef1α promoter. (D) 
Fluorescent microscopy showing an example of progenies resulting 
from crossing the flk1 activator line Tg(flk1:cre)qmc101 to the Cre 
reporter line Tg(ef1α:loxP-gfp-loxP-dsRed2), imaged on day 5 with 
(D) showing DsRed fluorescent protein expression restricted to the 
vascular endothelial tissues (blue arrows) and the caudal 
haematopoietic tissues CHT (yellow arrow). DsRed is also seen in the 
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thymus (yellow arrowhead) and also in the heart (blue arrow head). 
(E) Fluorescent microscopy showing the ubiquitis expression of gfp 
under the control of the ef1α promoter.      
 
 
 
 
To  study the effects of over-activation and blocking Notch pathway 
in ECs,   two constructs similar in their structure to the Cre reporter 
construct ef1α:loxP-gfp-loxP-dsRed2 were generated in our lab by a 
former student (Stone, 2010). The generated constructs have either 
the nicd or the dnRbpj gene downstream of a floxed cerulean gene 
that is falling downstream of the ef1α promoter (see Figure 1.13). 
Just before I started this project, the generated constructs were 
validated by sequencing then injected by Dr. Martin Gering to 
establish the transgenic lines, and as a preliminary step I started this 
project by characterizing these injected fish to identify transgenic 
founders that have the injected constructs in their germline.  
 
 
65 | P a g e  
 
 
Figure 1.13: Notch endothelial mis-expression constructs. 
Diagram showing constructs generated and injected to establish 
transgenic lines to enable mix-expressing Notch signalling specifically 
in the endothelium when present with the flk1:cre construct of the 
transgenic line Tg(flk1:cre)qmc101.  
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1.12 Tet proteins and oxidative demethylation of 
5mC in vertebrate development 
DNA methylation is a mechanism by which a methyl group is added 
to the cytosine base at its fifth carbon in a process mainly catalysed 
by the DNA methyl transferase enzymes (DNMTs) (Pastor et al., 
2013).  DNA methylation in vertebrates usually occurs in CG 
dinucleotide repeats upstream of genes CpG islands. Methylated 
promoter regions are largely associated with the suppression of 
downstream gene expression as transcription factors poorly bind to 
methylated promoters (Deaton and Bird, 2011). The methyl group 
can be removed passively (passives 5hmC) during cell division, or 
actively by the DNA oxidative ten eleven translocation (Tet) enzymes 
(see Figure 1.14), which  further modifies the 5hmC to 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC), which can 
subsequently be removed by base excision repair mechanism 
(Kriaucionis and Heintz, 2009, Tahiliani et al., 2009) .  The dynamics 
between methylation and de-methylation states comprise one of the 
main regulators of pluripotency and differentiation during 
development (Paranjpe and Veenstra, 2015). 
In consistent with this, experiments involving deletion of the  three 
tet genes in mouse ESC was found to hinder the correct differentiation 
of the embryonic stem cells (Dawlaty et al., 2014). In contrast, mESC 
with individual loss of tet1 were undistinguishable from their control 
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despite the slight reduction in 5hmC level and the increase in 5mC 
level (Koh et al., 2011). Interestingly, it was recently reported that 
individual tet1 or tet2   knockout mice are viable fertile and grossly 
normal (Li et al., 2011). Likewise,  tet3  knockout mice were viable 
through development and only dying on day 1 postnatal (Gu et al., 
2011). All three tet genes were shown to be expressed in the 
developing murine brain  and 5hmC was shown to be 10 times higher 
in mouse brain than in the ESC (Wu and Zhang, 2011). Moreover, 
deletion of tet1 gene in mouse mutants was shown to result in several 
neurological abnormalities and brain developmental complications 
that were associated with reduction in 5hmC levels (Zhang et al., 
2013, Rudenko et al., 2013). 
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Figure 1.14: Tet enzymes mediate active DNA demethylation 
that affect promoters accessibility to transcription factors. 
Diagram showing the chemical structures of cytosine bases at their 
methylated and demethylated states, the role of Tet enzymes in 
active cytosine demethylation and how could this process affect 
promoter accessibility to transcription factors and gene expression. 
 
 
On the other hand, tet2  was shown to be required for differentiation 
of haematopoietic stem  cells and its deletion leads  to  increased  
self-renewal  and was also linked to number of malignant  
transformations (Wu and Zhang, 2011). Further studies involving 
combined deletion of tet1 and tet2 also showed little alteration in 
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mouse development, while organogenesis  appeared un affected,  
thereby suggesting    a functional  overlap  with tet3 (Dawlaty et al., 
2013). Thus, the extent  to which the the  vertebrate  developmental 
program  depends  on  their  activities is currently unclear, including  
their  ability  to  oxidize  5mC.  
Unlike mammalian blastocysts and ESCs that are highly enriched for 
5-hmC, our lab in a collaboration with the Ruzov lab showed that 
chick and zebrafish embryos only gain the 5hmC mark during early 
organogenesis (Almeida et al., 2012). We also confirmed that the tet 
genes, known to play a rule in this epigenetic modification, only 
become detectable in zebrafish embryos at early somitogenesis and 
peak at the onset of organogenesis (Almeida et al., 2012, Collas, 
1998, Rai et al., 2008). 
Co-occurrence of Tet  enzymes and up-regulation of the 5-hmC mark 
at the onset of organogenesis strongly suggests that tet genes 
mediated epigenetic modifications are essential in regulating cellular 
pluripotency and differentiation. Moreover, loss of function studies 
that involved deletion of the enzymes essential for maintaining the 
methylation mark, such as Dnmt1 or Dnmt3, were shown to result in 
severe defective organogenesis. These defects include abnormal 
development of the brain, eye and the intestine (Rai et al., 2006, 
Anderson et al., 2009, Tittle et al., 2011, Rai et al., 2010, Seritrakul 
and Gross, 2014). While these findings highlighted the fact that 
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maintaining cellular pluripotency before gastrulation is not a universal 
mechanism across vertebrates, these studies also showed that 
utilizing this feature in zebrafish animal model can provide valuable 
information about the role of Tet enzymes in mammalian ESCs. 
Following this, to functionally test whether the Tet dependent DNA 
demethylation is required during embryonic organogenesis, a former 
student in our lab (Sabrina Boudon) performed a pilot study, in which 
she blocked expression of the tet genes during early development 
with anti-sense morpholinos. The morpholinos used in this 
experiment were designed to target the catalytic C-terminal of the 
dioxygenase domain in the three tet genes, leading to frame-shifts 
and premature termination of their translation. Consistent with this, 
she observed severe defects in organogenesis and developmental 
arrest after somitogenesis initiation in tet1 and tet3 morphants, 
whereas tet2 morphants developed normally and were 
indistinguishable from their controls even when examined on day 3. 
Next, we wanted to expand this pilot study, and also to utilize our in-
house Notch reporter transgenic lines together with other molecular 
tools to gain more insight on the mechanism by which Tet enzymes 
achieve this role.     
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1.13 Project aims 
- Although Notch signalling pathway was demonstrated to be essential 
in HSC development from hEC progenitors in the floor of DA, it was not 
clear when Notch signalling initiates in these progenitor cells and how it 
differently affects both arterial specification and HSC development. In 
this project, I am utilizing in-house generated Notch reporter lines with 
other zebrafish molecular tools to identify when Notch signalling initiates 
in these hECs and how it can differently affect these two fates.  
- Notch signalling was proposed to act cell autonomously in HSC in mice, 
but no data were available to address this question in zebrafish due to 
the lack of molecular tools. Recently, it was reported in zebrafish that 
non-cell autonomous Notch signalling is also required  for HSC 
development. One of this project's aims is to optimise currently available 
zebrafish molecular tools to enable mis-expressing Notch signalling 
pathway, specifically in the endothelium, to study the cell autonomous 
requirements for Notch in HSC formation, and if cell autonomous Notch 
induction is sufficient to expand HSC population. 
- In parallel to the Notch experiments a former student in the lab 
(Sabrina Boudon)  identified in her preliminary data an essential rule for 
tet1 and tet3 in zebrafish organogenesis. I then took over to firstly 
confirm these preliminary data and then to utilize our Notch reporter 
lines to investigate tet1 deletion effects on neurogenesis. 
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CHAPTER 2 
2 Materials and Methods  
2.1. Zebrafish maintenance  
Embryos and adult zebrafish (Danio rerio) were raised, bred and 
maintained under standard conditions at 28.5°C (Westerfield and 
Zfin, 2000) on a 14h light/10h dark cycle. The fish were fed twice a 
day with dry food and brine shrimp. Approximate embryo stages were 
determined under the dissecting microscope, as described by Kimmel 
et al. (1995). Experiments on zebrafish were performed under UK 
Home Office Licence 40/3457.  
Both live and fixed embryos to be imaged at time points later than 
24hpf were treated with 1-phenyl-2-thiourea (PTU) to prevent 
pigmentation by addition of 1.5ml of the 0.3% PTU solution into each 
petri dish. To facilitate imaging of live embryos, all  embryos to be 
imaged were  pre-anesthetized  by adding  about 500-750µl of  4g/l  
pH  7-7.5  tricaine  methanesulfonate (MS222)  into  each  petri  plate. 
 
2.2 General manipulation of zebrafish 
2.2.1 Microinjection 
Microinjection remains the simplest and most effective method to 
alter gene expression and manipulate genetic contents in the 
zebrafish animal model. This method enables researchers  to 
introduce RNA, DNA, proteins, antisense oligonucleotides and other 
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small molecules into fertilized embryo. Using this technique, an 
injection needle is filled with solution containing the injected 
molecules.  
 
2.2.2 Microinjection needle preparation 
The  microinjection  needles  were  made  by pulling  the glass 
capillaries  with  internal  filaments  into micropipettes. This is done 
using the micropipette puller (Sutter Instrument, Novato, CA) with 
the following parameters: heat (305), pull (200) time (115) and 
velocity (115). Needle tips were broken (just before use) with clean 
forceps to enable delivery of injected solution.  
 
2.2.3 Microinjection 
In general, unless specified, injections were done at one cell stage 
embryo. To perform injection, the collected healthy looking embryos, 
were lined up against a microscope slide in a petri dish lid, then kept 
moist with E3 buffer. Embryos were orientated so that their animal 
poles faced the injecting needle. The needle is then backfilled with 2-
3μl of the injection solution using a microloader pipette tip 
(Eppendorf, Hamburg, Germany). All injections were done on  the  
stage  of  a stereomicroscope equipped with the microinjector 
(picospritzer® III, Parker, Ohaio, USA). Injected  volumes ranged 
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from 0.2-1.0 nl of the solution per embryo. Injection of these volumes 
did not interfere with embryonic development. 
 
2.2.3.1 Co-injection of tol2 vectors and transposase 
mRNA for transient and stable transgenesis 
For all transient and stable transgene injection experiments in this 
project, the constructs of interest were firstly inserted into tol2 
backbone plasmids, then co-injected these tol2 plasmids with an in 
vitro synthesized transposase mRNA into WT embryos as described 
below: 
The injection solution mix was prepared by adding 1 μg of the tol2 
plasmid + 1μg of transposase mRNA, then the volume was completed  
to 10ul with H2O, to make a final concentration of  100pg/nl for each. 
About 2-3 μl of the mix was then loaded into the microinjection needle 
and the rest was put on ice. I then injected 0.3-0.5nl of the solution 
into each embryo, making the injected amount about 25-50pg of the 
tol2 plasmid + 25-50pg of the transposase mRNA. Injected embryos 
were raised at 28.5 ºC. In all constructs used in this project for 
transient and stable transgenesis, fluorescent reporter genes such as 
gfp or mCherry were included in the tol2 plasmids either flanked by 
loxP sites or fused to the gene of interest.  As a result, injection 
efficiency was evaluated based on the expression level and reporter 
protein distribution in the tissues of the injected embryo.  For stable 
transgenesis, embryos with mosaic expression  of the reporter 
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fluorescent proteins  were  raised to  adulthood. These F0 fish were 
screened to find those that transmitted the transgene through the 
germline. For this purpose, the fish were outcrossed to WT and at 
least 100 embryos of their offspring were examined under the 
fluorescent microscope for inheritance of the injected transgene. 
Identified embryos that appeared healthy and expressed the reporter 
gene in expected tissues and at decent level were then given a qmc 
line number and raised  to establish transgenic lines. 
 
2.2.3.2 Co-injection of attB donor vector and PhiC31 
integrase mRNA for site specific transgenesis 
For all PhiC31 mediated site-specific integration experiments, vectors 
were generated with either the minimal or the full attachment sites 
(attB) inserted upstream of genes of interest. PhiC31 integrase mRNA 
was also generated by  in vitro transcription, then the two 
components were co-injected into the in-house line 
Tg(gfi1.1:gfp)qmc551, which carries a single minimal attP landing site 
downstream of the endogenous gfi1.1 promoter. Injection amounts, 
ratios and procedures were identical to those used in Transposase 
mediated transgenesis (see above).  In general a solution with 
100pg/nl of attB vector and also PhiC31 integrase mRNA was 
prepared, then 0.3-0.5nl of the solution was injected into 
Tg(gfi1.1:gfp)qmc551 transgenic embryos at one cell stage, then raised 
at at 28.5 ºC. As none of the injected vectors carried a promoter, 
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expression of reporter genes in the injected vectors was dependent 
on successful integration behind the gfi1.1 promoter. As the gfi1.1 
promoter is active in pRBCs and the ECs in the ventral wall of DA, 
successful recombination should lead to reporter gene expression in 
these cell types. To screen for site specific integration injected 
embryos were screened for reporter gene expression in primitive 
blood cells and the vDA. PCR screening was also done using primers 
that amplify the sequence around the integration site to determine 
efficiency of integration.  
 
Table 2.1: sequences of the minimal and full length attB and 
attP attachment sites.   
Minimal attB 34bp 
 
gtgccagggcgtgcccttgggctccccgggcgcg 
 
Native full length attB 
285bp 
gtcgacgatgtaggtcacggtctcgaagccgcggtgcgggtgcc
agggcgtgcccttgggctccccgggcgcgtactccacctcacccat
ctggtccatcatgatgaacgggtcgaggtggcggtagttgatccc
ggcgaacgcgcggcgcaccgggaagccctcgccctcgaaaccg
ctgggcgcggtggtcacggtgagcacgggacgtgcgacggcgtc
ggcgggtgcggatacgcggggcagcgtcagcgggttctcgacg
gtcacggcgggcatgtcgac 
Minimal attP 39bp (Groth 
2000) 48bp 
 
gccccaactggggtaacctttgagttctctcagttggggg 
 
Minimal attP actually in 
Tg(gfi1.1:gfp)qmc551 
 
 
gtagtgccccaactggggtaacctttgagttctctcagttgggggc
gta 
Native full length attP 
221bp 
 (not used in this project) 
Gtactgacggacacaccgaagccccggcggcaaccctcagcgg
atgccccggggcttcacgttttcccaggtcagaagcggttttcggg
agtagtgccccaactggggtaacctttgagttctctcagttggggg
cgtagggccgccgacatgacacaaggggttgtgaccggggtgg
acacgtacgcgggtgcttacgaccgtcagtcgcgcgagcgcga 
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2.2.3.3 Co-injection of CRISPRs donor plasmid and 
DNA-Cas9 & guide mRNA for site specific 
transgenesis 
A solution made of donor plasmid, sgRNA and Cas9-encoding mRNA 
was prepared with varying concentrations of each components, 
initially starting with concentrations of 300ng/μl of Cas9 mRNA, 
30ng/μl of gRNA and 100ng/μl of donor plasmid or 30ng/μl of donor 
fragment. The prepared solution was then injected into 
Tg(gfi1.1:gfp)qmc551 embryos at one-cell stage.  As injected donor 
plasmids or fragments did not carry a promoter, expression of 
reporter genes in the injected vectors was dependent on successful 
integration behind the gfi1.1 promoter. To screen for successful 
integration, Injected embryos were examined for reporter gene 
expression in primitive blood cells and the vDA. PCR screening was 
also done with primers amplifying around the integration site to 
determine efficiency of this technique.  
 
2.2.3.4 cre mRNA in vitro synthesis and 
microinjection for whole embryo cre mediated 
recombination 
Using  SfiI,  the pBUT4-cre plasmid (P161) was linearized as  a 
template and the mRNA  of  the linearized construct was synthesised 
in vitro using the mMESSAGE t3 kit (Ambion), according to the  
78 | P a g e  
 
manufacturer’s  instructions.  The  quality  and  quantity  of  
synthesized  mRNA  were analysed using NanoDrop and 
electrophoresis.  For cre recombination experiments, 200 pg of the 
cre mRNA were injected into transgenic embryos with loxP  flanked  
sequences at one-cell stage. As all loxP  flanked  sequences in 
injected transgenic embryos encoded fluorescent reporter proteins, 
injection efficiency was determined by reduction of the excised gene's 
protein, and phenotypes associated with activation of downstream 
target.   
Table 2.2: mRNAs produced and their linearization and 
transcription polymerases. 
gene vector linearizing enzyme RNA polymerase 
cre p161 SfiI T3 
transposase p97 Not1 SP6 
PhiC31 integrase p382 SbfI T3 
cas9 p371 PmeI T7 
gfp guide RNA p373 draI T7 
 
2.2.3.5 Morpholino injections 
Antisense morpholino oligonucleotides were synthesized by  Gene 
Tools, (LLC,  Corvallis,  Oregon), Upon delivery, stocks were dissolved 
then subsequently diluted in sterile H20.  
The rbpja/b morpholino was originally published by Sieger et al. 
(2003), whereas tet genes' morpholinos were designed de novo. The 
working doses were determined as previously described (Nasevicius 
and Ekker, 2000).  
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2.2.4 Treatment with the γ-secretase Inhibitor XVI 
(DAPM) 
The γ-secretase Inhibitor XVI DAPM (5mg of 10 mM powder) was 
ordered from Calbiochem (Cat. No. 565777, San Diego, CA, USA). 
Stocks were dissolved in 1024μl DMSO at a concentration of 12.5 mM 
and stored in 100μl aliquots at -20ºC. Embryos were treated with  
100 μM of γ-secretase Inhibitor  XVI  starting from late epiboly stage 
(9hpf) until 26 hpf in batches of 25 embryos in 5ml E3 buffer to which 
41μl of the 12.5mM γ-secretase stock solution was added. For 
negative control, siblings embryos were treated similarly but with 
41μl DMSO instead of γ-secretase. Embryos were then either used for 
total RNA extraction or fixed in 4% PFA for in situ hybridization. 
 
 2.2.5 Heat shock experiments with the quadruple 
transgenic embryos Tg(hsp:loxp-mCherry-loxp-gal4-
vp16/flk1:cre/uas:nicd/csl:venus) 
To generate the quadruple transgenic embryos Tg(hsp:loxp-
mCherry-loxp-gal4-vp16/flk1:cre/uas:nicd/csl:venus), a triple 
transgenic Tg (flk1:cre/uas:nicd/csl:venus) fish was crossed to 
Tg(hsp:loxp-mCherry-loxp-tgal4-vp16)qmc138 fish, then the embryos 
were collected at one cell stage. The embryos were then raised at 
28.5ºC until 17hpf (16-18 somite stage), then transferred into 50 ml 
falcon tubes in batches of 30-50 embryos, then the E3 buffer volumes 
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in these tubes were made up to 5ml. To perform the heat shock, the 
tubes were incubated in a waterbath set to 38ºC for 20 minutes, then 
the embryos were transferred back to petri dishes with E3 buffer at 
room temperature. The embryos were then raised at 28.5 ºC until 
they were required for examination or fixation.  For late heat shock 
experiments, the embryos were raised until 40hpf then heat shocked 
for 20 minutes at 38ºC following the same procedures as with 17hpf 
heat shock. 
 
2.3 General DNA and RNA work   
 2.3.1 DNA Phenol-Chloroform Extraction  
 DNA extraction from single or pooled embryos was done to separate 
DNA from proteins, salts and other impurities. In this procedure, the 
DNA and due to the negative charge on its phosphate backbone, 
dissolves in water, whereas all other uncharged components such as 
proteins, salts and fats dissolve in the phenol.  In detail an equal 
volume of phenol:chloroform:isoamyl  alcohol  (25:24:1, cat  no  
P2069, Sigma, Germany) was added to the sample. The sample was 
mixed vigorously and then centrifuged at 13000 rpm in a table-top 
centrifuge.  The top layer (aqueous phase) was transferred into fresh 
tube and an equal volume of chloroform:isoamyl (24:1, cat no 
1.02432.2500, Merck, Germany) was added to it. Subsequently, the 
aqueous phase was transferred into another fresh tube and then the 
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DNA was precipitated by addition of 0.1 volume of sodium acetate 
(3M, pH5.2) and 2.5 volumes of 100% ethanol, incubated at -80C° 
for 30min-overnight, centrifugation at 13000 rpm then removing the 
supernatant and keeping the DNA pellet. The pellets were then 
washed with 70% ethanol, dried in air for at least 20 minutes, and 
finally re-suspended in an appropriate volume of autoclaved water. 
 
2.3.2 PCR amplification  
Several polymerase Chain Reaction (PCR) systems were used in this 
project. In general, for genotyping and other genetic screening, I 
used the regular NEB Taq polymerase (New England Biolabs, Ipswich, 
USA). For TA cloning, I used the Reddy mix extensor PCR/Abgene 
Mastermix (Termo Scientific cat. no. AB-0794/A, MA, USA) that 
contain in addition to Taq polymerase activity, a 
thermostable proofreading activity to minimize mutations and 
maintaining the adenine to the 3' end of the product for TA cloning. 
In cases where amplified fragments need to be cut with restriction 
enzymes before cloning or when amplified fragments need to be 
submitted directly for sequencing, I used the Q5 High-Fidelity DNA 
Polymerase (NEB).  Amplification reactions were carried out using 
TECHNE TC-512 (Bibby Scientific, Stafford UK) with the reaction 
components and volumes summarized in (table 2.3). Cycling 
conditions used in these PCR reactions are also summarized in (table 
2.4). 
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Table 2.3: PCR reaction volumes.  
components Taq polymerase 
reaction 
Q5 polymerase 
reaction 
Thermo (Abgene) 
mix reaction 
frwd primer 
(10 μM) 
2 μl 2.5 μl 2 μl 
revse primer 
(10 μM) 
2 μl 2.5 μl 2 μl 
Template 
(100ng/μl) 
2 μl 2.5 μl 2 μl 
dNTPs (2mM) 5 μl 5 μl - 
buffer 5 μl (10XTaq buffer) 10 μl (5X Q5 buffer) - 
Taq polymeras 0.5 μl - - 
Q5 polymerase - 0.5 μl - 
Thermo mix - - 25 μl 
H2O 33.5 μl 27 μl 19 μl 
Total volume 50 μl 50 μl 50 μl 
 
Table 2.4: PCR reaction cycling conditions.  
cycling condition Taq polymerase 
reaction 
Q5 polymerase 
reaction 
Thermo (Abgene) 
 mix reaction 
initialization 94ºC for 5 min. 94ºC for 2 min. 94ºC for 2 min. 
4
0
 X
 fo
r Taq
 P
. 
3
0
 X
 fo
r Q
5
 &
 Th
e
rm
o 
Denaturing 
 
94ºC for 30 sec. 94ºC for 15 sec. 94ºC for 15 sec. 
Annealing 
 
57ºC for 30 sec. 
may be optimized 
57ºC for 30 sec. 
may be optimized 
57ºC for 30 sec. 
may be moptimized 
Extension 
 
72ºC for (1 min./kb) 72ºC for (1 min./kb). 68ºC for (1 min./kb). 
for extension 72ºC for 5 min. 72ºC for 5 min. 68ºC for 5 min. 
for hold 4ºC until collected. 4ºC until collected. 4ºC until collected. 
 
2.3.3 Restriction enzyme digestion  
All DNA restriction enzymes used in this project were ordered from 
NEB. Restriction digests were performed using the manufacturer's 
recommended buffers and incubation temperature. For mini-prep 
screenings and plasmid analysis, a typical 20 μl digestion mix was 
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used and set up as shown in Table 2.5, then incubated for one hour 
and examined by agarose gel electrophoresis. In case of digestion for 
cloning purposes, a 100 μl digestion mix was used  and set up as in 
Table 2.5. To ensure complete digestion of DNA with a minimal 
degradation of the DNA cohesive  ends, the digestion mixes  were 
typically incubated for four hours. 
 
Table 2.5: Typical restriction digest reactions.  
components 20 μl digestion mix 100 μl digestion mix 
DNA 
(100ng/μl) 
4 μl 20 μl 
enzyme buffer 2 μl 10 μl 
10X BSA 
 (100ng/μl) 
2 μl 10 μl 
restriction 
enzyme 
0.5 2 μl 
H2O (2mM) 11.5 μl 58 μl 
Total volume 20 μl 100 μl 
 
 
 
2.3.4 Agarose gel electrophoresis 
DNA fragments were examined by gel electrophoresis using (0.8-2 % 
based on fragment size) agarose gels in 0.5 X TAE buffer (40mM  Tris  
acetate,  5mM  ethylene diamine tetraacetic  acid).    Agarose gels  
were  prepared  by dissolving  the required agarose powder in  0.5x  
TAE buffer by  boiling  the  mixture  in  a  microwave. When cooled, 
Ethidium Bromide was added to enable visualization of DNA.  To 
facilitate loading and to determine fragment sizes, NEB loading 
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buffers and molecular ladders (NEB) were used in all gel experiments,  
and gels were usually run by applying a voltage of 120V for 30 
minutes, or 80V for one hour if fragments need to be recovered from 
the gel.  The fragments were visualised by exposure to UV light using 
the Bio-Rad Chemi XRS Gel Documentation system and the Bio-Rad 
(Quantity One® software, CA, USA). 
 
2.3.5 Extraction of DNA from agarose gels  
Following the gel electrophoresis, bands of interest were located and 
cut out with a scalpel blade while the gel  was visualised on a UV 
light. The  DNA  was  then  extracted from the gel using NucleoSpin 
kit (Duren, Germany) following the manufacturer's instructions. 
 
2.3.6 DNA ligation and transformation 
DNA ligations were carried out in 20 µL volumes (see Table 2.6), 
using T4 DNA ligase (NEB) following manufacturer's instructions. 
Reactions were incubated overnight in heat block at 16ºC, then 
chilled on ice and finally used to transform chemically competent 
bacteria. For ta cloning, (Promega) pGEM-T Easy plasmid and T4 
ligase  were used. The incubation was done overnight at 4ºC. To 
determine the amount of insert required in each ligation the following 
equation was used:  
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 Following ligation, samples were used to transform chemically 
competent E.coli (in-house E.coli for plasmids<6kb, or NEB high 
efficiency competent E.coli for larger plasmids). To determine the 
success of the ligation, plasmid DNA was isolated from the 
transformants and digested with appropriate restriction enzymes. 
The digests were then examined on agarose gel. 
 
Table 2.6: Example of a ligation reaction.   
COMPONENT 20 μl REACTION 
10X T4 DNA Ligase Buffer 2 μl 
Vector DNA (3 kb) 50 ng (0.025 pmol) 
Insert DNA (1 kb) 50 ng (0.076 pmol) 
Nuclease-free water to 20 μl 
T4 DNA ligase 1 μl 
 
2.3.7 Plasmid DNA Isolation 
To isolate plasmid DNA, bacterial  cultures  were  prepared by firstly  
picking  and  inoculating  transformed bacterial colonies into 3ml 
(mini-prep) or 50ml (midi-prep) of SOC medium containing the 
appropriate  antibiotic  (100 μg/ml ampicillin or  50 μg/ml 
kanamycin).  Bacterial cultures  were  grown  overnight  at  37°C  
(14-16  hours)  with  shaking.  Plasmid  DNA was isolated from 
bacteria using Mini-prep or Midi-prep kits (NeucleoSpin plasmid 
NucleoBond Xtra Midi/Maxi, Duren, Germany), according to the 
manufacturer's instructions.  
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2.3.8 Measurement of nucleic acid concentrations 
Purified DNA and RNA concentrations were determined using  a  
NanoDrop  ND-1000 (Termo Scientific, MA, USA). A260/280 
wavelength ratios of ≈1.8 and ≈2.0  were used as purity criteria for 
DNA and RNA, respectively. In cases were the absorbance curve was 
skewed or showed multiple peaks, the nucleic acid was re-
precipitated and its concentration was re-quantified. 
 
2.3.9 DNA Sequencing    
DNA sequencing was performed by Source Bioscience Company 
(Nottingham, UK). 
 
2.3.10 Gibson assembly 
Gibson assembly is a simple robust method that allows joining 
multiple DNA fragments with overlapping sequences in a single 
isothermal reaction. The assembly in this method is done by the 
simultaneous action of a 5′ exonuclease, a DNA polymerase and a 
DNA ligase that are all included in one tube reaction (Figure 2.1).  
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Figure 2.1: One-step assembly of fragments with overlapping 
sequences with the Gibson assembly approach. 
Diagram showing the Gibson assembly principle and enzymes 
utilised. In the process, the exonuclease enzyme firstly removes 
nucleotides from the 5' ends to generate single strand overhangs. 
Complementary sequences of adjacent fragments then annealed 
together. DNA polymerase  then extends the 3' ends to fill in any 
gaps. Finally, DNA ligase covalently join adjacent fragments.    
 
 
The technique was first published in 2009 as an alternative to the 
classical approach in experiments that have led to the construction of 
synthetic viral and mitochondrial genomes (Gibson et al., 2009, 
Gibson et al., 2010, Siridechadilok et al., 2013). In this project this 
technique was utilised to generate several plasmids and also to fuse 
the gfp reporter gene in-frame with the 3' nicd gene in the flk1:nicd-
gfp (P405) and fli1:nicd-gfp (P409) plasmids. The steps used to 
assemble plasmids using this technique are explained below. 
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2.3.10.1 Primer design, PCR amplification and 
backbone plasmid preparation 
Primers used in the assembly were between 30-40 bp long. They were 
made of 15-20bp of the amplified fragment and preceded by the last 
15-20 bp of the fragment with which the PCR fragment needed to be 
ligated (using 40bp primers, unless specified otherwise). When 
ligating to a linearized backbone plasmid, a minimum of 20bp overlap 
was included at both ends of the PCR product.  In cases when specific 
sequences needed to be introduced such as  restriction sites or kozak 
sequence, the sequence between the overlap was added at the 5’, 
and the template sequence at the 3’ end. For all PCR amplified 
fragments, Q5 high fidelity polymerase (NEB cat M0491S) was used 
with 57°C annealing temperature for 30 seconds and one minute/kb 
extension, and  30 cycles of amplification. PCR products were run on 
a preparative gel, cut out from the agarose gel and purified. The DNA 
concentration was determined on the NanoDrop. Furthermore, a 
small aliquot was run on a gel. To increase the assembly efficiency, 
the backbone plasmids were linearized using suitable restriction 
enzymes for four hours to ensure complete digestion with minimal 
degradation and nicking of the backbone plasmid. 
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2.3.10.2 Calculating needed fragment concentration 
Gibson assembly enzymes are highly sensitive to DNA fragments 
concentrations and proportions. For the best outcome the fragments 
concentration formula of: 1 ng per 100 bp for a total reaction mix of 
20 µl was used; thus, if 1kb fragment and 10 kb backbone were to 
be assembled, then 10ng of the insert and 100 ng of the backbone 
were added to 10 µl assembly mix, with the volume completed to 20 
µl with H2O.   
 
 2.3.10.3 Assembly mix incubation 
Assembly incubation was done in the thermal cycler at 50°C for 1 
hour. To increase efficiency, in some cases the assembly mix was 
divided after addition of the DNA fragments into 4 X5µl aliquots and 
the thermal cycler program was modified to provide a gradient with 
temperatures ranging from 40°C-60°C. The four tubes were then 
distributed in the gradient. After incubation, the four aliquots were 
pooled again and used to transform E.coli. The assembly mix was 
then incubated on ice for at least one minute before transformation. 
10 µl of the chilled assembly mix was used to transform high 
efficiency competent E.coli (NEB) according to the manufacturer's 
protocol. Plating and colony screening were all done following 
standard procedures. Comprehensive restriction analysis and 
sequencing were done to confirm the correct assembly of the plasmid. 
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2.3.11 Zebrafish embryo sampling for quantifying 
remaining Notch activity in DAPM treated and mib 
mutant embryos by quantitative PCR 
DAPM treatment was performed on embryos  generated from crossing 
Tg(csl:venus)qmc61+/- ♂ X WT ♀. To determine the remaining Notch 
activity in mibta52b mutants, the Tg(csl:venus)qmc61+/- transgene 
was introduced in the background of mibta52b carriers.  Next, ♂ 
Tg(csl:venus)qmc61+/-; mibta52b heterozygous were crossed to ♀ 
mibta52b heterozygous carriers. Due to the difficulty to identify the mib 
homozygous mutants at 26hpf, and to maintain the percentage of 
affected venus +ve embryos, mib mutants, DAPM treated and un-
treated control samples were corrected as shown in (Figure 2.2).  This 
makes the final number of embryos used for total RNA extraction in 
each batch 200. Before performing the RNA extraction, embryos were 
dechorionated, anesthetised then collected in 1.5 ml Eppendorf 
tubes. They were then de-yolked, washed and finally frozen at -80°C 
for RNA extraction. Three biological samples were collected from each 
group.  
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Figure 2.2: Sampling method for quantifying the remaining 
Notch reporter gene mRNA in DAPM treated, mib mutants 
compared to control embryos. 
Schematic  representation of the method used to collect equivalent 
samples of Tg(csl:venus)qmc61 to quantify the remaining venus mRNA 
with DAPM treatment (A) or mib mutants (B) compared to their un-
treated control (C).     
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2.3.12 Total RNA extraction 
Total RNA was isolated from pooled zebrafish embryos using the 
RNeasy Plus Mini Kit (Qiagen,  Germany). To improve the yield in 
these extactions, embryos pooled in each tube were firstly 
homogenized with RNase-free masher in 1ml of TRI reagent (Sigma, 
USA) for at least five minutes. They were then incubated at room 
temperature for five minutes,  vortexed for two minutes then spun in 
a benchtop centrifuge (Thermo Fisher Scientific, USA) at 13000 rpm 
for ten minutes. The aqueous phases were transferred into fresh 
tubes then 200 μl of (none-isoamyl alcohol) chloroform (Sigma, USA) 
was added to each tube. The tubes were vortexed again for about 30 
minutes then centrifuged at 13000 rpm for 15 minutes. To remove 
all DNA from these samples, the top phases were transferred into 
gDNA eliminator columns (Qiagen,  Germany)  which, in combination 
with the high-salt buffer, selectively and efficiently removes genomic 
DNA, spun at 13000 rpm speed for one minute, then the gDNA 
columns were discarded and an equal volume of 70% ethanol was 
added to the filtrates. These mixes were loaded into RNA-Easy RNA 
extraction columns. Extractions were preceded following the 
manufacturer's instructions then samples were eluted in 30-50 μl  
H2O, their concentrations were determined by the NanoDrop, then 
they were stored at -80°C. 
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2.3.13 Reverse transcription and cDNA synthesis 
First  strand  cDNA  was  synthesized  using  SuperScript™  III  
Reverse  transcriptase (Life Technologies, USA) according to the 
manufacturer's guidelines. For each sample, an RT- control (with no 
reverse transcriptase) was prepared in parallel to the cDNA sample. 
In general, 1.5 μg of isolated total RNA, together with 1 μl of the 10X 
non specific hexa-nucleotide  primers (Roche, Germany) and  1 μl of 
10mM dNTPs (NEB) were pipetted into a 1.5 sterile tube. Sterile water 
was added to a final volume of 13 μl. The mixture was heated to 65°C 
for five minutes and then quickly chilled on ice for one minute. The 
mixture was subsequently centrifuged then this step was followed by 
the addition of 4 μl 5X first strand buffer, 1 μl 0.1 M DTT, and 1 μl 
(200 units) of SuperScript™ III Reverse Transcriptase for the cDNA 
tubes or 1 μl H2O for RT- tubes.  The  mixtures  were pipetted up and 
down to mix the contents. They were  then left at room temperature 
for five minutes, then incubated in the heat block at 50°C  for  one 
hour  prior to inactivation in heat block at 70°C for 15 minutes. The 
samples were finally diluted (1 in 5) with H2O and then stored at -
20°C for PCR amplification.   
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2.3.14 Relative quantitative PCR (qPCR) 
2.3.14.1 TaqMan 
The expression of Notch reporter gene (venus) was quantified relative 
to the house keeping gene ef1α by using the universal Absolute qPCR 
ROX Mix kit (Thermo Scientific, cat. AB-1133/A, USA) with primers 
and TaqMan probes (Sigma) that were previously validated in our lab 
by a former PhD student (Modhara, 2014). The primers were 
designed to amplify about 100 bp fragments in venus and ef1α cDNA. 
The TaqMan probes used carried a FAM fluorophore at the 5' end and 
a TAMRA quencher at the 3' end. The master mix was prepared using 
the following formula per reaction: qPCR Mix 12.5 μl; forward/reverse 
primer (10μM) 1 μl each; probe (10μM) 0.5 μl, H2O 5 μl. The reactions 
were set up in a standard 96 well plate (Life Technology, cat AB-
0800). 20 μl master mix was added into each well with 5 μl cDNA. 
Three technical replicates were setup for each experimental sample, 
including the RT- and H2O negative controls. The plate was sealed 
using a MicroAmp Optical Adhesive Film (Life Technology, cat 
4360954) and PCR reaction was performed on the ABI 7500 Fast Real 
Time PCR System (Applied Biosystems, Life Technology, USA). The 
cycling conditions used were as follow: initial denaturing at 95°C for 
15 minutes, then 40 cycles of 95°C for 15 seconds, and 60°C for one 
minute. Primers and probes used are listed in Table 2.7. 
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2.3.14.2 SYBR Green 
The SYBR Green quantitative real-time PCR was carried out to 
quantify the reduction in tet1 and tet3 genes transcript's cDNA 
following their morpholino injections, and also to quantify enrichment 
for 5hmC in immunoprecipitated DNA (DIP) from tet1 injected, tet3 
injected and uninjected control. In the DIP quantification, a 
preliminary 10 cycles PCR were performed to amplify the starting 
templates of the 12 fragments targeted (2X6 genes) and to normalize 
the results, we used no antibody input.  
The SYBR Green PCR was setup in 96 well plates (Life Technology, 
cat AB-0800) and performed using SYBR Green JumpStart PCR 
master mix (Sigma, cat S4438-500RXN) following manufacturer 
instructions, using an ABI 7500 Fast Real Time PCR system (Applied 
Biosystems, Life Technology, USA). The cycling conditions used were 
as follow: initial denaturing at 95°C for 15 minutes, then 40 cycles of 
95°C for 15 seconds, and 60°C for one minute. Primers and probes 
used are listed in Table 2.7. 
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Table 2.7: Primers and probes used in quantitative real time 
PCR. 
  
2.4 Histology  
2.4.1 Whole mount in situ RNA Hybridization (WISH)  
2.4.1.1 Embryo collection and fixation 
 Embryos older than 18hpf were firstly de-chorionated  manually, 
then fixed in 4% para formaldehyde reagent (PFA) in phosphate-
buffered saline tween 20 (PBSTw) overnight at room temperature. 
Embryos younger than 18hpf were fixed in their chorions. The next 
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day, embryos were washed three times with PBSTw. Embryos 
younger than 18hpf were de-chorionated. All embryos were 
dehydrated from the PBSTw in ascending concentrations (25%; 50%; 
75%; 100%) of methanol and kept at -20°C.  
 
2.4.1.2 Whole-mount RNA in situ hybridization 
(WISH) 
Methanol preserved embryos were rehydrated into PBSTw by washing 
them in descending concentrations (75%;50%;25%) of methanol in 
PBSTw followed by five washes in only PBSTw. Embryos older than 
24hpf were firstly permeabilized with Proteinase K while younger 
embryos were taken directly to the hybridization step. 
Permeabilization was done by digesting embryos with  Proteinase  K  
(10μg/ml, Sigma, Germany) for an appropriate time (Table 2.8). 
 
Table 2.8: Proteinase K treatment durations according to age 
of embryos. 
age of embryo duration of Proteinase K treatment 
(min) 
0-24hpf 0 minutes 
25-31 hpf 5 minutes 
2 days 20 minutes 
3 days 30 minutes 
4 days 45 minutes 
5 days 1 hour 
 
  After permeabilization, embryos were washed three times with 
PBSTw then re-fixed with 4% PFA for twenty minutes at room 
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temperature, then washed with PBSTw for five times. 
Prehybridization was then performed by  firstly washing embryos in 
50% hybridization buffer in PBSTw then 100% hybridization buffer 
(Hyb) for at least one hour at 65°C. The hybridization buffer was then 
replaced with Hyb buffer containing DIG or fluorescein labelled RNA 
probe containing Hyb (500ng/1ml Hyb) and incubated overnight at 
65°C (Table 2.8 shows probes used for in situ studies discussed in 
this work). In general, probe synthesis was done from linearized 
plasmids following standard in vitro transcription  but with Sp6, T3  
or  T7  RNA  polymerase  primers and DIG or flourescein labelling 
DNTP mixes. Two hours incubation at 37°C was used, then the 
templates DNA was digested by DNAseI. RNA quality was analysed 
by running a small aliquot on agarose gel.   
 
2.4.1.3 post hybridization 
Probes were recovered, then embryos were washed in descending 
concentrations of Hyb in 2XSSCTw then successively washed with 
2XSSCTw, followed by four washes with 0.2 SSCTw, all at 65°C. 
Embryos were equilibrated with ascending concentrations of MABTw, 
then blocked with 2% blocking solution (Roche, Germany) for one 
hour. They were then incubated in 2% blocking solution containing 
DIG or fluorescein antibodies in 1:5000 for anti-DIG Ab or 1:1000 
dilution for anti Fluorescein Ab (Roche) for 30 min at room 
temperature, then overnight at 4°C. The next day, embryos were  
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washed eight times with MABTw at room temperature, washed three 
times with the developing buffer (BCLIII), then stained with 50%  
BM-purple in BCLIII and left in the dark until embryos were stained 
sufficiently. The reaction was then stopped by washing the embryos 
3 times in PBSTw 20mM EDTA and they were then fixed in 4% PFA 
for 20 minutes,  washed three times with PBSTw then slowly taken 
through ascending concentrations of glycerol in PBSTw (30%, 50% 
then 80%). At this stage embryos were ready for microscopic 
examination, thus they were stored at 4°C until needed in the future. 
In  the  case  of  fluorescent  labelling double in situ,  embryos  were 
incubated in 100 μl of 1:25 dilution of Cy3 tyramide or fluorescein 
tyramide with amplification reagent (PerkElmer)  for 30 minutes in 
the  dark, then stained with tyramide substrate then washed with 
PBStw after that stored in glycerol as in normal in situ.  
 
Table 2.9: RNA probes used in this project.  
marker gene vector name in 
 Gering lab database 
 
reference 
c-myb P77 Thompson  et al., (1998) 
runx-1 P86 Kalev-Zylinska  et al., (2002) 
efnb2a P193 Lawson et al., (2001) 
flt4 P59 Thompson  et al., (1998) 
gfi1.1 P287 Developed in our lab; Thambyrajah., (2011) 
580 bp fragment from gfi1.1 cDNA 
her4.1 P243 Takke  et al., (1999) 
elavl3/ zHuC Received from 
Sablitzky’s lab 
Kim  et al., (1996) 
neurog1/ngn1 Received from 
Sablitzky’s lab 
Blader et al., (1997) 
dla P117 Haddon  et al., (1998) 
notch1b P113 Kortschak., (2001) 
gfp/venus P308 In-house (whole gene) 
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2.5 Image acquisition and data analysis 
For all bright field and  fluorescent examination and imaging of 
embryos, I used a fluorescence dissection microscopes (Nikon, Model. 
SMZ1500, Japan) equipped with 100W super high pressure mercury 
lamp (Nikon, 100 W, C-SHG1, Japan) and FITC, TRITC and Cyan-Gfp 
filter set. For images and movies acquisition, coloured (Nikon 
DXM1200F/DS-5MC, Japan) or black and white (Hamamatsu ORCA-
ER C474280, Japan) digital cameras were attached to these 
microscopes. All signal density quantifications were performed using 
imageJ software (v1.48, National  Institutes  of Health). Adobe 
Photoshop software was used to assemble and edit images where  
necessary. Statistical analyses and graphical representations were 
done with GraphPad Prism v6.0 and Microsoft Excel Software 
(GraphPad; Microsoft, USA), and statistical significance of results was 
determined using  two-tailed, unpaired t test and presented as the 
mean ± SEM in three repeats and in  all  cases, any  P  value  of  <  
0.05  was  considered  to  be  significant.  
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Table 2.10: primers used in this project.  
 
Primer 
name 
d
ire
ctio
n 
 
sequence 
 
target 
 
Fragment 
size 
DB414 F cctcgtcgacgccaccatgaagctgctgagtagtat gal4-vp16 gene 710bp 
DB415 R gaggatcgatttatccaccgtactcatcaa 
DB162 F catcgcgtctcagcctcac uas-nicd region 459bp 
DB163 R cggaatcgtttattggtgtcg 
DB143 F ctgaataagtagatagcctatc flk1-cre region 592bp 
DB144 R cgatgcaacgagtgatgag 
DB542 F atccgaacgtgaagtgacat Truncated gal4-vp16 gene 624bp 
DB543 R cgatgaggatcgatttacatatcgagcgctccgtatg 
DB608 F gagtatcattcgggatcacagccaccatggagcaaaagct nicd to fuse with gfp 2314bp 
DB609 R agctcctcgcccttgctcaccttgaaggcttctggaatat 
DB610 F atattccagaagccttcaaggtgagcaagggcgaggagct gfp to fuse with nicd 757bp 
DB611 R atcatcatcggatccgaattttacttgtacagctcgtcca 
DB612 F aaacacaggccagatgggcccggatctcatctttgaccca fli1 promoter for GIBSON 2066bp 
DB13 R agcttttgctccatggtggctgcgcgtctgaattaattcc 
DB28 F ggaattaattcagacgcgcagccaccatggagcaaaagct nicd-gfp 3031 bp 
DB611 R atcatcatcggatccgaattttacttgtacagctcgtcca 
DB143 F ctgaataagtagatagcctatc flk1-cre fragment 592bp 
DB144 R ctcatcactcgttgcatcg 
DB347 F cctcgggcccaccagcaaagttctagaatttgtcg Ubi promoter 3490bp 
DB348 R cctccctgcaggctgtaaacaaattcaaagtaagattagc 
DB377 F cctcccgcgggccaccatggtgagcaagggcgagga mCherry 740bp 
DB378 R gaggcttaagttacttgtacagctcgtcca 
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CHAPTER 3 
3 Result I  Notch reporter gene expression pattern 
during zebrafish early development   
3.1 Introduction 
At the start of this project, as described in Chapter 1, three in-house 
Notch reporter lines were generated in our lab: Tg(csl:venus)qmc61, 
Tg(csl:cerulean)qmc63 and Tg(csl:mCherry)qmc97. The three lines were 
identical in their inserted transgene structure but with different 
reporter fluorescent proteins. Because these three lines were 
dependent on artificial regulatory elements to drive expression of the 
reporter fluorescent protein in Notch-active cells, and the fact that 
they might also be influenced by the position where they were 
inserted in the genome, it was an essential prerequisite to re-asses 
the usefulness of these generated lines as tools for reporting Notch 
activity. Moreover, despite the accumulating evidence of Notch 
requirements in arterial specification and HSC development, it was 
still to be shown whether te presence of Notch receptors and ligands 
in the arterial and haematopoietic progenitors in the AGM region 
during early embryogenesis was associated with activation of Notch 
pathway, and to what level it is required.  
It was also still not clear when Notch activity initiates in these arterial 
and haematopoietic progenitors, and how it varies from the time point 
of arterial specification until HSCs formation.  Therefore, the aims of 
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this chapter were to carefully examine the in-house generated Notch 
reporter lines and asses their usefulness in reporting Notch activity. 
In addition, to utilising these lines to determine when Notch signalling 
initiates in the hEC progenitors forming the DA and how the level of 
Notch signalling in the DA varies from the time point of arterial 
specification to the time point of HSCs development.   
 
3.2 The three in-house generated Notch reporter 
lines have identical expression patterns 
Even though the Notch reporter regulatory elements were 
successfully used ex vivo and in vivo in mammalian model to report 
Notch activity, it was still necessary to examine if the system also 
efficiently reports Notch activity in the zebrafish.  In parallel to our 
efforts to establish our in-house Notch reporter lines, two Notch 
reporter lines were published by Parsons et al. (2009) utilising the 
same regulatory elements, Tg(tp1βglob:gfp)um13 and 
Tg(tp1βglob:hmgb1-mCherry)jh11. The published lines were verified 
by the authors and shown to efficiently report Notch activity in the 
zebrafish animal model. To test if our in-house generated lines have 
expression pattern, identical to the verified Parsons et al. (2009) 
lines, transgenic fish were crossed from our generated lines to wild 
type fish. I then examined their embryos at 1 dpf to firstly see if the 
inserted transgenes led to an identical pattern of expression in the 
three transgenic lines, as an indicator of promoter specificity. Careful 
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examination of embryos from the three lines showed that apart from 
the differences in type of reporting fluorescence proteins, all three 
transgenic lines showed identical expression pattern (Figure 3.1) with 
only slight variation in the level of fluorescent protein expression, 
which could be due to the differences in their fluorescent intensity, 
maturation  or folding and fluorophore formation. I then compared 
expression pattern in the three in-house lines with that in the 
published transgenic line Tg(tp1 βglob:gfp)um13 and the results 
showed an identical expression pattern with characteristic strong 
reporter genes expression in the telencephalon , heart , dorsal aorta 
, neural tube and medial fin fold (white arrows in Figure 3.1). 
Moreover,  blocking the Notch pathway with different approaches also 
blocked expression of the reporter genes in these lines as in the lines 
published by the Parsons et al. (2009), as shown in Figure 4.4.  We 
also noticed some inter-embryonic variations in level of fluorescent 
proteins. These variations are at least in part due to the biological 
and environmental conditions. The other possible cause of these 
inter-embryonic variations is the spontaneous transgene 
suppression, associated with the use of 12 csl binding repeats. 
Transgene suppression, or complete silencing by adopting 
methylated or closed conformation, are common issues in transgenic 
lines that contain repetitive regulatory sequences, such as the Gal4 
binding repeats (Goll et al., 2009, Thummel et al., 2006).  
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Figure 3.1: Generated in-house Notch reporter lines drive 
identical expression pattern.  
The Figure shows embryos from the three Notch reporter transgenic 
lines established in our lab. A Tg(csl:venus)qmc61, B 
Tg(csl:cerulean)qmc63 and C Tg(csl:mCherry)qmc97. The three lines 
show identical expression pattern as indicated with the arrows. TE 
telencephalon, HE heart, DA dorsal aorta, NT neural tube, MFF medial 
fin fold.    
 
To overcome this problem, only embryos with robust reporter gene 
expression were used to maintain these lines, and fish that gave 
progenies with notably low reporter fluorescent protein levels were 
excluded from Notch reporter level quantifications in Chapter 4. On 
the other hand, transgenic fish that gave progenies with universally 
low reporter fluorescent protein levels were used to report and 
quantify endothelial specific Notch over-activation. Together, the fact 
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that all three in-house Notch reporter lines have identical expression 
patterns and the high similarity between our lines and the lines 
generated and validated independently in another lab strongly 
suggest that the reporter genes expression in our in-house generated 
lines faithfully recapitulate Notch activity. 
 
3.3 Notch signalling activity is detectable at the 5 
somite stage (11.5 hpf) with fluorescent reporter 
proteins 
To precisely determine when Notch activity appears in the embryo, 
male Tg(csl:mCherry)qmc97 fish were out-crossed to female WT, and 
to precisely determine the age of studied embryos, dividers were 
used to control the timing of fertilisation. The next day, the dividers 
were removed, then the embryos were collected 30 minutes later. 
Collected embryos were then quickly sorted and incubated at 28.5ºC. 
Embryos were examined under dissecting fluorescent microscope 
every 30 minutes to determine the earliest detectable Notch activity.  
Expression of the fluorescent reporter protein was first seen at the 5 
somite stage (11.5hpf). Notch activity at this stage was mainly in the 
midline in the position of the hypochord (Figure 3.2 A'; blue arrow in 
A''). Notch activity was also seen in the developing somites (Figure 
3.2 A'; yellow arrowheads in A''). As the somitogenesis proceeds, 
Notch reporter fluorescent protein  become stronger in the somites 
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and hypochord and also become detectable at other tissues, and by16 
somite stage (17hpf) several  other developing organs also become 
Notch-active (Figure 3.2 B'). At this stage, some of the early 
migrating blood and endothelial progenitors had arrived to the 
midline. Despite the fact that Notch might be active in these early 
migrating cells, due to the high Notch activity in the hypochord and 
its close proximity to the midline, we found it difficult to clearly 
identify Notch-active blood and endothelial precursors at this stage 
with fluorescent microscopy. 
These results show that the earliest zygotic Notch reporter 
fluorescent protein signal only becomes detectable at 11.5hpf. The 
earliest Notch-active tissues are mainly the hypochord and the 
developing somites. By the 16 somite stage a high Notch activity was 
reported in the nervous system and the developing somites.  Other 
tissues that were Notch-active at 16 somites are annotated in (Figure 
3.2  B’).         
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Figure 3.2: Notch activity is detectable in Notch reporter line 
at 5 somites stage (11.5hpf).  
A bright field microscopy showing the developmental stage with 
somites highlighted. A' same embryo examined with fluorescent 
microscopy. The reporter mCherry protein is detectable in the 
hypochord (Hy) and developing somites (D.So). A'' Magnification of 
the boxed area in A'. the yellow arrowheads label the developing 
somites, blue arrow labels the hypochord. B shows the developmental 
stage of Notch reporter embryo under bright field microscopy. B' 
same embryo under fluorescent microscopy. The image shows strong 
Notch activity in several tissues. Labelled Notch-active tissues in 
image B' are somites(So), neural tube (NT), hypochord (Hy), median 
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fin fold (MFF), neural crest (NCr), Kuppfer's vesicle (KV), 
telencephalon (TE), middle  and hind brain (MHB), otic vesicle (OV).   
 
 
3.4 Notch reporter protein is detectable in the 
position of the DA by 18hpf by fluorescence 
microscopy 
In zebrafish it was previously shown that the migrating lateral 
mesodermal vascular and haematopoietic progenitors express the 
Notch ligands dlc and dll4, and their expression persists in the 
developing DA (Lawson et al., 2001). However, it was not known if 
the presence of Notch receptors in these migrating cells was 
associated with active Notch signalling before they arrive to the 
midline to form the main axial vessels (DA and CV), which is known 
to occur between 17-18hpf (Medvinsky et al., 2011). To determine if 
these progenitors are Notch-active at this time point, the Notch 
reporter embryos were carefully examined starting from 17hpf for 
expression of Notch reporter protein just below the hypochord. Even 
though a weak Notch activity appeared to be present in the mid-line 
just below the hypochord in trunk area by 17hpf (Figure 3.2 B’). But, 
due to the close association of these apparently Notch active cells to 
the highly Notch active hypochord, and possibly the low number of 
cells arriving to the midline by this time point, it was difficult to clearly 
distinguish these cells. An hour later (18hpf), all migrating cells had 
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arrived to the midline to form the main axial vessels, and with early 
maturation of the DA, arterial and haematopoietic progenitors of the 
vDA become distant from the hypochord (white arrowheads in Figure 
3.3). The position of the dDA remained in very close proximity to the 
highly Notch-active hypochord (yellow arrows in Figure 3.3), and so 
it is still difficult to distinguish by normal fluorescent dissecting 
microscope.         
 
Figure 3.3: Notch signalling is detectable in the position of 
arterial and haematopoietic progenitors in the DA by 18hpf.  
Fluorescent microscopy images of live embryo of Notch reporter Tg 
(csl:mCherry)qmc97 embryo. (A) lateral view of 18hpf embryo. (A') 
Magnified area indicated by the box in (A). Yellow arrows point to 
hypochord, arrowheads point to vDA angioblasts and progenitor cells.  
 
From this experiment, it appears that Notch is active in the progenitor 
cells forming the DA by the time point of the DA formation, as 
determined by Notch reported activity below the hypochord in the 
position of the developing DA.  
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3.5 Double in situ hybridization shows co-localization 
of Notch and the endogenous endothelial gene (flk1) 
mRNA at 18hpf. 
To further confirm our fluorescent microscopy observation at 18hpf, 
and also to confirm the identity of these Notch-active cells observed 
below the hypochord in the position of the DA, double in situ 
hybridization was performed to investigate whether these Notch-
active cells are also expressing the endothelial marker flk1. To 
achieve this I crossed the Notch reporter line Tg(csl:venus)qmc61 to 
WT, raised their embryos until 18hpf then stopped and fixed in PFA. 
A standard double in situ hybridization was then performed on these 
embryos using venus digoxigenin- and flk1 fluorescein-labeled 
probes. The the Cy3 and fluorescein tyramide were used for signal 
development respectively. Upon completion, embryos were examined 
under fluorescent dissecting microscope.  
Double in situ hybridization showed a strong venus expression in the 
position of the DA (yellow arrows in Figure 3.4 A) in all of the venus 
positive embryos (50% in heterozygous). On the other hand, and as 
the flk1 probe was designed to target the endogenous flk1 gene 
mRNA, all examined embryos (100%) showed expression in the 
vascular endothelial tissues including the DA and the CV. 
Interestingly we noticed a higher flk1 expression in the DA  compared 
to the CV (blue arrowheads in Figure 3.4 A'-A''). When digitally 
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merged images were obtained for venus and flk1 expression, the co-
localization, of flk1 expression and the venus expression was 
observed at the position of the DA in 100% of the 11 double positive 
embryos. (Figure 3.4 A''). 
To further confirm the double in situ fluorescent microscopy results 
and to clearly demonstrate that the Notch-active cells at this stage 
were localizing within the endothelial cells forming the DA, confocal 
microscopy was performed on these embryos and the obtained 
images further confirmed these findings (Figure 3.4 B-B'').  Both 
normal and confocal fluorescent microscopy imaging illustrated that 
Notch signalling is active in the DA endothelial cells upon their arrival 
to the midline to form the DA precursors. 
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Figure 3.4: double in situ hybridization shows co-localization 
of the Notch reporter RNA and the endogenous endothelial 
marker flk1 RNA.  
Double in situ fluorescent microscopy images of Tg(csl:venus)qmc61 
+/- embryos at 18hpf. (A) Shows venus expression in Notch-active 
tissues. (A') Shows expression of the endogenous flk1 gene in the 
endothelium. (A'') Digitally merged image of the same embryo 
showing co-localization of venus and flk1 expression in the 
developing DA. Yellow arrows point to the developing DA, white 
arrowheads point to CV. (B-B'') Confocal imaging of 
Tg(csl:venus)qmc61+/- embryos at 18hpf. (B) Shows venus expression 
in the trunk region. (B') Shows expression of the endogenous flk1 at 
the same area as in (B). (B'') Merged image of (A) and A' showing 
co-localization of venus and flk1 expression in the developing DA. The  
images  were  acquired using  a confocal  microscope then processed 
with Imaris software. 
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3.6 Notch activity increases in the developing DA 
from the time point of DA formation to the time point 
of HSC development 
Notch is required for both arterial specification and HSC development, 
yet it is not clear how Notch signalling can differentially affect these 
two fates. While monitoring Notch activity in the AGM region we have 
established that  Notch activity becomes detectable with the early 
arrival of the Haemogenic endothelial progenitors to the midline. At 
this stage, Notch reporter gene expression of the developing DA 
appears as a weak signal. Continued monitoring of Notch reporter 
expression after its appearance, revealed a rapid increase in its 
activity in the DA as the embryo grows older (Figure 3.5 A-E).  
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Figure 3.5: Notch activity in the DA increases after arterial 
specification. 
Fluorescent microscopy images of live embryo of Notch reporter 
Tg(csl:mCherry)qmc97 embryo from 16-25hpf (A-E). The images show 
a rapid increase in Notch activity in the DA (indicated by the blue 
arrows) after the time point of arterial specification,  which continues 
to increase until the time point of HSC emergence at 25hpf, as 
indicated by the blue arrow.    
  
3.7 In situ hybridization of Notch reporter mRNA 
expression strongly suggests initiation of Notch 
activity in the migrating hEC progenitors before their 
arrival to the mid-line 
Previously it was shown that before a fluorescent protein gains the 
ability to absorb energy and emit light its chromophore needs a 
period of time to mature (Sniegowski et al., 2005). The maturation 
process starts with the translation of the mRNA message followed by 
the correct protein folding and finally acquiring the fluorescing 
property.   According to Sniegowski et al. (2005), at least one hour 
is required for Gfp protein maturation in E.coli at 37°C. Due to the 
wide number of variables affecting maturation time added to the 
technical variables associated with exciting and detecting fluorescent 
proteins we decided to estimate the time difference between first 
detection of Notch reporter mRNA and the time when reporter 
fluorescent protein can be detected with fluorescent microscopy. To 
achieve this, embryos were stopped and fixed from Notch reporter 
line Tg(csl:venus)qmc61 at different time points starting from 6hpf then 
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carried out in situ hybridization. In situ hybridization results showed 
that Notch reporter mRNA  becomes detectable in the neural 
progenitor cells as early as 8hpf, which is 3.5 hours earlier than the 
time point when the reporter fluorescent protein become detectable 
with fluorescent microscopy (Figure 3.6). 
Considering the 3.5 hours delay associated with the Notch reporter 
protein maturation, these findings strongly suggest that the 
migrating hECs progenitor cells must have active Notch signalling 
activity a few hours before their arrival to the midline to form the DA, 
i.e. at least starting from 14 hpf.   
 Interestingly, our in situ data shows that while Notch activity rapidly 
increase in the DA after arterial specification and persists at a high 
level during the time window at which HSCs emerge from the vDA, 
Notch activity sharply falls by 48hpf to hardly detectable levels (see 
Figure 3.6).  
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Figure 3.6: Notch reporter mRNA become detectable at 8hpf.  
In situ hybridization for Tg(csl:venus)qmc61 embryos showing 
expression of the reporter mRNA in the position of neural progenitor 
cells starting from 8hpf (red arrow heads) and extent along the 
migrating cells that form the hypochord by 10hpf. At 12 hpf the 
developing somites also become Notch-active (blow arrows). At 18 
hpf Notch activity in the hypochord become hardly detectable while 
the DA Notch activity become clearly detectable and then increases 
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towards the time point of HSC formation at 24hpf (yellow arrows). 
At 48hpf Notch activity in the DA sharply down-regulated to hardly 
detectable levels.    
 
3.8 Discussion of results 
Comparative analysis of the expression pattern in the in-house 
Notch reporter lines revealed high specificity of reporter gene 
expression. In the three in-house generated Notch reporter lines, 
reporter gene expression was restricted to tissues of known Notch 
activities, such as the telencephalon and heart dorsal aorta (Scheer 
et al., 2001) in identical pattern, and also to the Notch reporter 
lines generated and published independently by the Leach Lab 
(Parsons et al., 2009). We also noticed occasional suppression of 
the reporter gene expression in embryos generated from known 
Notch reporter transgenic fish. Nevertheless, such suppression is a 
common issue with transgenes containing multiple repeats in their 
promoters (Goll et al., 2009, Thummel et al., 2006), but due to the 
extremely low number of embryos with suppressed expression, the 
impact of this variation is extremely low, especially when large 
sample sizes are used or the same embryos are followed over time.  
Utilizing these Notch reporter lines, we presented data showing 
mature and detectable fluorescent reporter protein in the DA as 
early as 18hpf. By comparing the time point of earliest reporter 
gene mRNA and the earliest fluorescent protein detection, we 
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estimated the time required for the reporter protein translation, 
maturation and accumulation to a detectable level to be 3-4 hours. 
Based on this, we concluded that the haemogenic endothelial 
progenitors (derived from the mesoderm then migrated to the 
midline) must have become Notch-active a few hours before their 
arrival to the midline to from the DA. Due to the close association 
between the developing DA and the highly Notch active hypochord, 
we performed double in situ hybridization at 18 hpf with venus and 
flk1 probes, to determine the identity of these Notch active cells.  
Our double in situ hybridization analysis confirmed the endothelial 
identity of these Notch active cells, as both fluorescent and confocal 
microscopy showed overlap between venus and flk1 expression. 
Fluorescent microscopy examination also showed the persistence of 
the reporter fluorescent protein in the DA after arterial specification. 
Due to high protein stability, it was essential to investigate if the 
observed reporter protein resulted from continuous Notch activity 
in the DA and not from earlier Notch activity. For this, we examined 
expression of the reporter gene at the mRNA level with in situ 
hybridization and the results showed high expression of the reporter 
gene in the DA, even when examined eight hours after arterial 
specification. Interestingly, unlike with fluorescent microscopy, we 
noticed a dramatic reduction in the Notch reporter mRNA on day 
two.  
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Together, our findings suggest an early Notch activity in the 
progenitor cells forming the DA, including the haemogenic 
endothelium in its ventral wall. The on-going prolific Notch activity 
in the DA after arterial specification until the point of HSCs 
specification, then its reduction to a hardly detectable level, 
suggests that high Notch signalling could be required for HSCs 
specification from the ventral wall of the DA.  
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CHAPTER 4 
4 Result II   Low level of Notch is sufficient for 
arterial specification whereas high level is required 
for HSCs formation 
4.1 Introduction 
In vertebrates, HSCs are specified from  arterial endothelial cells in 
the ventral wall  of the Dorsal Aorta (Bertrand et al., 2010a, Kissa 
and Herbomel, 2010, Lam et al., 2010). Studies on zebrafish, birds 
and mammals have shown that both arterial and HSC specification 
are both derived from one common precursor, the haemangioblasts. 
Soon after formation of the DA, a sub-population of the cells  forming 
the vDA further differentiate  into HSCs. This differentiation step is 
dependent on type and level of signal they receive added to the 
competency of these cells. Notch is one of the signalling pathways 
that are known to be essential for both arterial endothelial and HSCs 
development (Lawson et al., 2002, Gering and Patient, 2005). In 
zebrafish, several Notch receptors and ligands are expressed in the 
Angioblasts fated to form the DA (Lawson et al., 2001), suggesting 
an early role for Notch in arterial specification. However, Notch 
activity is maintained after arterial gene induction until the time point 
of HSCs cluster formation in the DA. 
This is reflected by persistence of Notch reporter mRNA and 
fluorescent protein in Notch reporter transgenic lines. Due to their 
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close association and the shared requirement for Notch in arterial 
specification and HSCs development, it was still not understood how 
Notch differently specify these two fates in the DA. Notch gain of 
function studies show that high level of Notch is sufficient to expand 
HSCs formation in WT embryos as well as Notch over-activation could 
also rescue Hh, Vegf and Hey2 depleted embryos (Rowlinson and 
Gering, 2010). These findings suggest that high level of Notch may 
be needed for HSCs development. Notch loss of function studies with 
different approaches including mib mutant homozygosity,  have also 
shown loss of HSCs specification (Gering and Patient, 2005). 
Interestingly we noticed that only some approaches interfere with 
arterial specification. Our careful analysis of the Notch activity 
reported by expression of the reporter genes in our zebrafish 
transgenic lines revealed a clear up-regulation of Notch reporter 
expression in the DA angioblasts and endothelial cells from 20 to 26 
hpf. This up-regulation was also confirmed in our lab at the mRNA 
level by RT-PCR experiments performed on FAC-sorted Flk1:Gfp+ 
trunk endothelial cells harvested from flk1 reporter transgenic 
embryos at different time points  (Modhara, 2014). Together, these 
observations suggest that different levels of Notch are required for 
arterial specification and hEC induction, and that low level of Notch 
activity is sufficient for arterial specification, whereas a high level of 
Notch is needed for hEC induction. In this study I used our in-house 
developed Notch reporter line Tg(csl:venus)qmc61 to measure the level 
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of Notch activity during DA development and hEC induction in wild-
type and Notch-depleted embryos. I also used in situ hybridization as 
well as quantitative RT-PCR to measure the remaining Notch reporter 
gene expression in mib mutants, rbpja/b morphants and DAPM-
treated embryos, and its correlation with maintaining or losing 
arterial and HSC marker genes expression. 
 
4.2 Notch activity is up-regulated in the DA after 
arterial specification to the time point of HSCs 
development  
From our observation of the fluorescent protein expression in our 
Notch reporter lines, we noticed that the Notch reporter protein 
becomes detectable in the endothelial progenitors located just below 
the hypochord between 17-18hpf (see Figures 3.2 and 3.3). At this 
stage Notch reporter expression is low and barely detectable in these 
progenitor cells with normal fluorescent microscopy. In situ 
hybridization analysis showed that these progenitors were specified 
as arterial, indicated by their expression of arterial markers such as 
efnb2a (Gering and Patient, 2005). Interestingly, after arterial 
specification we noticed an increase in Notch reporter protein 
expression, and this up-regulation continued until the time point of 
HSCs development (see Figures 3.4,3.6 and 4.1). To exclude the 
contribution of inter-embryonic variation in Notch reporter protein 
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level that we reported earlier (chapter 3) and to quantify the up-
regulation of the reporter fluorescent protein, ImageJ software was 
used to measure the intensity of fluorescent protein at 20hpf, 24hpf 
and 27hpf all from same embryo and same imaging and analysis 
settings. Average intensity means of the sample measured showed 
about three fold increase in venus intensity from 20hpf to 24hpf and 
another two fold increase from 24hpf to 27hpf as shown in Figure 4.1 
D. Even though these quantifications came from one embryo, when 
added to fluorescent microscopy and in situ hybridization that showed 
upregulation in the reporter fluorescent protein and reporter gene 
mRNA, this suggests a true upregulation in Notch activity rather than 
the expected inter-embryonic variation in the Notch reporter activity.   
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Figure 4.1: Notch reporter fluorescent protein expression is 
up-regulated after arterial specification of the DA to the time 
point of HSC development. 
(A-C) Venus fluorescent protein expression in Tg(csl:venus)qmc61 
showing an increase in the Venus fluorescent protein expression from 
20hpf-27hpf. (A) Shows a very weak venus expression in the 
developing DA located just below the hypochord (yellow arrowhead) 
that is high in Venus at this stage. Boxed area in A is magnified in 
(A'). (B-B') Venus fluorescent protein level at 24hpf become very 
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prominent along the DA. Boxed area in B is magnified in (B'). (C-C') 
Venus fluorescent protein expression  increases in the DA at 27hpf 
compared to 24hpf. Boxed area in C is magnified in (C'). (D) 
Comparison of the Venus fluorescent protein intensity along the DA 
at 20hpf, 24hpf and 27hpf measured  by  obtaining the fluorescence 
intensity along  the  DA using  a  line  tool  in  imageJ  drawn through 
the dorsal aorta endothelium. (E) Comparison of the average aortic 
Venus fluorescence intensity, showing a 3-fold increase in Venus level 
from 20hpf to 24hpf and another a 2-fold increase from 24hpf to 
27hpf. Data are shown from five measurements done on images from 
a single embryo imaged at different time points on the same day 
using the same conditions and settings (mean ± SEM; unpaired t 
test; **** = p<0.0001).  
 
 
4.3 High level of Notch coincides with loss of Flt4 in 
the DA at the time point of HSC development 
Previously, Lawson et al. (2001) showed that Notch signalling is 
needed for Flt4 suppression in the DA and that flt4 mRNA persists in 
mib mutants DA. They also showed the persistence of flt4 mRNA in 
the DA coincides with loss of HSC markers expression in the vDA. On 
the other hand, Rowlinson (2010) showed that Notch over-activation 
in the whole embryo leads to flt4 mRNA suppression not only in the 
DA, but also in the CV. Moreover, Rowlinson (2010) showed that Flt4 
suppression coincides with expansion of HSC marker expression to 
include the CV. 
Interestingly, we noticed that the developing DA endothelium 
expresses flt4 as well as arterial markers such as efnb2a at 18-20hpf 
in the presence of low Notch activity as indicated by low level of the 
reporter fluorescent protein in our reporter line Tg(csl:venus)qmc61 
(Figure 4.2). However, as the Notch activity increases in the DA at 
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24h, flt4 expression becomes much weaker (Figure 4.2), and is 
completely lost at 27hpf. These findings suggest a correlation 
between up-regulation of Notch activity and suppression of flt4 
expression in the DA at the time point of HSC development.  
 
 
Figure 4.2: High level of Notch activity correlates with Flt4 
downregulation in the DA at the time point of HSC 
development. 
(A,C,E) Venus fluorescent protein expression in Tg(csl:venus)qmc61 
showing an increase in the Venus fluorescent protein from 20hpf (A), 
24hpf (C), and 27hpf (E). (B,D,F) In situ hybridization of flt4 
expression showing strong flt4 expression in the DA at 20hpf (B). flt4 
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expression become hardly detectable in the DA as the Notch activity 
increase in the DA (D), flt4 expression become completely lost at 
27hpf (F).  
 
4.4 Blocking Notch pathway with different 
approaches leads to absence of HSCs markers in the 
vDA but with differential effects on arterial 
specification. 
In our lab it was noticed that blockade of the Notch pathway in the 
mib mutants or rbpja/b morphants leads to loss of expression of both 
arterial and haematopoietic markers, whereas blocking Notch 
pathway pharmacologically with γ-secretase inhibitor (DAPM) leads 
only loss of haematopoietic markers but with intact arterial 
specification. To confirm earlier findings, a double transgenic/mutant 
fish was generated by crossing an identified mind bomb (mibta52b) 
carrier to a heterozygous Tg(csl:venus)qmc61 fish, then the Venus 
positive embryos were grown to adulthood. At adulthood, these fish 
were characterised to carry the mib mutation by crossing them to 
known mib carriers and observing the distinct neurogenic, 
somitogenic and vasculogenic phenotypes, and also the absence of 
pigmentation in their trunk and tail (white tail) starting from day2 
(Jiang et al., 1996, Schier et al., 1996). 
 The identified mib+/-/venus+/- males were then crossed to mib mib+/- 
females and embryos were collected from these crosses at 24hpf for 
efnb2a in situ hybridization, and at 26hpf for flt4 and runx1 in situ 
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hybridization and for fluorescent microscopy. I also crossed 
Tg(csl:venus)qmc61+/- male to WT females and separated collected 
embryos into three batches, then  injected the first batch with rbpja/b 
morpholinos (see Methods), and treated the second batch with the γ-
secretase inhibitor DAPM from 9 hpf  till the time collected for in situ, 
while the third batch was left un-treated as negative control. Embryos 
from the three batches were also collected at 24hpf for efnb2a in situ 
and at 26hpf for flt4 and runx1 in situ hybridization and also for 
fluorescent microscopy. 
 
Table 4.1: Summary of Notch inhibition approaches used and 
percentage expected to be affected in each experiment.  
sample crosses treatment affected 
embryos 
affected and 
Venus +ve 
mib 
mutants 
mib+/-/csl:venus+/- ♂ X 
mib+/- ♀ 
mib 
mutation 
25% 12.5% 
DAPM  
treated  
csl:venus+/- ♂ X WT ♀ DAPM 
treatment 
100% 50% 
rbpja/b 
Morphants 
csl:venus+/- ♂ X WT ♀ rbpja/b 
Mo. 
100% 50% 
Control csl:venus+/- ♂ X WT ♀ None 100% 50% 
       
4.5 Blocking Notch pathway with different 
approaches differentially affect Notch reporter 
expression in the DA. 
Even though the three approaches shown in Table 4.1 dramatically 
reduced Notch signalling in the whole embryo, I noticed that some 
Venus protein remained with each of the approaches used, with the 
mib mutants having the least venus expression, as only some cells in 
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the heart and the inner ear were still expressing the reporter gene 
(Figure 4.3 A-B’). On the other hand, parts of the brain remained 
Notch-active in the rbpja/b morphants and DAPM treated embryos 
(Figure 4.3 C-F’). Moreover, in DAPM treated embryos some 
remaining Notch reporter expression was still detectable in the DA 
(Figure 4.3 E-F’). 
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Figure 4.3 Blocking Notch pathway with different approaches 
differentially affects Notch reporter expression. 
(A-B) Comparison of Venus fluorescent protein expression at 30hpf 
in Tg(csl:venus)qmc61+/- (A) compared to 
mibta52b+/+/Tg(csl:venus)qmc61+/- (B) showing a complete loss of Venus 
protein in the whole embryo except the heart (white arrowhead in B') 
and the inner ear (blue arrowhead in B'), which showed Venus 
fluorescent protein starting from 30hpf.  B' is amplification of the 
boxed area in B. (C-D) Comparison of Venus fluorescent protein at 
26hpf in Tg(csl:venus)qmc61+/- (C) compared to their rbpja/b 
morphant siblings(D), showing a complete loss of Venus fluorescent 
protein in the trunk and tail, whereas there is some remaining venus 
expression in the brain, inner ear (blue arrowhead in D') and hind 
brain (yellow arrowhead in D'). D' is magnification of the boxed area 
in D. (E-F) Comparison of Venus fluorescent protein at 26hpf in 
Tg(csl:venus)qmc61+/- (E) compared to their DAPM treated siblings (F), 
showing a weak venus expression in the DA (red arrows) and the 
medial fin fold. A weak venus expression is also seen in the head and 
neck region, the brain and the inner ear. F' is magnification of the 
boxed area in F.  
 
 
To understand how the remaining Notch signalling using each of these 
approaches affects arterial specification and HSC development, in situ 
hybridization was performed on embryos from the four batches for 
endothelial and haematopoietic markers expression in these embryos 
(Figure 4.4). In situ hybridization results showed a complete loss of 
the HSC marker  runx1 in all treated embryos. While consistent with 
fluorescent microscopy data, the arterial marker efnb2a was 
maintained in DAPM treated embryos, while lost in mib mutants and 
rbpja/b morphants. Moreover, the venus marker flt4 suppression in 
the DA failed in all three approaches.  
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Figure 4.4 Blocking Notch pathway with different approaches 
differentially affect arterial and haematopoietic specification. 
Whole mount in situ hybridization of efnb2a, flt4 and runx1 
expression of  WT (A-C) and Notch inhibited embryos (D-L). In WT 
efnb2a expression is restricted to the DA at 24hpf (blue arrow in A), 
while flt4 is suppressed from DA and only present in the CV at 26hpf 
(B), whereas runx1 is only seen in the vDA at 26hpf. Inhibiting Notch 
pathway with DAPM does not affect the arterial identity of the DA and 
expression of efnb2a is still seen in the DA (blue arrow D), but it fails 
to suppress flt4 (red arrow in E), and also losses expression of the 
haematopoietic marker runx1 (F). Blocking Notch pathway with the 
rbpja/b morpholinos leads to complete loss of arterial marker 
expression in the DA (G), failing to suppress flt4 in the DA (H), and 
also losing the haematopoietic marker runx1 (I). In mib mutants, the 
arterial marker efnb2a was lost in the DA (J), suppression of flt4 in 
same tissue failed (K), and  also expression of the haematopoietic 
marker runx1 was lost (L). 
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4.6 Quantification of the residual Notch activity revealed 
that low level of Notch is sufficient for arterial gene 
expression while high levels are required for hEC 
induction   
To quantify the residual Notch activity in DAPM treated embryos and 
mib mutants compared to un-treated controls, the sampling protocol 
included in materials and methods was followed, then total RNA was 
extracted from all three groups, reverse transcribed, then the 
remaining Notch levels was quantified with real time PCR on cDNA 
from three biological samples for each of the three groups. The 
results showed that the most efficient inhibition of Notch pathway 
was with mib mutation, while Notch activity was partially maintained 
in DAPM treated embryos. A summary of the results is shown in 
Figure 4.5. 
Together, quantitative RT-PCR data, in agreement with both in situ 
hybridization and fluorescent microscopy, suggest that high levels of 
Notch are required in the DA after arterial specification to suppress 
venous fate and to initiate HSCs specification, while low level of Notch 
activity is sufficient to support the arterial fate of the DA.   
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 Figure 4.5 Notch reporter remaining levels in DAPM treated 
and mib mutants compared to un-treated control. 
(A)Amplification plot showing cycles difference between DAPM 
treated and mib mutants compared to un-treated control. (B) 
Histogram of remaining Notch reporter mRNA compared to ef1α 
mRNA by RT-PCR. (C) Magnification of the boxed area in (B). 
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4.7 Discussion of results 
During zebrafish development, the haemogenic endothelial 
progenitors specified from the posterior lateral mesoderm migrate to 
the midline to form the main axial vessels, the DA and the CV. At 
18hpf, these progenitor cells further specify into arterial or venous 
endothelial and organize to form the developing DA and CV. Arterial 
and venous specification are determined by expression of the arterial 
markers such as efnb2a for arterial specification, and flt4 for venous 
specification.  
Notch is known to act upstream of efnb2a to regulate arterial 
specification at this developmental stage. In the previous chapter we 
showed that Notch activity persists at a high level in the DA after 
arterial specification, thus suggesting that a high Notch signal is 
required for HSCs specification from the vDA. In this chapter we 
performed a semi-quantification analysis of DA fluorescent protein 
intensity after arterial specification and until the time point of HSCs 
specification. Our analysis showed a remarkable increase in the 
reporter protein intensity from 20hpf to 27hpf, which further supports 
the theory that high Notch signal is required for HSCs specification.  
During the early stages of arterial specification of the DA, both efnb2a 
and flt4 are expressed in this region, then flt4 expression becomes 
undetectable in the DA by the time of HSCs emergence. Notch was 
shown previously to act upstream of flt4 suppression (Lawson et al., 
2001). Our in situ data show that downregulation of flt4 after arterial 
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specification coincides with the upregulation in Notch activity. The 
fact that flt4 expression is maintained in the DA when Notch activity 
is low while it is lost at higher levels suggests that a high Notch 
activity may be required after arterial specification to suppress flt4 
expression in the DA.  
Consistent with this, we found that blocking Notch pathway in mib 
mutants or rbpja/b morphants led to loss of both arterial specification 
and HSCs development, while blocking Notch pathway with the less 
efficient approach (DAPM treatment) only interferes with HSCs 
specification. To confirm fluorescent microscopy and in situ 
hybridization data, we also quantified the remaining Notch reporter 
mRNA in mib mutants and DAPM treated embryos by RT-PCR and 
found less remaining Notch activity in mib mutants.  
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CHAPTER 5 
5 Result III   Developing a molecular tool to over-
activate/ block Notch pathway in the endothelium 
 The efforts to develop molecular tools that enable mis-expressing 
Notch signalling pathway specifically in the endothelium started in the 
Gering lab a few years before starting this PhD project. These efforts 
yielded the generation and characterization of several transgenic 
lines, including Tg(flk1:cre)qmc101 and Tg(flk1:cre-ERT)qmc104. 
Crossing these lines to the (Sinha et al., 2010) cre reporter line 
Tg(ef1α:loxP-gfp-loxP-dsRed2) which was received as a kind gift from 
Dr. Bally-Cuif’s lab. The line was shown to drive cre induced 
recombination, specifically in the endothelial progenitors and the cells 
derived from them in temporal and spatial manners (Jalali, 2012). 
The next step was when the former student in the lab (H. Stone) 
replaced the dsRed in the cre reporter line with either nicd or dnRbpj 
genes shown to over-activate/block Notch pathway in zebrafish 
respectively (Latimer et al., 2002, Scheer and Campos-Ortega, 
1999). The new constructs were then injected by Dr. M. Gering to 
establish the lines then grown to adulthood. At this stage, I took over 
and started by characterising the injected fish to identify F0 founders 
that have the injected constructs in their germlines. The plan was 
then to cross the identified transgenic fish to the Tg(flk1:cre)qmc101 or 
Tg(flk1:cre-ERT)qmc104 lines to specifically recombine and over-
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activate/block Notch pathway in the endothelium and study the cell 
autonomous requirements for Notch in zebrafish HSCs formation. 
In addition to the described experiments, I also cloned the mouse 
rosa26 promoter and used to replace the ef1α in the Sinha et al. 
(2010) Cre reporter  after successful use of rosa26 as a ubiquitous 
promoter in frogs (Gross et al., 2006) however no zygotic expression 
of the floxed fluorescent gene was detected. I also tried the emerging 
genome editing tools CRISPR and PhiC31 Integrase to specifically 
integrate the cre gene or the gal4-vp16 downstream of the gfi1.1 
promoter in our gfi1.1 gene trap line Tg(gfi1.1:gfp)qmc551, however 
none of these efforts were successful.  
 
5.1  Identification of ef1α nicd and Ef1α dnrbpj 
transgenic founders. 
Embryos with mosaic cerulean expression after  injection with the 
tol2 constructs (ef1α-loxP-cer-loxP-dnRbpj and ef1α-loxP-cer-loxP- 
nicd) were grown to adulthood. These fish were then crossed with 
wild type fish and their progenies were observed for cerulean 
expression on day one. Out of  7390 embryos examined,   72 embryos 
from 6 transgenic founders were identified, as shown in Tables 5.1 
and 5.2). 
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Table 5.1: Identified Tg(ef1α-loxP-cer-loxP-nicd) transgenic 
founders. 
ef1α nicd Identified founders 
Founder 
Name 
Cerulean+ 
embryos 
Normal 
embryos 
Level of 
expression 
Survived 
to day 5 
Line 
established 
qmc121 3 Yes Low Yes Yes 
qmc122 1 Yes Low Yes Yes 
qmc123 5 No Strong No No 
qmc124 4 Yes Extremely 
low 
Expression 
lost 
No 
  
Table 5.2 Identified Tg(ef1α-loxP-cer-loxP-dnRbpj) 
transgenic founders. 
ef1α dnRbpj Identified Founders 
founder 
Name 
Cerulean+ 
embryos 
Normal 
embryos 
Level of 
expression 
Survived 
to day 5 
Line 
established 
qmc131 23 yes Strong Yes Yes 
qmc132 33 yes Strong Yes Yes 
 
As shown in Tables 5.1 and 5.2, even though four transgenic founders 
were identified for Tg(ef1α-loxP-cer-loxP- nicd), only two lines were 
established, Tg(ef1α-loxP-cer-loxP- nicd)qmc121 and Tg(ef1α-loxP-cer-
loxP-nicd)qmc122; see Figure 5.1). This was because the transgenic 
embryos from the other founders either had extremely weak cerulean 
levels and their expression was lost on day 4 (qmc124), or they did 
not survive due to the severe abnormalities associated with strong 
cerulean expression, (qmc123; see Figure 5.1).  
On the other hand, four transgenic founders were identified for the 
other construct, the ef1α-loxP-cer-loxP-dnRbpj. Their progenies 
showed decent and stable cerulean expression and displayed no 
visible abnormalities.  The fact that the Tg(ef1α-loxP-cer-loxP-nicd) 
embryos with strong cerulean expression were abnormal, and 
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developed severe phenotypes and died early in development raised 
the possibility of premature Notch over-activation from a readthrough 
the polyA in the loxP floxed fragment and expression of nicd even 
before the Cre recombination. Read-through the SV40 polyA 
termination signal was previously detected by in situ hybridization in 
transgenic embryos with similar constructs (Drew, 2010). Based on 
these observations, we expected that the established lines, Tg(ef1α-
loxP-cer-loxP-nicd)qmc121 and Tg(ef1α-loxP-cer-loxP-nicd)qmc122, 
despite their low ef1α activity, are still able to over-activate the Notch 
pathway in the endothelium after the Cre recombination.    
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Figure 5.1 identified Tg(ef1α-loxP-cer-loxP-nicd) and Tg(ef1α-
loxP-cer-loxP-dnRbpj) transgenics. 
(A-F) Fluorescent images of identified F1 nicd and dnRbpj 
transgenics.  (A-B) The established transgenic lines Tg(ef1α-loxP-cer-
loxP-nicd)qmc121 and Tg(ef1α-loxP-cer-loxP-nicd)qmc122 F1 showing 
weak ubiquitous cerulean  expression compared to their WT siblings. 
(C-D) Embryos from the other two founders with (C) showing strong 
cerulean expression but with severe defects and (D) showing 
extremely weak ubiquitis cerulean expression. (E-F) Established 
transgenic lines Tg(ef1α-loxP-cer-loxP-dnRbpj)qmc131 and Tg(ef1α-
loxP-cer-loxP-dnRbpj)qmc132 F1 showing strong ubiquitous cerulean  
expression compared to their WT siblings.  
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5.2 Injecting the transgenic Tg(ef1α-loxP-cer-loxP-
nicd) and Tg(ef1α-loxP-cer-loxP-dnRbpj) F1 embryos 
with cre mRNA 
To test whether the loxP sequences in the generated transgenics are 
intact and can be recombined by the Cre enzyme to enable activation 
of downstream genes (nicd or dnRbpj), I first injected cre mRNA into 
two cell stage embryos from these lines. The expected outcome was 
removal of the floxed fragments and over-activation/blocking the 
Notch pathway in the whole embryo. Notch over-activation in the 
whole embryo with the hsp70:gal4-uas:nicd system was previously  
shown to lead to severe somite defects, with embryos of short and 
stumpy appearance (Scheer and Campos-Ortega, 1999). On the 
other hand, Notch inhibition in the whole embryo both with non-
functioning Ubiquitin Ligase or with γ-secretase inhibitors, leads to 
abnormality in somitogenesis,  loss of pigmentation in the tail (white 
tail) and defected vascular and HSCs formation (Jiang et al., 1996, 
Schier et al., 1996). The following steps were undertaken to prepare,  
complete and validate this experiment.  
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5.2.1 cre mRNA efficiently recombines the loxP sites 
in the Cre reporter line Tg(ef1α:loxP-gfp-loxP-
dsRed2) and activates expression of downstream 
gene 
Before injecting the in-house generated cre mRNA (see Material 
Methods) to the Tg(ef1α-loxP-cer-loxP-nicd) and Tg(ef1α-loxP-cer-
loxP-dnRbpj)  lines. The cre mRNA was firstly injected to the Cre 
reporter line Tg(ef1α:loxP-gfp-loxP-dsRed2) to check whether the in-
house generated cre mRNA can be efficiently translated and whether 
the produced Cre protein is able recombine the loxP sites and so 
remove the floxed gfp in the reporter line to activate the downstream 
dsRed. It was also necessary to determine the cre mRNA amount 
required to efficiently drive the recombination with minimal toxicity 
to the embryos. To achieve this, Tg(ef1α:loxP-gfp-loxP-dsRed2) fish 
were in-crossed, then different batches of their embryos  were 
injected with 100 pg and 200 pg of cre mRNA at 1-8 cell stage, as 
shown in Table 5.3.  
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Table 5.3: cre mRNA titration. 
stage of 
injection 
cre mRNA injected gfp expression 
(day 1) 
dsRed 
expression (day 
1) 
abnormal 
embryos 
1-2 cell 
stage 
200 pg 100% 
(36)/36 
94% 
(34/36) 
8% 
(3/36) 
2 cell stage 200 pg 100% 
(48/48) 
85% 
(41/48) 
4% 
(2/48) 
4 cell stage 100 pg 100% (58/58) 84% 
(49/58) 
2% (1/58) 
4-8 cell 
stage 
100 pg 100% (41/41) 85% 
(35/41) 
2% (1/41) 
Non-
injected 
Not injected 100% 
(110/110) 
0% 
(0/110) 
0% 
(0/110) 
 
cre mRNA injections confirmed that our in-house synthesised cre 
mRNA was efficiently translated and it efficiently removed the floxed 
gfp-polyA fragment, enabling expression of the downstream dsRred 
gene. This experiment also showed that the general injection 
efficiency was about 87% (94%+85%+84%+85%/4=87%). The 
results also demonstrated that cre mRNA has a high diffusion 
capacity, even when injected at slightly later stages in development. 
It was also found that cre mRNA has low toxicity, as even with 
injecting 200 pg the death rate of injected embryos did not exceed 
8%. Together, these findings suggest that the optimal injection 
amount is 100 pg injected at 1-2 cell stage.  
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Figure 5.2 cre mRNA injection to the Cre reporter line.  
(A)Diagram showing the un-recombined structure of the Cre reporter 
line. (B) Diagram showing the Cre recombined structure of the Cre 
reporter line. (C-E) Bright field image showing Cre reporter embryo 
injected with 100pg at 1 cell stage compared to their uninjected Cre 
reporter embryos (D) and uninjected WT embryos (E) with no 
observed abnormalities. (C'-E'') Same embryos imaged with 
fluorescent microscopy with a FITC (C'-E') and aTRITC filter sets (C''-
E'').     
 
5.2.2 Injecting the generated Tg(ef1α-loxP-cer-loxP-
nicd)qmc122 with cre mRNA does not produce specific 
phenotypes 
Before over-activating Notch signalling in the endothelium, we 
wanted to test whether we could over-activate Notch in the whole 
embryo by inducing recombination and expression of nicd in all 
embryonic tissues by injecting embryos with amount of cre mRNA 
that we have established in previous step. Consequently, I crossed 
Tg(ef1α-loxP-cer-loxP-nicd)qmc121 to WT fish then injected their 
progenies with cre mRNA following procedures and amounts injected 
to the Cre reporter line in previous step. Transgenic embryos injected 
with the cre mRNA showed a reduction in cerulean expression that 
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was relative to the amount of cre mRNA injected. A summary of 
injections amounts and observed phenotypes are shown in Table 5.4. 
 
Table:5.4 cre mRNA injections to the nicd transgenic embryos 
results.  
batch  amount 
injected 
No. of 
embryos 
Notch over-activation phenotypes 
1st 
batch 
100 pg 75  no clear phenotypes  
2nd 
batch 
90 pg 134 no clear phenotypes 
3rd 
batch 
100-200 pg 82 no clear phenotypes 
 
 
5.2.3 Injecting the generated Tg(ef1α-loxP-cer-loxP- 
dnRbpj)qmc131 with cre mRNA does not block Notch 
signalling 
Next, I examined whether the Notch pathway could be blocked in the 
whole embryo by inducing recombination and expression of the 
dominant negative version of Rbpj gene (dnRbpj) in all tissue. For 
this purpose, I injected the transgenic embryos Tg(ef1α-loxP-cer-
loxP- dnRbpj)qmc131 with cre mRNA. In this experiment, six batches of 
transgenic embryos were injected with cre mRNA concentrations 
ranging from 100-200 pg.  These injected embryos  showed a 
reduction in cerulean fluorescent protein that is relative to the 
amount of cre mRNA injected (Figure 5.3 A-B). Injecting higher 
amounts of cre mRNA (200-400pg) seems to increase the efficiency 
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of recombination, but it results in higher death rates and severe 
unspecific defects on injected embryos (Figure 5.3 C-D). These 
observations are likely to be resulting from the interference of the 
high cre mRNA with the cellular activities in injected embryos. The 
fact that injecting amounts ranging between 200-400pg cre mRNA 
led to toxic defects while earlier experiments with injection of 200pg 
did not, may result from inter-experimental variation and related 
difficulties in precisely determining and controlling the amount of 
injected molecules. For example, injecting a drop size of six graticules 
instead of five on a normal dissecting microscope (estimated by the 
examiner) doubles the amount of injected volume. The other 
possibility is that the increased defective embryos were partly 
resulting from injecting needles with different tip widths.  Wider 
needle tips create larger holes in the embryo and the chorion, which 
increases damage to the developing embryonic tissues, and so 
increases abnormalities and death rates in embryos.    
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Table:5.5: cre mRNA injections to the Tg(ef1α-loxP-cer-loxP- 
dnRbpj)qmc131 embryos does not produce Notch loss of 
function phenotypes.      
Batch 
No. 
Amount 
injected 
No of 
embryos 
Presence of 
phenotypes 
Type of phenotypes 
1st 
batch 
125pg 58 No phenotypes - 
2nd 
batch 
100pg 73 50% abnormal control showed 20% 
abnormal (non-specific)  
(batch issue) 
3rd 
batch 
90pg 49 No phenotypes - 
4th 
batch 
200pg 26 17/26 (65%) looks 
abnormal 
control showed 6% 
abnormal (non-specific) 
Cerulean completely lost 
5th 
batch 
100pg 47 No phenotypes - 
Cerulean greatly 
reduced 
6th 
batch 
150&200pg 81 No phenotypes - 
Crossed to the cre 
reporter Tg  
(can’t see Cer. as Gfp very 
strong and no vascular 
defects) 
7th 
batch 
200-400pg 36 Severe 
phenotypes in 
most embryos, 
death was high 
Non-specific 
phenotypes 
Cerulean either lost or 
greatly reduced 
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Figure 5.3 cre mRNA injection to Tg(ef1α-loxP-cer-loxP- 
dnRbpj)qmc131 embryos. 
Fluorescent microscopy for Tg(ef1α-loxP-cer-loxP- dnRbpj)qmc131 
uninjected controls (A,C) compared to their cre mRNA injected 
siblings (B,D) showing some remaining ubiquitis Cerulean fluorescent 
protein (yellow arrow) and normal embryological development with 
injection of 100pg of cre mRNA (B). Injecting higher amounts of cre 
mRNA on the other hand leads to almost a complete loss of Cerulean 
fluorescent protein (red arrow) and is associated with severe 
embryological development, but does not appear similar to mib 
mutants (D). 
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5.2.4 Embryos generated from crossing the Tg(ef1α-
loxP-cer-loxP-nicd)qmc122 to Tg(flk1:cre)qmc101 
appeared normal 
Mouse studies that involved Notch over-activation in the endothelium 
showed severe defects in the endothelium and absence of HSCs 
formation and eventually early death before the time point of 
definitive HSCs formation (Venkatesh et al., 2008). Because zebrafish 
embryos can live normally on diffusion in absence of blood circulation, 
we expected the survival of zebrafish embryos, despite the severe 
vascular and haematopoietic defects after endothelial Notch over-
activation. To test this hypothesis, I setup several crosses involving 
Tg(ef1α-loxP-cer-loxP-nicd)qmc122 fish to Tg(flk1:cre)qmc101, then 
collected embryos were examined under microscope at 24hpf. Careful 
microscopic examination of these embryos at 24hpf showed no 
distinguishing differences between them and their controls with only 
slight delay in the initiation of blood circulation at 26hpf (which could 
be a biological difference). 
Examining the embryos with delayed circulation a few hours later,  
showed the restoration of functioning blood and vascular system. 
Moreover, inter-somatic vessels had developed normally in all 
examined embryos. Together these data suggest that endothelial 
specific recombination of the loxP sites and expression of nicd under 
ef1α in Tg(ef1α-loxP-cer-loxP-nicd)qmc122 embryos and over-
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activaation of Notch in the does not lead to distinguished blood or 
vascular defects.  These findings also agree with whole embryo Cre 
mediated recombination in Tg(ef1α-loxP-cer-loxP-nicd)qmc122,  which 
did not show any clear Notch  specific phenotypes. Together, the two 
experiments suggest that the amount produced of Nicd protein was 
not sufficient to overcome the homeostasis in embryos. A higher 
amount of endothelial specific Nicd protein may be need to be 
produced to over-come endothelial toleration for the produced Nicd 
in the embryo. 
 
5.2.5 Embryos generated from crossing the Tg(ef1α-
loxP-cer-loxP- dnRbpj)qmc131 to Tg(flk1:cre)qmc101 
appeared normal 
In order to block Notch pathway specifically in the endothelium, I 
setup several crosses with Tg(ef1α-loxP-cer-loxP- dnRbpj)qmc131 
crossed to Tg(flk1:cre)qmc101. No published data are currently 
available about blocking Notch specifically in the endothelium in the 
zebrafish animal model. In mice, blocking the Notch pathway either 
in the whole embryo in Notch -/- mutants or specifically in the 
endothelium both lead to severe vascular remodelling defects and 
early death of mouse embryos at E.10.5 (Kumano et al., 2003, Krebs 
et al., 2004). Blocking Notch pathway in in zebrafish whole embryo 
with different approaches is also associated with severe vascular and 
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haematopoietic defects (Gering and Patient, 2005, Lawson et al., 
2001). These studies strongly suggest that blocking Notch pathway 
in the endothelium affects vascular and hematopoietic development, 
however none of the embryos resulting from crossing the Tg(ef1α-
loxP-cer-loxP- dnRbpj)qmc131 to Tg(flk1:cre)qmc101 showed vascular or 
haematopoietic defects, even when examined at later times in 
development (days2-5). 
This observation, together with earlier findings, all suggest that the 
amounts of Nicd or DnRbpj proteins produced in the endothelium in 
both experiments were not sufficient to over-activate/block the Notch 
pathway. 
A stronger promoter may be required for production of higher levels 
of both Nicd and DnRbpj proteins to overcome cellular tolerance. 
Recently, Mosimann et al. (2011) identified a 3.6 kb DNA fragment 
in the zebrafish genome that is homologous to human ubiquitin 
promoter (zebrafish ubi promoter). Generation of transgenic lines 
having this ubi promoter upstream of fluorescent proteins genes  
showed strong ubiquitous expression of downstream genes as soon 
as the zygotic genome transcription begins. The expression of 
fluorescent proteins then persisted in in all examined tissues 
throughout the embryonic development (Mosimann et al., 2011). To 
improve our Notch mis-expressing constructs, we decided to replace 
the ef1α promoter in our constructs with the zebrafish ubiquitin 
promoter.  
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5.2.6 Using the zebrasish ubi promoter instead of the 
ef1α promoter 
A plasmid containing the zebrafish ubi promoter was received as a 
kind gift from Dr. R. Wilkinson, Sheffield University. To enable 
replacing the ef1α promoter in our tol2- ef1α-loxP-cerulean-pA- loxP- 
nicd and the tol2-ef1α- loxP-cerulean-pA- loxP-dnRbpj constructs, I 
amplified the ubi promoter with addition of restriction sites that 
enable its insertion instead of the ef1α promoter (see Appendix 6 for 
cloning procedures). The final new constructs were then verified by 
restriction analysis and partial sequencing, then they were given the 
database names tol2-ubi-loxP-cerulean-pA-loxP-nicd (P325) and 
tol2-ubi-loxP-cerulean-pA-loxP-dnRbpj (P323).  
 
5.2.7 Injecting the P323 and P325 constructs and 
establishment of the Tg(ubi-loxP-cer-loxP-nicd) and 
Tg(ubi-loxP-cer-loxP-dnRbpj) lines 
WT in-crosses were setup with dividers then embryos were collected 
the next day as soon as they were laid.   Next, about 25pg of the 
P323 or P325 constructs were co-injected with transposase mRNA to 
these WT embryos soon after their collection and before the cellular 
division was initiated. The next day, injected embryos and non-
injected controls were examined under fluorescence microscope for 
mosaic Cerulean fluorescent protein in their developing tissues. As 
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predicted, the majority of injected embryos showed mosaic cerulean 
expression and appeared normal. The results also showed that 
Cerulean positive cells contribute to the growing tissues with no signs 
of toxicity. Positive embryos were then sorted and kept in 28.5ºC 
untill day5, then 50 embryos of each batch were grown in the 
aquarium to establish the transgenic lines Tg(ubi-loxP-cer-loxP-nicd) 
and Tg(ubi-loxP-cer-loxP-dnRbpj). 
 
5.2.8 Screening the P323 and P325 injected fish for 
Tg(ubi-loxP-cer-loxP-nicd) and Tg(ubi-loxP-cer-
loxP-dnRbpj) founders. 
The putative founders of the two transgenic lines Tg(ubi-loxP-cer-
loxP-nicd) and Tg(ubi-loxP-cer-loxP-dnRbpj) were checked frequently 
until adulthood. Among the 50 embryos grown for  Tg(ubi-loxP-cer-
loxP-nicd), 34 survived until adulthood. On the other hand only 18 
fish reached adulthood for Tg(ubi-loxP-cer-loxP-dnRbpj). The 
surviving putative founders were then out-crossed to WT fish and 
their progenies were examined for cerulean expression on day one. 
Screening embryos from nine successful crosses of the Tg(ubi-loxP-
cer-loxP-nicd) with WT resulted in identification of one founder that 
gave living embryos with good ubiquitous cerulean expression 
starting from day 1 and remained positive till day 5 (Figure 5.4 A). 
From this cross, 424 embryos were examined, and 84 were found 
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positive (about 20% transgenesis). Identified fish were then given 
the name Tg(ubi-loxP-cer-loxP-nicd)qmc125 F0 and 50 Cerulean 
positive embryos of its progeny were grown in the aquarium as F1 
generation of  this line. On the other hand, out of  the 18 Tg(ubi-loxP-
cer-loxP-dnRbpj) putative founders, only 10 were found to be fertile 
and gave aliving embryos, however screening all embryos from these 
10 putative founders,  revealed that none of them was positive for 
Cerulean fluorescent protein. 
  
 
Figure 5.4 ubi promoter drive ubiquitous cerulean expression 
in Tg(ubi-loxP-cer-loxP-nicd)qmc125 F1. 
(A-B) Fluorescent microscopy of Tg(ubi-loxP-cer-loxP-nicd)qmc125 F1 
embryos (A) compared to WT on day 2. ubi promoter in Tg(ubi-loxP-
cer-loxP-nicd)qmc125 line leads to decent ubiquitous expression of the 
cerulean gene. 
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5.2.9 Injecting the Tg(ubi-loxP-cer-loxP-nicd)qmc125 
embryos with cre mRNA 
To investigate whether recombining the loxP sites in the whole 
embryo would lead to phenotypes similar to those previously 
published with the Gal4-Uas system by Scheer and Campos-Ortega 
(1999). For this, I injected cre mRNA into Tg(ubi-loxP-cer-loxP-
nicd)qmc125 embryos at one cell stage as with earlier similar 
experiments,  then the embryos were observed for blood and vascular 
endothelial defects and for loss of cerulean expression. cre mRNA 
injected Tg(ubi-loxP-cer-loxP-nicd)qmc125 embryos showed a 
reduction in cerulean expression relative to the amount of cre mRNA 
injected. When higher amounts of cre mRNA (200 pg) were injected, 
a significant loss in cerulean expression was observed with 
phenotypes similar to that seen in Notch over-activation in the whole 
embryo with the Hsp70 GAL4-UAS Nicd system by Scheer and 
Campos-Ortega (1999). Observed phenotypes were neural and 
somatic deformation with a short and stumpy appearance (Figure 5.5 
B-B'). Unlike the phenotypes observed with Notch over-activation 
with Gal4-Uas system, the phenotypes observed in injected embryos 
appeared less severe and were partially reversed later in 
development.  
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Figure 5.5 Injecting cre mRNA to the Tg(ubi-loxP-cer-loxP-
nicd)qmc125 embryos produce neurological and somatic 
phenotypes. 
(A-B) Bright field microscopy of uninjected (A) and cre mRNA injected 
Tg(ubi-loxP-cer-loxP-nicd)qmc125 embryo on day one. Injected 
embryos appeared shorter and with neural and somatic 
abnormalities. (A',B') Fluorescent microscopy of the same embryos 
showing reduction in cerulean expression in cre mRNA injected 
embryo (B') compared to non-injected sibling (A'). 
 
    
Following these observations, I crossed Tg(ubi-loxP-cer-loxP-
nicd)qmc125 to Tg(flk1:cre)qmc101 and examined their progenies for 
vascular and haematopoietic defects. Yet, out of more than 300 
embryos examined, none appeared distinguishable from WT controls. 
Careful examination of these embryos also showed normal vascular 
development and normal blood circulation, which suggests that 
endothelial produced Nicd after endothelial recombination was 
tolerable for the embryos. 
Putting together  the data collected from the first two lines generated 
with ef1α promoter that showed high death rates among embryos 
with high cerulean expression and the high death and low fertility rate 
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among grown the Tg(ubi-loxP-cer-loxP-dnRbpj) fish. This is added to 
the read-through reported by the former student in the lab 
concerning embryos having similar transgenic structures (Drew, 
2010), read-through and premature expression of nicd/dnRbpj genes 
before recombination and removal of the floxed cerulean-polyA 
fragment in our injected embryos is evident. Consequently, we were 
not be able to generate transgenic lines with strong, ubiquitous 
cerulean expression or the downstream nicd/dnRbpj after the 
recombination. The read-through issue was also previously reported 
with experiments in the mouse model, and several strategies  were 
devised to overcome this problem.  
One of the strategies used, was including more than one polyA stop 
signal in the floxed cassette, such as the using a super stop cassette 
by  Jackson et al. (2001). In Jackson's super stop cassette, four 
consecutive SV40 polyA signals were employed and shown to provide 
much higher efficiency in blocking read-through. A similar super stop 
cassette was also shown to be effective in the zebrafish animal model 
(Bertrand et al., 2010a). To further improve our tol2-ubi-loxP-
cerulean-pA-loxP-nicd (P325) and tol2-ef1α-loxP-cerulean-pA-loxP-
dnRbpj (P323), I decided to replace the single polyA signal in these 
constructs with the four polyA cassette described by Jackson et al. 
(2001).  This is to efficiently silence the nicd and dnRbpj genes before 
the recombination, and so enable the survival of embryos in cases at 
which these constructs get integrated in open chromatin and in higher 
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supportive regions, thus achieving higher levels of expression of the 
studied genes after recombination. 
 
5.2.10 Generation of the tol2-ubi-loxP-mCherry-
s.stop-loxP-nicd (P351) and tol2-ubi-loxP-mCherry-
s.stop-loxP-dnRbpj (P352) Constructs  
In order to replace the polyA sequence in both P323 and P325 
constructs with the s.stop cassette, I ordered the plasmid  published 
by Jackson et al. (2001) from Addgene (ID 11584). The s.stop 
cassette and the mCherry gene was then used to replace the cerulean 
polyA fragments in P323 and P325 constructs following the cloning 
steps described in Appendix 7. This resulted in the generation of the 
constructs: tol2-ubi-loxP-mCherry-s.stop-loxP-nicd (P351) and tol2-
ubi-loxP-mCherry-s.stop-loxP-dnRbpj (P352).  
 
5.2.11 Injecting the P351 and P352 constructs and 
establishment of Tg(ubi-loxP-mCherry-s.stop-loxP-
nicd) and Tg(ubi-loxP-mCherry-s.stop-loxP-dnRbpj) 
lines  
P351 and P352 constructs injections were performed following the 
steps used to generate earlier described transgenic lines. Injected 
embryos were then examined for mosaic mCherry expression and 
positive embryos were sorted (see Figure 5.6).  50 normal mCherry 
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positive embryos were picked and grown from each batch to establish 
the transgenic lines Tg(ubi-loxP-mCherry-s.stop-loxP-nicd) and 
Tg(ubi-loxP-mCherry-s.stop-loxP-dnRbpj).  
When the grown embryos reached adulthood, they were screened for 
potential founders, and several lines were identified with slight 
variation in the levels of the ubiquitously expressed mCherry gene. 
Out of the several identified founders, one representative founder for 
the Nicd experiment was selected and named Tg(ubi-loxP-mCherry-
s.stop-loxP-nicd)qmc127 and one representative of the founder for 
dnRbpj was selected and named Tg(ubi-loxP-mCherry-s.stop-loxP-
dnRbpj)qmc129; mCherry positive embryos from these two founders 
(Figure 5.6 E-F F) were grown as F1 of these lines. 
 
161 | P a g e  
 
 
Figure 5.6 Establishment of the Tg(ubi-loxP-mCherry-s.stop-
loxP-nicd)qmc127 and Tg(ubi-loxP-mCherry-s.stop-loxP-
dnRbpj)qmc129 lines 
(A-B) Fluorescent microscopy of WT embryos co-injected with the 
constructs P351 and transposase (A) or P352 and transposase (C) 
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compared to uninjected siblings (B,D). (E-F) Fluorescent microscopy 
images showing embryos from the established transgenic lines 
Tg(ubi-loxP-mCherry-s.stop-loxP-nicd)qmc127 and Tg(ubi-loxP-
mCherry-s.stop-loxP-dnRbpj)qmc129.  
 
Following this, I crossed Tg(ubi-loxP-mCherry-s.stop-loxP-nicd)qmc127 
and Tg(ubi-loxP-mCherry-s.stop-loxP-dnRbpj)qmc129 fish to 
Tg(flk1:cre)qmc101 fish, then examined their progenies for vascular 
and haematopoietic defects. They all appeared normal with normal 
vascular development and normal blood circulation, suggesting that 
the produced Nicd or DnRbpj proteins in the endothelium were as in 
previous experiments still tolerated by the embryos.  
 
5.3 Discussion of results 
Data presented in previous chapters suggested that the migrating 
haemogenic endothelial progenitor cells become Notch active soon 
after somitogenesis, and that the early low Notch signal in these cells 
is sufficient for arterial specification, as indicated by expression of 
efnb2a by 18hpf. Maintaining Notch in the DA endothelium at high 
levels also suggests that a high Notch level is required for HSCs 
specification from the vDA. Recently, several reports have also 
demonstrated a non-cell autonomous requirement for Notch in HSCs 
specification. To improve our understanding about Notch 
requirements in haematopoietic stem cell development, we 
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generated transgenic lines to enable endothelial specific Notch over-
activation/blocking, utilizing the Cre LoxP system.  
While in mice rosa26 promoter is used to reliably drive ubiquitous 
expression of downstream genes, no similar tool is available in 
zebrafish. rosa26 promoter was also shown to drive strong ubiquitous 
expression in frogs (Gross et al., 2006), however when we injected 
constructs with rosa26 promoter up-stream of fluorescent protein 
genes into zebrafish embryo, no expression was observed in these 
embryos. We then tried to optimize currently available tools and used 
the ef1α promoter as a ubiquitous promoter in the effector transgenes 
together with the flk1:cre transgene as activator  for that transgene.  
The read-through of the pA signal in the floxed loxP cassette was one 
of the obstacles faced during this process, which likely led to 
premature expression of the downstream genes and death of 
embryos with good expression. To overcome this obstacle, we 
replaced the single pA in the floxed fragment with a super-stop 
cassette made of four pA signals to ensure complete silencing of the 
downstream gene. Another obstacle we faced was the low expression 
level of downstream gene after the Cre induced recombination and 
removal of the floxed cassette. To address this, we replaced the ef1α 
promoter in the effector transgene with the ubi promoter that was 
recently identified in the zebrafish genome by Mosimann et al. 
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(2011), and proposed to drive strong ubiquitous expression of 
downstream genes during embryogenesis and until adulthood.  
Nevertheless, activating expression of downstream genes by the ubi 
promoter was still compensated by the embryos. It was concluded 
that a system that provides a higher level of endothelial Nicd or 
DnRbpj proteins may be required to overcome embryonic 
compensation. Therefore, we decided to further improve our 
constructs to allow production of higher levels of Nicd or DnRbpj 
proteins in the endothelium after recombination. The Gal4-Uas 
system is among the genetic tools that have been used successfully 
to over-activate Notch signalling in zebrafish whole embryo (Scheer 
and Campos-Ortega, 1999), and the system showed very efficient 
expression of genes downstream of the Uas binding sites in the 
presence of the Gal4 protein. Due to the time constraints we limited 
cloning and transgenesis experiments to endothelial specific Notch 
gain of function studies. These experiments are the main focus of the 
next chapter. 
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Chapter 6 
6 Result IV  Endothelial Notch induction is sufficient 
to expand HSCs   
6.1 Introduction 
In continuation of the optimization efforts aiming to mis-express 
Notch signalling specifically in the endothelium, and due to the 
likelihood of low expression levels of nicd or dnRbpj under the ef1α 
or ubi promoters after the endothelial Cre recombination that might 
be tolerated by the embryo. It was planned to combine both the Gal4-
Uas system and the Cre-loxP system to amplify the amount of  
produced Nicd in endothelial cells and examine whether this would 
expand HSC formation in the axial vessels and the CHT as indicated 
by expansion of the HSC marker genes like runx1, c-myb and gfi1.1. 
 
6.2 Haemogenic endothelial Notch over-activation by 
combining the GAL4-UAS and Cre-loxP systems 
6.2.1 Generating the Tol2-ubi-loxP-mCherry-s.stop-
loxP-gal4-vp16 construct 
The ubi-loxP-mCherry-s.stop-loxP-gal4-vp16 construct was 
generated by inserting a full length codon optimized  gal4-vp16 
downstream of the floxed mCherry-s.stop fragment to enable 
expression of the inserted gal4-vp16 in tissues where the floxed 
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cassette got removed by the Cre enzyme. Activation of the Gal4-vp16 
in the endothelium in the presence of the uas:nicd transgene in the 
background then leads to activation of Notch pathway specifically in 
recombined tissues. Following the cloning steps shown in (Appendix 
8), we generated the tol2 plasmid ubi-loxP-mCherry-s.stop-loxP-
gal4-vp16 and entered it in our database under the name P356.  
6.2.2 Injecting the P356 and establishment of the 
Tg(ubi-loxP-mCherry-s.stop-loxP-gal4-vp16) 
transgenic lines 
To establish transgenic lines with the newly generated tol2 plasmid 
P356,  the plasmid was co injected with transposase, then embryos 
with mosaic mCherry expression  were analysed for and 
abnormalities, then 50 appearingly normal embryos were grown in 
the aquarium to adulthood to establish the transgenic line.  
  
6.2.3 Identification of the Tg(ubi-loxP-mCherry-
s.stop-loxP-gal4-vp16) founders qmc130, qmc133, 
qmc134, qmc135 
At adulthood, 33 fish were screened for expression of the floxed 
mCherry downsteam of the ubi promoter. The screen yielded 
identification of four transgenic F0 founders. The transgenic founders 
were used to establish the qmc lines qmc130, qmc 133, qmc134 and 
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qmc135. Out of these four identified founders, two lines were found 
to express the mCherry at low levels (qmc133-qmc134), while the 
other two (qmc130, qmc135) expressed mCherry and potentially 
gal4-vp16 at stronger levels (see Figure 6.1). 
 
Figure 6.1 identification of embryos with strong 
ubiquitous expression of mCherry from outcrossing injected 
fish to WT and establishment of the transgenic lines Tg(ubi-
loxP-mCherry-s.stop-loxP-gal4-vp16)qmc130, and qmc135. 
(A) Diagram showing the main components of the P356 construct. 
(B-C) Fluorescent microscopy images of live 5days old embryos from 
outcrossing injected fish to WT. The images show strong ubiquitous 
and homogenous mCherry in all tissues. The identified fish were given 
the founder names of qmc130 and qmc135 and their mCherry 
positive embryos were grown as (F1) generations of these lines. 
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6.2.4 Generation of the triple transgenic fish 
Tg(f.flk1:cre;uas:nicd;csl:venus) 
To enable endothelial Notch induction and to enable reporting  this 
over-activation, I firstly crossed a Tg(uas:nicd) fish (Scheer and 
Campos-Ortega, 1999) to our in-house Tg(csl:venus)qmc61 fish and 
grew their embryos to adulthood. I then crossed the identified 
Tg(uas:nicd;csl:venus) double transgenic fish to the Bertrand et al. 
(2010a) Cre line that expresses the cre gene under the control of the 
full length flk1 promoter in the endothelium Tg(f.flk1:cre)s898. 
Embryos were grown to adulthood then characterized for carrying the 
three transgenes Tg(f.flk1:cre;uas:nicd;csl:venus). The identified 
triple transgenic fish was then used in combination with the Tg(ubi-
loxP-mCherry-s.stop-loxP-gal4-vp16) to enable over-activating 
Notch in the endothelium and reporting any alteration in Notch 
activity in these embryos. 
 
6.2.5 Endothelial Notch induction up-regulates 
expression of the Notch reporter gene specifically in 
the endothelium 
To over-activate Notch specifically in the endothelium, the triple 
transgenic activator fish Tg(f.flk1:cre;uas:nicd;csl:venus) was 
crossed to the effector transgenic fish  Tg(ubi-loxP-mCherry-s.stop-
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loxP-gal4-vp16)qmc135. Utilising the Notch reporter transgene in the 
background of 50% of produced embryos wherein the effect of 
endothelial recombination and activating expression of the nicd in the 
endothelium on the level of the Notch reporter fluorescent protein 
was studied. The results showed a clear up-regulation in the Venus 
fluorescent protein level in the DA and the ISV starting from day 1 
(Figure 6.2). Examining these embryos on day 1 showed even 
stronger expression of the venus gene and no expression was 
reported outside the endothelium. Quantifying the up-regulation 
showed about ten fold difference in Notch reporter fluorescence 
intensity along the DA in induced compared to un-induced embryos 
(Figure 6.3, A-D). Undesirably, we also observed that about half of 
the embryos produced from these crosses do not have a functioning 
blood circulation by day 2 (Table 6.1 shows the expected and 
observed numbers of embryos from one of these crosses).  
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Figure 6.2 Endothelial Notch induction up-regulates 
expression of the Notch reporter gene.  
Fluorescent image of live 30hpf embryos from crossing  the triple 
transgenic Tg(f.flk1:cre;uas:nicd;csl:venus) to the transgenic fish  
Tg(ubi-loxP-mCherry-s.stop-loxP-gal4-vp16)qmc135 f1 fish. (A) Shows 
a sample of a quarter of the mCherry positive-venus positive embryos 
that have also shown a strong up-regulation of the Notch reporter 
fluorescent protein Venus in the DA and ISV, as indicated by the blue 
arrow compared to their counterparts (yellow arrow) in 3/4 of the 
embryos, as shown in (B).  
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Figure 6.3 Quantification of the difference in Notch reporter 
fluorescent protein level between un-induced and endothelial 
Notch-induced embryos.  
(A-B) Fluorescent image of live 48hpf embryos from crossing  the 
triple transgenic Tg(f.flk1:cre;uas:nicd;csl:venus) to the effector 
Tg(ubi-loxP-mCherry-s.stop-loxP-gal4-vp16)qmc135 f1 fish. (A) Shows 
sample of a quarter of the mCherry positive embryos that have also 
shown strong up-regulation of the Notch reporter gene in the DA and 
ISV compared to the 3/4 counterpart embryos (B) that have low 
venus expression in the DA and ISV. (C) Comparison of intensity of 
the Venus fluorescent protein in Un-Induced and Endothelial Notch- 
induced in 650 points systematically picked along the DA. (D) 
Comparison of the means of points measurements in (C) showing 
about 10 fold increase in fluorescent protein intensity in the DA (Mean 
and SEM; **** p<0.0001; t test).    
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Table 6.1: the table shows expected and observed embryos on 
day2 with the Notch activity reported with the csl:venus 
transgene. 
Tg(ubi-loxP-mCherry-s.stop-loxP-gal4-vp16)qmc135 
                                                                                   X 
Tg(f.flk1:cre;uas:nicd;csl:venus) 
 
   Total no of embryos collected = 555 all were mCh+ve 
tg Fluorescent 
Microscopy 
phenotype expected observed 
- cre 
+ gal4 
- nicd 
- venus 
Red Normal 69.4 Normal  
Circulation 
147 
- cre 
+ gal4 
+ nicd 
- venus 
Red Normal 69.4 
+ cre 
+ gal4 
- nicd 
- venus 
Red Normal or 
 
Circulation?? 
69.4 No 
Circulation 
146 
+ cre 
+ gal4 
+ nicd 
- venus 
Red High Notch 
 
Circulation?? 
69.4 
- cre 
+ gal4 
- nicd 
+ venus 
Red+green Normal 69.4 Notch low 
Normal 
circulation 
 
130 - cre 
+ gal4 
+ nicd 
+ venus 
Red+green Normal 69.4 
+ cre 
+ gal4 
- nicd 
+ venus 
Red+green Normal 
 
Circulation?? 
69.4 Low Notch 
No 
Circulation 
61 
+ cre 
+ gal4 
+ nicd 
+ venus 
Red+ 
high green 
High Notch 
 
Circulation?? 
69.4 High Notch 
No 
Circulation 
71 
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To investigate whether loss of circulation was due to recombination 
and endothelial expression of gal4-vp16, and also to investigate 
whether observed up-regulation in Notch reporter fluorescent protein 
(Venus) was due to endothelial Notch induction and not due to loss 
of circulation. For these reasons, I performed single embryo DNA 
extraction then PCR genotyping for transgenes, as shown in Table 
6.2.  
Table 6.2: embryos used in single embryo genotyping.  
  
Observed phenotype 
No. of embryos used for single embryo 
DNA extraction and PCR genotyping  
Venus low with normal circulation 10 embryos 
Venus low with lost circulation 10 embryos 
Venus high with lost circulation 10 embryos 
 
6.3 Single embryo PCR results confirmed that 
endothelial Notch reporter up-regulation was due to 
endothelial Notch induction while lack of circulation 
might be caused by Gal4-vp16 protein accumulation  
Utilising primers that specifically recognise and amplify fragments of 
the uas:nicd and the flk1:cre transgenes, I found a 100% n=10/10 
correlation between up-regulation in Notch reporter activity and the 
presence of the  four constructs (see Figure 6.4 C-C'). I also found a 
100% n=10/10 correlation between the absence of circulation and 
endothelial recombination leading to expression of the gal4-vp16 in 
the endothelium (see Figure 6.4, B-C').   
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Figure 6.4 Single embryos PCR genotyping shows a strong 
correlation between endothelial Notch induction and Notch 
reporter fluorescent protein up-regulation.  
Two sets of primers were used (DB143 and DB144; DB162 and 
DB163) to detect and amplify  ~600bp fragment of the flk1:cre 
transgene and  ~460bp  fragment of the uas:nicd transgene 
respectively. (A-A') Shows that none of the embryos with low Notch 
reporter gene expression and normal blood circulation 0% (0/10) 
carried the flk1:cre Tg. Irrespective of presence of the uas:nicd tg.  
(B-B') Shows that 100% (10/10) embryos lost blood circulation have 
the flk1:cre tg. and that loss of blood circulation was not sufficient to 
up-regulate the  Notch reporter fluorescent protein in absence of the 
uas:nicd tg. (C-C') Shows that 100% (10/10) of the embryos that 
have high Notch reporter fluorescent protein are positive for both 
flk1:cre and uas:nicd tg. (First lanes in all gel images show NEB 
100bp ladder, whereas lanes 11 and 12 are known positive and 
negative controls).  
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It was previously reported that accumulation of Gal4-vp16 protein in 
the cells might result in interference with other genes, however as 
the cells in these embryos appeared viable and they were contributing 
to the DA and ISV,  I wanted to know if the endothelial Notch 
induction has an effect on vascular formation similar to that 
previously published in zebrafish chimera (Siekmann and Lawson, 
2007), which indicated a loss of tip cell formation in cells with over-
activated Notch activity. To investigate this, I generated the triple 
transgenic activator Tg(f.flk1:cre;f.flk1:gfp;uas:nicd) to highlight the 
endothelial cells and to enable studying their behaviour when Notch 
is induced specifically in these cells. 
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Table 6.3 the table shows expected and observed embryos on 
day2 with the vascular system highlighted with f.flk1:gfp Tg. 
Tg(ubi-loxP-mCherry-s.stop-loxP-gal4-vp16)qmc135 
                                                                                   X 
Tg(f.flk1:cre; f.flk1:gfp;uas:nicd) 
 
   Total no of embryos collected = 125 all were mCh+ve 
tg Fluorescent 
Microscopy 
phenotype expected observed 
- cre 
+ gal4 
- nicd 
- gfp 
Red Normal 15.6 Normal  
Circulation 
25 
- cre 
+ gal4 
+ nicd 
- gfp 
Red Normal 15.6 
+ cre 
+ gal4 
- nicd 
- gfp 
Red Normal or no 
 
Circulation 
15.6 No 
Circulation 
31 
+ cre 
+ gal4 
+ nicd 
- gfp 
Red High Notch 
 
Circulation 
15.6 
- cre 
+ gal4 
- nicd 
+ gfp 
Red+green 
normal vessels  
Normal 15.6 Notch low 
Normal 
circulation 
 
37 - cre 
+ gal4 
+ nicd 
+ gfp 
Red+green 
normal vessels 
Normal 15.6 
+ cre 
+ gal4 
- nicd 
+ gfp 
Red+green 
normal vessels 
Normal 
 
Circulation 
15.6 Low Notch 
No 
Circulation 
17 
+ cre 
+ gal4 
+ nicd 
+ gfp 
Red+ green 
defected vessels 
High Notch 
 
Circulation 
15.6 High Notch 
 
No ISV 
15 
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Figure 6.5 Endothelial Notch induction perturbs normal tip cell 
migration in response to VEGF signal and leads to defective 
ISV sprouting.  
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Fluorescent images of live 48hpf embryos from crossing  the triple 
transgenic Tg(f.flk1:cre;f.flk1:gfp;uas:nicd) to Tg(ubi-loxP-mCherry-
s.stop-loxP-gal4-vp16)qmc135 f1 fish. (A) Shows sample of a quarter 
of the MCherry;Gfp positive embryos that have also shown failure of 
proper ISV formation and restriction of branches to mid somites. (B) 
A sample of the three quarters of embryos with normal ISV formation 
(A' and B' are higher magnification views of the boxed region in A and 
B.  (C-D) are samples of embryos on day 3 with (C) showing a clear 
failure in ISV sprouting (yellow arrow) and shunting at the mid 
somites  (blue arrow) compared to normal ISV sprouting in (D). 
 
Interestingly, only half of embryos with lost circulation had defected 
ISV formation and absence of tip cells (Figure 6.5), so we wanted to 
know whether this phenotype was due to over-activation of Notch in 
these cells. To address this question, I performed single embryo 
genomic DNA extraction then PCR genotyping, as in the previous 
experiment from embryos, as summarised in Table 6.4. 
 Table 6.4: embryos used in single embryo genotyping. 
Observed phenotype No. of embryos used for single embryo 
DNA extraction and PCR genotyping  
Normal ISV formation with normal circulation 10 embryos 
Normal ISV with  lost circulation 10 embryos 
Defected ISV with lost circulation 10 embryos 
 
6.4  PCR results showed strong correlation between 
endothelial Notch induction and ISV defects and loss 
of tip cells: 
While the PCR results showed 100% n=10/10 of embryos that lack 
the transgene uas:nicd have proper ISV formation  regardless of 
maintaining or absence of blood circulation, 80% n=8/10 of the 
embryos with defective ISV and lack of tip cells had the four 
transgenes; the ubi-loxP-mCherry-s.stop-loxP-gal4-vp16; f.flk1:cre; 
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f.flk1:gfp; uas:nicd (Figure 6.6, A-C'). However, the negative PCR 
results for two embryos shown in Figure, 6.6 C' may be due to 
technical problems due to incorrect sorting or PCR failure. The other 
possibility is that these two embryos had higher endothelial Gal4-
vp16 activity, which led to earlier defects in the vascular system and 
prevented ISV and tip cells formation. 
     
 
Figure 6.6 Single embryos PCR genotyping shows a strong 
correlation between endothelial Notch induction and defected 
ISV sprouting and absence of tip cells. 
Two sets of primers were used (DB143 and DB144; DB162 and 
DB163) to detect and amplify  ~600bp fragment of the f.flk1:cre 
transgene and  ~460bp  fragment of the uas:nicd transgene 
respectively. (A-A') Shows that none of the embryos with normal ISV 
formation and normal blood circulation 0% (0/10) carry the f.flk1:cre 
Tg, irrespective of the presence of the uas:nicd transgene. (B-B') 
Shows that 100% (10/10) embryos that lost blood circulation have 
the f.flk1:cre transgene and that loss of blood circulation does not 
affect ISV sprouting in absence of the uas:nicd transgene. (C-C') 
Shows that 100% (10/10) of the embryos with lost blood circulation 
and defected ISV sprouting have the f.flk1:cre and most of them 80% 
(8/10) also have the uas:nicd transgene (the first lane in all gel 
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images shows NEB 100bp ladder, lanes 11 and 12 are known positive 
and negative controls).  
 
 
We then wanted to investigate whether Notch endothelial induction 
in these embryos lead to up-regulation of HSCs formation, so in situ 
hybridization was performed on embryos from the same crosses 
stopped and fixed at 26 hpf (Figure 6.7). 
  
 
Figure 6.7 Endothelial Notch induction partially recue the loss 
of HSC formation caused by accumulation of Gal4-vp16 
protein in the endothelium. 
Whole mount in situ hybridization of gfi1.1, runx1, efnb2a and flt4 
expression at 26hpf in mCherry positive embryos resulting from 
crossing Tg(ubi-loxP-mCherry-s.stop-loxP-gal4vp16) to 
Tg(f.flk1:cre; uas:nicd) fish. (A) Red arrow heads show normal gfi1.1 
expression in the vDA compared to severely reduced expression 
indicated by the green arrowheads (B) or complete loss of gfi1.1 
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expression in the vDA (C). (D) Red arrow heads show normal runx1 
expression in the vDA compared to reduced expression indicated by 
the green arrowheads (E) or complete loss of runx1 expression in the 
vDA (F). (G) Red arrow heads show normal efnb2a expression in the 
DA. (H) Red arrow heads show normal flt4 expression in the CV. 
 
 
From in situ hybridization analysis, it appears that both DA and CV 
were specified correctly as indicated by maintaining their normal 
expression of arterial and venous genes in all embryos (Figure 6.7 G-
H). On the other hand, in situ hybridization data suggest that 
accumulation of Gal4 in the endothelial cells that we found to affect 
blood circulation also severely reduce HSCs markers expression as 
indicated by the severe reduction in runx1 and gfi1.1 expression (see 
Figure 6.7, A-F). The fact that around a quarter of these embryos 
have partially maintained runx1 and gfi1.1 (Figure 6.7, B-HE) also 
suggests that over-expressing Notch in the endothelium partially 
rescues HSCs in these embryos. However, genotyping of embryos 
with partial HSCs markers expression is still needed to confirm these 
findings.  
 
6.5 Generating the hsp-loxP-mCherry-pA-loxP-tgal4-
vp16 construct P385 
To eliminate the undesired effects of the Gal4-vp16 accumulation in 
the endothelium, and to add a temporal control on when to over-
activate Notch in the endothelium. For this, I further modified  the 
construct by attenuating the effect of Gal4-vp16 protein through 
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truncating its last 20 amino acids sequence as previously published 
(Davison et al., 2007, Inbal et al., 2006, Koster and Fraser, 2001, 
Sagasti et al., 2005, Scott et al., 2007).  I then replaced the ubi 
promoter with the heat shock promoter (see Appendix 9 for cloning 
steps), which led to generating the tol2 construct hsp-loxP-mCherry-
pA-loxP-tgal4-vp16 and entered it into our database under the 
construct name P385. 
 
6.6 Injecting the P385 construct and establishment 
of Tg(hsp-loxP-mCherry-pA-loxP-tgal4-vp16) lines 
The P385 construct co-injection with transposase and identification of 
potential founders to grow were all done as in previously generated 
lines. Screening the embryos produced from these potential founders 
was done after a brief heat shock of these embryos at 37ºC, then 
they were examined for ubiquitous expression of mCherry. This led 
to the identification of three founders with varying levels of mCherry 
fluorescent protein. Embryos from these three founders were given 
the transgenic names  qmc136, qmc137 and qmc 138, with qmc136 
being the lowest in mCherry expression and qmc138 being the 
highest (Figure 6.8).  
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Figure 6.8 Establishment of the transgenic lines Tg(hsp-loxP-
mCherry-pA-loxP-tgal4-vp16) qmc136, qmc137 and qmc138. 
(A) Diagram showing the main components of the P385 construct. 
(B-D) Fluorescent images of live 24hpf embryos from outcrossing 
P385 injected fish to WT that were briefly heat shocked at 17hpf. The 
images show strong ubiquitous and homogenous mCherry expression 
in all tissues with the qmc138 line being the highest in mCherry 
expression. The identified fish were given the founders names 
qmc136, qmc137 and qmc138 and their mCherry positive embryos 
were grown as (F1) of these lines. (D-E) Comparison between a 
qmc138 transgenic embryo compared a non-transgenic sibling (E). 
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6.7 Endothelial Notch induction after heat shock 
leads to prominently high Notch activity in the 
endothelium 
To investigate the usability of our generated Tg(hsp-loxP-mCherry-
pA-loxP-tgal4-vp16) in  over-activating Notch in the endothelium,    I 
crossed Tg(hsp-loxP-mCherry-pA-loxP-tgal4-vp16)qmc138 to 
Tg(f.flk1:cre;uas:nicd;csl:venus). The resulting embryos were then 
heat shocked, then examined by fluorescent microscopy for venus 
expression. Examining these embryos showed that with this 
approach, we efficiently over-activated Notch in the endothelium, 
indicated by up-regulation of the Venus fluorescent protein in the DA 
and the ISVs (Figure 6.9). 
 
Figure 6.9 Endothelial Notch induction up-regulates 
expression of the Notch reporter gene specifically in the 
endothelium.  
Fluorescent image of live 3-day-old embryos from crossing Tg(hsp-
loxP-mCherry-pA-loxP-tgal4-vp16)qmc138 to Tg(f.flk1:cre;uas: 
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nicd;csl:venus) fish then heat shocking embryos at 17hpf then at 
40hpf. (A) A quarter of the mCherry-Venus double positive embryos 
have also shown strong up-regulation of the Notch reporter gene 
expression in the DA and ISV (the blue arrow), compared to their un-
induced counterparts (yellow arrow) in 3/4 of the embryos (B).  
 
6.8 Notch endothelial induction moderately expands 
HSC markers but most cells do not leave the DA to 
seed the CHT. 
Following fluorescent microscopy, we wanted to examine how Notch 
endothelial upregulation affects HSCs development. Endothelial 
Notch-induced embryos were stopped at 26hpf then analysed by in 
situ hybridization for expression of the haematopoietic markers 
gfi1.1, runx1and c-myb. In situ hybridization on day one showed only 
moderate up-regulation in the HSCs markers' expression. 
Interestingly, despite the normal blood circulation, it could be seen 
that  most of the positive cells were arrested in the vDA and the 
mesenchyme beneath instead of seeding the CHT (Figure 6.10).   
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Figure 6.10 HSC specification is altered with endothelial Notch 
induction. 
Whole mount in situ hybridization of gfi1.1, runx1 and c-myb 
expression at 26hpf in mCherry positive embryos resulting from 
crossing Tg(hsp-loxP-mCherry-pA-loxP-tgal4-vp16)qmc138 to 
Tg(f.flk1:cre;uas:nicd;csl:venus) fish then heat shocking their 
embryos at 17hpf. (A) Shows the normal gfi1.1 expression in the vDA 
(black arrow) compared to (B). In addition to gfi1.1 expression in the 
vDA (black arrow) also shows aggregation of gfi1.1 expressing cells 
in the mesenchyme below (red arrow heads). (C) Normal expression 
of runx1 in the vDA. Compared to (D), where in addition to runx1 
expression in the vDA (black arrow) also shows aggregation of runx1 
expressing cells in the mesenchyme below (red arrow heads). (E) 
Normal expression of c-myb in the vDA and CHT. Compared to (F) 
that in addition shows aggregation of c-myb expressing cells in the 
mesenchyme below, and the more positive cells in the CHT (red arrow 
heads). 
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Consistent with day 1 results, we also reported an expansion of the 
same HSC markers in the CHT and in the vDA on day 2. Interestingly, 
we also found that, unlike in WT that lost gfi1.1 at this developmental 
stage, gfi1.1 expression was maintained in a quarter of the transgenic 
embryos (Figure 6.11). Accumulation of positive cells in the vDA on 
day 1 and failure to downregulate gfi1.1 by day 2 both suggest that 
the continuous expression of nicd in the endothelium arrested these 
cells soon after they gained the haematopoietic fate. Thus the sharp 
drop in Notch signalling we showed earlier in this thesis may be 
critical for HSCs maturation and migration to the CHT.   
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Figure 6.11: HSC expansion persists until day 2 with Notch 
endothelial induction. 
Whole mount in situ hybridization of gfi1.1, runx1 and c-myb 
expression at 48hpf in mCherry positive embryos resulting from 
crossing Tg(hsp-loxP-mCherry-pA-loxP-tgal4-vp16)qmc138 to 
Tg(f.flk1:cre;uas:nicd;csl:venus) fish then heat shocking their 
embryos at 17hpf then at 40hpf. (A) Shows the normal down-
regulation of gfi1.1 expression in the vDA and CHT, compared to (B) 
that shows the persistence of gfi1.1 expression along the vDA (red 
arrow heads). (C) Shows the normal expression of runx1 in the vDA 
and CHT compared to (D) that in addition shows aggregation of runx1 
expressing cells in the vDA and the mesenchyme below. (E) Shows 
the normal expression of c-myb in the vDA and CHT. Compared to 
(F) that in addition shows aggregation of c-myb expressing cells in 
the vDA and mesenchyme below and more positive cells in the CHT 
(red arrow heads). 
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Next, we wanted to know if endothelial to haematopoietic transition 
is restricted to the developmental window between 28-48hpf as 
previously proposed by Bertrand et al. (2007). For this, I repeated 
the experiment but with late endothelial Notch induction. Therefore, 
in this experiment I heat shocked the embryos 40hpf then stopped 
and fixed them at 48h for in situ hybridization. In agreement with 
proposed developmental window for endothelial to haematopoietic 
transition, we also found that late endothelial Notch induction has no 
substantial effect on HSC formation (see Figure 6.12), thus giving 
direct evidence on restricting the effect of Notch induction on 
endothelial to haematopoietic transition to a confined developmental 
window. 
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Figure 6.12 Late endothelial induction does not expand HSC. 
Whole mount in situ hybridization of gfi1.1, runx1 and c-myb 
expression at 48hpf in mCherry positive embryos resulting from 
crossing Tg(hsp-loxP-mCherry-pA-loxP-tgal4-vp16)qmc138 to 
Tg(f.flk1:cre;uas:nicd;csl:venus) fish then heat shocking their 
embryos at 40hpf. (A) Shows the normal down-regulation of gfi1.1 
expression in the vDA and CHT compared to (B) that shows only a 
few cells with gfi1.1 expression along the vDA and CHT (red arrow 
heads). (C) Shows the normal expression of runx1 in the vDA and 
CHT in all examined embryos. (D) Shows the normal expression of c-
myb in the vDA and CHT in all examined embryos.  
 
 
From our previous work in the lab we noticed that transgenic fish with 
the minimal flk1 promoter m.flk1 only start expressing the 
downstream genes after 18 somites (Drew, 2010), compared to 12-
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14 somites in transgenic with the f.flk1 promoter (Bertrand et al., 
2010a). To investigate how the delay in recombination affect HSCs 
formation and if the recombination the m.flk1 promoter driven Notch 
induction is sufficient to expand HSC, I generated double transgenic 
fish Tg(m.flk1:cre;uas:nicd). I then crossed these double transgenic 
fish to Tg(hsp-loxP-mCherry-pA-loxP-tgal4-vp16)qmc138 then heat 
shocked one batch of their embryos at 17hpf and the other at 40hpf. 
The embryos were then stopped at 48hpf and fixed for in situ. In line 
with earlier data, m.flk1:cre mediated recombination and Notch 
induction showed more gfi1.1 expressing cells in the vDA and the 
mesenchyme with early heat shock (Figure 6.13 A-B) and far less 
positive cells with late induction (Figure 6.13, C-D).  
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Figure 6.13 Early endothelial Notch induction with m.flk1:cre 
promotes HSCs self-renewal while late induction does not. 
Whole mount in situ hybridization of gfi1.1 at 48hpf in mCherry 
positive embryos resulting from crossing Tg(hsp-loxP-mCherry-pA-
loxP-tgal4-vp16)qmc138 to Tg(m.flk1:cre;uas:nicd;csl:venus) fish then 
heat shocking their embryos either at 17hpf (A-B) or at 40hpf (C-D). 
(A) Shows persistent of gfi1.1 expression along the vDA (red arrow 
heads) compared to (B) that shows the normal down-regulation of 
gfi1.1 expression in the vDA and CHT. (C) Shows a very low gfi1.1 
expression in the vDA in late heat shocked embryos compared to (D) 
that shows the normal down-regulation of gfi1.1 expression in the 
vDA and CHT at this time point. 
 
 
Even though with this strategy we demonstrated that endothelial 
specific Notch induction is sufficient to expand HSC markers in the 
CHT. Yet, the fact that gfi1.1 was maintained in the DA even on day 
2 further indicates that Notch induction might only be needed 
transiently, then get switched off. This hypothesis is also supported 
by our observation of a sharp fall in Notch expression in WT DA on 
day 2.  To enable transient endothelial specific Notch induction, I 
decided to generate constructs that enable expression of nicd 
downstream of m.flk1 promoter transiently before they get diluted 
and finally degraded by the raped cellular division and the cellular 
nucleases.  
 
6.9 Generation and injection of the tol2-m.flk1:nicd-
gfp construct P405. 
To enable assembly of the tol2-m.flk1:nicd-gfp components into one 
construct, I utilised the Gibson assembly approach (Gibson et al., 
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2009).  In this process, I firstly fused the nicd gene after exclusion of 
its stop codon in-frame with the gfp gene then ligated  these fused 
genes downstream of the 2.3kb flk1 minimal promoter m.flk1. To 
facilitate construct integration to host DNA and consequently increase 
the construct half-life, and so increase expression efficiency, tol2 
backbone plasmids were used in generating the final construct P405 
(as shown in Appendix 10). I then co-injected the P405 plasmid with 
Transposase to one cell stage embryos resulting from in-crossing  the 
Tg(csl:mCherry)qmc97 Notch reporter fish.  Embryos were then then 
analysed  under fluorescent microscope for Gfp fluorescent protein 
and also for up-regulation of the Notch reporter protein mCherry in 
the endothelium. Examining injected embryos at 24hpf showed a 
strong  endothelial specific expression of the gfp fused to the nicd 
(Figure 6.14, A-B), thus indicating the level of Nicd protein produced 
in these tissues. I then examined these embryos for up-regulation of 
the Notch reporter protein mCherry in the endothelium in response 
to nicd expression. Consistent with expression of the fused nicd-gfp 
there was also a strong up-regulation in mCherry expression along 
the DA in most injected embryos (Figure 6.14, A'-B'). We also noticed  
a slight variation of mCherry expression, which is normal with 
ejection efficiency, but importantly, the level of mCherry in all 
examined embryos corresponded to the level of gfp expression. The 
co-localization of Gfp and MCherry further confirmed the correlation 
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between the up-regulation in Notch reporter and endothelial Notch 
induction by the injected construct (Figure 6.14, A''-B''). 
 
195 | P a g e  
 
 
Figure 6.14 Transient endothelial Notch induction after 
injecting the tol2-m.flk1:nicd-gfp construct P405 up-
regulates Notch reporter fluorescent protein in Notch reporter 
embryos.  
Fluorescent images of live 30hpf Notch reporter Tg(csl:mCherry)qmc97 
embryos co-injected with the tol2-m.flk1:nicd-gfp plasmid P405 
compared to their uninjected siblings. (A) Shows expression of the 
gfp fused in-frame with the nicd specifically in the endothelial tissues 
including the DA  (the blue arrow) and the ICM (yellow arrow) under 
the m.flk1 promoter, compared to complete absence of gfp 
expression in their uninjected siblings (B). (A') Shows an endothelial 
specific up-regulation of the Notch reporter fluorescent protein 
mCherry in injected embryos including the DA (blue arrow) and ICM 
(yellow arrow), compared to their uninjected siblings (B'). (A'') 
merged image of same embryos showing co-localization of gfp 
expression and mCherry up-regulation in injected embryos DA (blue 
arrow) and ICM (yellow arrow) compared to uninjected siblings. 
 
Interestingly, we observed a great reduction in gfp expression by 
48hpf (Figure 6.15) and complete loss of Gfp fluorescent protein by 
day 3. A possible explanation for this sharp down regulation of Gfp is 
the dilution of the injected construct due to the rapid cell division 
adding to the degradation of un-integrated DNA by the cellular 
machinery. On the other hand, we noticed that Notch reporter gene 
expression peaked on day 2, which is a day after Gfp (Figure 6.15). 
This delay may reflect the time needed for the Nicd-Gfp fusion protein 
to bind the csl binding sequence in the Notch reporter transgene and 
activation of  mCherry expression, and the time required to convert 
produced mRNA into mature and detectable mCherry protein. 
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Figure 6.15 Transient endothelial Notch induction after 
injecting the tol2-m.flk1:nicd-gfp plasmid P405 expand Notch 
reporter expression in CHT.  
Fluorescent images of live 48hpf Notch reporter Tg(csl:mCherry)qmc97 
embryos co-injected with the tol2-m.flk1:nicd-gfp plasmid P405 
compared to their uninjected siblings. (A-B) Show a sharp decline in 
Notch induction by day2, reflected by loss of Gfp in injected embryos. 
(A') Shows a very high  endothelial specific up-regulation of the Notch 
reporter fluorescent protein mCherry in injected embryos both in the 
DA (blue arrow) and the CHT(yellow arrow), compared to their 
uninjected siblings (B'). Boxed area in (A'-B') is magnified in (A''-B'') 
which shows high mCherry expressing round cells in the CHT (green 
arrow heads) that resemble the shape and location of the HSC.   
 
In addition, blood circulation was maintained in the majority of 
injected embryos (71/78), and even the loss of blood circulation in  
(7/78) was  likely due to injection complications rather than the Nicd 
protein up-regulation. To investigate whether this endothelial Notch 
induction was sufficient to expand the HSCs  in the DA and the CHT, 
I stopped these embryos at 48hpf and performed in situ hybridization 
on them for the HSCs markers runx1 and c-myb. In situ hybridization 
results revealed that expression of the HSCs markers runx1 and c-
myb were dramatically increased with this transient endothelial Notch 
induction, and the result showed seemingly intact HSCs 
differentiation in which more cells were able differentiate and leave 
the DA to seed the CHT (Figure 6.16). 
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Figure 6.16 Transient endothelial Notch induction in  tol2-
m.flk1:nicd-gfp injected embryos expand expression of the 
haematopoietic markers runx1 and c-myb. 
Whole mount in situ hybridization showing expression of  runx1 and 
c-myb at 48hpf in tol2-m.flk1:nicd-gfp injected embryos (A and C) 
compared to their uninjected siblings (B and D). (A) Shows dramatic 
expansion in runx1 expression in both the DA (blue arrow heads) and 
the CHT  (the yellow arrows) compared to their uninjected siblings 
(B), which only showed low runx1 expression in the CHT (yellow 
arrows). (C) Shows dramatic expansion in c-myb expression in both 
the DA (black arrow heads) and the CHT  (red arrows) compared to 
their uninjected siblings (D), that only showed c-myb expression in 
the CHT (red arrows).  
 
 
6.10 Generation and injection of the tol2-fli1:nicd-
gfp construct P409. 
Even though flk1 promoter is highly active in haemogenic endothelial 
progenitors, its activity is greatly down regulated in the AGM 
endothelial cells fated to become HSC (North et al., 2002). This down 
regulation occurs through the direct suppression of the flk1 promoter 
by the HSC transcription factor runx1, which becomes active in these 
cells (Hirai et al., 2005). To overcome this suppression, and to 
investigate the role of Notch induction in these runx1 positive cells 
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and whether maintaining Notch signalling in HSCs will further expand 
this population, we replaced the flk1 promoter with fli1 promoter in 
the tol2 backbone plasmid.  
Plasmid construction was done by the Gibson assembly method, in 
which I firstly amplified the fli1 promoter with  a 5' overlap to the tol2 
backbone plasmid and 3' overlap to nicd-gfp fusion. I then amplified 
the nicd-gfp fusion gene with a 5' overlap to fli1 promoter and 3' 
overlap to the tol2 backbone, and finally all fragments were 
assembled in one plasmid with the Gibson approach (see Appendix 
11). The final construct tol2-fli1:nicd-gfp was then entered in the 
database as P409. 
I then co-injected the construct P409 with transposase into 
Tg(csl:mCherry)qmc97 embryos, as in the previous experiment. 
Injected embryos were then analysed under fluorescent microscope 
for Gfp in the endothelium as an indicator of the fused Nicd and for 
up-regulation of the Notch reporter fluorescent protein mCherry in 
the endothelium. Examining these injected embryos revealed that the 
fused gfp expression fell dramatically on day 2, whereas expression 
of the reporter gene mCherry peaked at this period. These findings 
further confirmed the data generated by injecting the tol2-
m.flk1:nicd-gfp plasmid, and suggested that both approaches led to 
generally similar outcomes (Figure 6.17). Interestingly, with we 
noticed enlargement and pocket formation in in the vessels forming 
the CHT in a quarter of tol2-fli1:nicd-gfp injected embryos, this 
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phenotype may have been caused by prolonged activation of the 
Notch pathway in the endothelial cells (Figure 6.18). 
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Figure 6.17 Transient endothelial Notch induction in tol2-
fli1:nicd-gfp injected embryos up-regulates Notch reporter 
fluorescent protein. 
Fluorescent microscopy images of live 26hpf Notch reporter 
Tg(csl:mCherry) embryos co-injected with the tol2-fli:nicd-gfp 
plasmid P409 compared to their uninjected siblings. (A) Shows 
expression of the Gfp protein fused in-frame with the nicd specifically 
in the endothelial tissues. This includes the DA  (the blue arrow) and 
the CHT (yellow arrow), under the fli1 promoter compared to 
complete absence of Gfp in their uninjected siblings (B). (A') Shows 
an endothelial specific up-regulation of the Notch reporter fluorescent 
protein mCherry in injected embryos including the DA (blue arrow) 
and CHT (yellow arrow), compared to their uninjected siblings (B'). 
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Figure 6.18 Transient endothelial Notch induction by injecting 
the tol2-fli1:nicd-gfp plasmid P409 expand HSCs in the DA and 
CHT.  
Fluorescent images of live Notch reporter Tg(csl:mCherry) embryos 
co-injected with the tol2-fli1:nicd-gfp plasmid P409 were compared 
to their uninjected siblings at 48hpf. (A-B) Show a decline in Notch 
induction by day2, reflected by down regulation of the Gfp in injected 
embryos. (A') Shows a high endothelial specific up-regulation of the 
Notch reporter fluorescent protein,mCherry in injected embryos in 
the DA (blue arrow) and also in the CHT (yellow arrow) compared to 
their uninjected siblings (B'). The boxed area in (A'-B') is magnified 
in (A''-B'') and shows high mCherry expressing round cells in the CHT 
(green arrow heads) that resemble the shape and location of the HSC. 
(C-D) Show an example of about 1/3 of injected embryos in which 
Gfp persisted in day2 compared to uninjected siblings. (C') Shows 
high endothelial specific up-regulation of the Notch reporter 
fluorescent protein mCherry in injected embryos in both axial vessels 
DA and CV (blue arrow) and also in the CHT (yellow arrow). There 
was also notable enlargement of blood vessels and pocket formation 
in the CHT (white arrow heads). The boxed area in (C'-D') is 
magnified in (C''-D''), showing high mCherry expressing round cells 
in the CHT (green arrow heads) that resemble the shape and location 
of the HSC,  added to the enlarged and deformed vessels (white 
arrows heads).   
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6.11 Discussion of results 
This chapter explained that combining the Cre/LoxP system and the 
Gal4/Uas system remarkably amplified the amount of produced Nicd 
protein in the endothelium, evidenced by the significant up-regulation 
in Notch reporter fluorescent protein produced in these cells. It also 
revealed that high Notch signal in the DA inhibits endothelial cells 
migration in response to the Vegf signal to form the ISVs, and instead 
remain in the DA as previously described (Siekmann and Lawson, 
2007).  
Undesirably, we noticed that accumulation of the Gal4-vp16 protein 
in transgenes with the full length Gal4-vp16 interfered with the 
maturation of blood vessels, leading to loss of blood circulation. In 
situ hybridization results also suggest that this accumulated Gal4-
vp16 protein also interferes with HSCs specification from the vDA 
endothelium, and that this defect can be partially rescued by 
endothelial specific Notch over-activation. To minimize the toxic 
effect of the Gal4-vp16, we generated transgenic fish with attenuated 
Gal4-vp16, in which we truncated the last 20 amino acids (Davison 
et al., 2007, Inbal et al., 2006, Koster and Fraser, 2001, Sagasti et 
al., 2005, Scott et al., 2007). We also replaced the ubi promoter in 
this transgene with the hsp promoter to add a control on when to 
over-activate Notch signalling in the endothelium. With this approach, 
we presented data suggesting that continuous endothelial expression 
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of nicd, and thus continuous up-regulation of Notch pathway in the 
endothelium only slightly expands HSCs that can migrate to seed the 
CHT.  
In situ hybridization analysis also showed that most HSC specified 
cells in these embryos remain in the DA and fail to down-regulate the 
early HSCs marker gfi1.1, which suggests that after HSCs 
specification the marker must be down-regulated to allow specified 
cells to mature and leave the vDA. To test this hypothesis, we over-
activated Notch pathway transiently in the endothelium, and reported 
remarkable expansion in the haematopoietic markers runx1 and c-
myb, both in the DA and also in the CHT. Utilizing the fli1 promoter 
instead of flk1 promoter for endothelial Notch induction showed 
similar up-regulation in Notch reporter fluorescent protein in the DA 
and CHT, but with the presence of some defective blood vessels in 
some of injected embryos that may be resulting from earlier 
expression of the nicd-gfp in the injected construct.  
Expansion of the round Notch reporter positive cells in the CHT in 
these embryos also suggested similar HSCs expansion with the use 
of fli1 promoter as with the flk1 promoter. Together, these findings 
show that transient endothelial specific Notch over-activation is 
sufficient to expand HSCs formation both in the DA and the CHT. In 
this model we showed that while high Notch endothelial signal is 
required for HSCs specification from the vDA endothelium, the low 
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Notch signal after specification is essential for their differentiation into 
mature HSCs that can leave the DA and seed the CHT. 
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CHAPTER 7 
7 Results V Both Tet1 and Tet3 enzymes are essential 
for organogenesis in zebrafish 
In zebrafish, we have previously shown existence of three tet genes 
as in mammals (Almeida et al., 2012). The enzymes produced by 
these genes are also identical to their mammalian counterparts, with 
the only exception that Tet3 lacks its dioxygenase domain. To 
understand the regulatory roles for the Tet enzymes in embryogenic 
development, we decided to block expression of the three tet genes 
individually or in combination with morpholinos and study the effects 
resulting from losing these genes on embryogenic development.  
Utilising our in-house Notch reporter line, we also intended to 
determine the role of Tet enzymes on the development of Notch-
active tissues such as the nervous and cardiovascular systems.  
 
7.1 Zebrafish tet genes morpholinos design and 
injection 
To precisely target the catalytic C-terminal dioxygenase domain in 
the three tet genes, we designed morpholinos that target the splice 
junctions of exons preceding the dioxygenase domain exons in the 
three tet genes (Figure 7.1, A-L). Removal of targeted exons was 
predicted to lead to frame shifts and pre-mature termination of the 
proteins, and so deletion of the dioxygenase domains in the three tet 
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genes (Figure 7.1, C-D, G-F, K-L). Morpholinos sequence design was 
performed by Dr. Martin Gering and Dr. Alexey Ruzov, and then 
verified and synthesized by Gene Tools (see Figure 7.1 and Table 7.1 
for morpholinos design and targeted exons). 
 
 
Figure 7.1 tet morpholinos designed to delete the dioxygenase 
domains sequences in the tet genes. 
(A-L) Schematic diagrams of zebrafish tet1, tet2 and tet3 cDNA and 
their proteins in WT embryos, compared to predicted tet genes in the 
morphants. The white boxes in (A, C, E,G,I,K) are the non-coding 
exons, while red boxes are the coding exons. Orange arrows show 
the open reading frames that are intact in WT, and prematurely 
terminated in the morphants. (B, D, F, H, J, L) Are the Tet protein 
domains in WT and tet morphants, showing the main functional 
domains and the dioxygenase domains in all WT Tet proteins (green 
boxes) and its loss in all their tet morphants counterparts. The pink 
boxes are for the CXXC domains that present in tet1 WT as well as 
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tet1 morphants. The grey lines indicate the WT amino acids, while 
the yellow lines indicate the frame shift and protein termination 
resulting from splicing to next exons. The cDNA schematics were 
produced with SnapGene software (from GSL Biotech; available 
at snapgene.com). The tet genes sequences were from ENSEMBL 
versions (dtet1, ENSDARG00000075230.4), (dtet2, 
ENSDARG00000076928.6), (dtet3, ENSDARG00000062646.6).  
 
Table 7.1: List of tet morpholinos used. 
Mo name sequence Target Reference  
sequence 
tet1 E7 ac 5′-TTCTTCATCTCTCCTGTTAGTCGTA-3′ tet1 exon 7 
splice 
acceptor 
ENSDARG000000
75230 
tet1 E7 do 5′-CCATCCAATGCTCACCTCCTTAGGA-3′ tet1 exon 7 
splice 
donor 
tet2 E5 ac 5′-TTCTCCTAAGGACAGTGATCGAAAT-3 tet2 exon 5 
splice 
acceptor 
ENSDARG000000
76928 
tet2 E5 do 5′-TTTGTGTGAGCATCTCACCTCCTT-3′ tet2 exon 5 
splice 
donor 
tet3 E3 ac 5′-AAGGTGAGGAGGGAAAGATATCCTT-3′ tet3 exon 3 
splice 
acceptor 
ENSDARG000000
62646 
tet3 E3 do 5′-TTGTATTATCTCACTTACCTACGCA-3′ tet3 exon 3 
splice 
donor 
 
The morpholinos were then co-injected (0.5 ng of each) into WT 
embryos at two cells stage and observed for phenotypes (these 
preliminary injections were performed by a former student in our lab 
Sabrina Boudon). When examined under bright field microscopy at 
early development (8hpf), injected embryos appeared identical to 
their uninjected siblings (Figure 7.2 A).  However, soon after initiation 
of somitogenesis, injected embryos showed a clear arrest in 
development and failure in organogenesis that resulted in death 
before 24hpf. Interestingly, the observed developmental arrest 
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coincided with the time point at which tet1/2/3 expression become 
detectable in the embryo (Almeida et al., 2012).  
We then wanted to study the effect of knocking down individual tet 
genes, so we injected WT embryos with tet1, tet2 and tet3 
morpholino pairs separately, and then examined injected embryos 
both at early somitogenesis, and at 24hpf. Our analysis of injected 
embryos showed a significant developmental arrest in embryos 
injected individually with tet1 and those injected individually with the 
tet3 morpholinos, 25% and 80% respectively. The remaining 75% 
and 20%, that appeared normal at early somitogenesis, also  
developed specific developmental abnormalities when examined at 
24hpf. By comparing the severity of the observed phenotypes, we 
found that tet3 morphants developed generally more severe 
phenotypes compared to those of tet1 morphants (Figure, 7.2 B). The 
observed abnormalities in tet1 morphants included reduced and 
malformed head structures, abnormally developed eyes, considerably 
shortened and curved bodies. This is added to missing pigmentation 
and formation of anomalous U-shaped (instead of chevron-shaped) 
somites in most injected embryos (65%). The head and posterior 
structures were also poorly formed in the remaining 10% of tet1 
morphants. On the other hand, the 20% surviving tet3 morphants 
showed very severe failure in organogenesis and did not develop any 
anterior or posterior structures, and they also failed to form the 
regular patterning of the somites (Figure 7.3, A-D).  
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Figure 7.2 Tet1 and Tet3 but not Tet2 are essential for 
zebrafish organogenesis. 
(A-E) Bright field microscopy of tet morphants compared to their 
uninjected controls. (A) Embryos co-injected with tet1/2/3 
morpholinos appear normal and un-distinguishable from their 
uninjected controls at 8hpf. (B) Both tet1 and tet3 morphants showed 
generally similar phenotypes at 24hpf compared to their uninjected 
controls. (C) Co-injection of tet1/3 morpholinos lead to more severe 
phenotypes at 24hpf than with individual knockdown of individual 
genes. (D) tet2 morphants appeared normal and un-distinguishable 
from their uninjected controls, event when examined at 72hpf. (E) 
Including the tracking dye (mini Ruby) in the tet3 morpholinos 
injection mix indicates that the phenotype severity correlates with 
the injected amounts.    
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Figure 7.3 tet1 and tet3 morphants develop severe 
abnormality in organogenesis. 
Analysis of tet1/2/3 morphants phenotypes compared to uninjected 
or mini Ruby dye only injected controls at 24hpf. The embryos were 
categorized based on the severity of their phenotypes under bright 
field microscope, into: Normal with no observed abnormalities. Mild 
for embryos that lost pigmentation, have reduced body axis and small 
malformed eyes. Intermediate for embryos with small abnormal 
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head, missing eyes, considerably reduced and curved body and 
irregular somitogenesis and strong for embryos with more severe 
defects that include no anterior and posterior structures and no 
recognizable patterning. Mean percentages for at least three 
experiments are shown for each MO combination. Experimental error 
is expressed as s.e.m. Total numbers of assessed embryos are 
presented for each morpholinos combination. (B) tet1 and tet3 
morphants phenotypes compared to their uninjected control at 24hpf. 
(C) Enlarged images of anterior region of tet1 and tet3 morphants 
phenotypes compared to their uninjected controls. (D) Enlarged 
images of posterior region of same embryos. The black arrows in 
(C,D) indicate absent or underdeveloped head structures and 
abnormal patterning of somites in the posterior region. 
 
Interestingly, both tet1 and tet3 morphants were not viable beyond 
one day post fertilisation, which suggests the developmental arrest 
of these injected embryos. To assess the possible causes of observed 
variation among injected embryos, mini-Ruby dye was included in the 
morpholino injection mix, and we noticed that the severity of 
observed phenotypes correlates with the intensity of the dye in 
injected embryos (Figure 7.2, E), which shows that the observed 
variation in phenotype was dose dependent.  We then wanted to know 
whether knocking tet1 and tet3 genes simultaneously leads to more 
severe phenotypes, and we found that with combined tet1 and tet3 
blockage, the phenotypes become more severe, as most injected 
embryos showed failed tissue differentiation and loss of both anterior 
and posterior structures (Figure 7.2 C). On the other hand, injecting 
tet2 morpholinos even with much higher amounts compared to tet1 
and tet3 was found to be tolerated by embryos as injected embryos 
appeared normal even when examined on three days post fertilization 
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(Figure 7.2, D, Figure 7.3, A). Together, our morpholino study 
suggests an essential role for tet genes in zebrafish tissue 
differentiation. 
 
7.2 Observed tet1 and tet3 morphants phenotypes 
are specific to depletion of tet1 and tet3 transcripts 
and not due to binding to un-intended targets 
To test for morpholino specificity, one option was to rescue the 
phenotypes by injecting the targeted genes mRNA (Bedell et al., 
2011). However, as endogenous tet1/2/3 mRNAs are only expressed 
in the after embryonicsomitogenesis, injecting the tet mRNAs would 
lead to premature expression of the tet genes in these morphants 
and so premature 5mC modification, which may invalidate the 
results. Other confirmatory options that could be used include 
generating mutants with similar phenotypes, or recapitulating these 
phenotypes by injecting morpholinos targeting non-overlapping 
sequences in the same mRNA (Eisen and Smith, 2008). Due to the 
unavailability of published tet mutant lines at the time of designing 
the experiment. Added to the time and costs associated with 
generating and characterising new mutant lines, we decided to design 
and inject WT embryos with tet1 and tet3 morpholinos targeting 
splice sites in different exons in tet1 and tet3 genes (Table 7.2). 
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Table 7.2: List of confirmatory morpholinos used. 
Mo. 
name 
sequence Target 
tet1 E10 5′-AAGTGCATACCTGTGGTTTACAGGA-3′ tet1 exon 10 splice 
acceptor 
tet3 E4 5′- TCTCTCTGACTCCCTTAGACCAAGT-3′ tet3 exon 4 splice 
acceptor 
p53 Mo 5’-GCGCCATTGCTTTGCAAGAATTG-3’ Translation blocking 
 
 
The first morpholino was designed to target the splice acceptor of 
exon 10 in the tet1 gene, leading to splicing of exon9 to exon11, 
which is predicted to introduce a frameshift and premature 
termination of tet1 transcript (Figure 7.4, A-D). The other morpholino 
was designed to target the splice acceptor of exon4 in tet3 gene, 
leading to splicing of exon3 to exon5, which was predicted to also 
introduce a frameshift and premature termination of tet3 transcript 
(Figure 7.4 E-H).  
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Figure 7.4 Confirmatory tet1 and tet3 morpholinos with 
different targets and similar predicted outcome. 
(A-H) Schematic diagrams of zebrafish tet1, and tet3 cDNA and 
proteins in WT embryos compared to predicted tet genes morphants. 
The white boxes in (A, C, E,G) are the non-coding exons while red 
boxes are the coding ones. Orange arrows show the open reading 
frames that are intact in WT and prematurely terminated in the 
morphants. (B, D, F, H) are the Tet protein domains in WT and tet 
morphants, showing the main functional domains, the dioxygenase 
in all WT tet proteins (green boxes) and their loss in their tet 
morphants counterparts. The pink boxes are for the CXXC domains 
that present in tet1 WT as well as tet1 morphants. The grey lines 
indicate the WT amino acids, the green line indicates the in-frame 
part of the dioxygenase domain, while the yellow lines indicate the 
frame shift and protein termination resulting from splicing to next 
exons. The cDNA schematics were produced with SnapGene® 
software (from GSL Biotech; available at snapgene.com). The tet 
genes sequences were ENSEMBL versions (dTet1, 
ENSDARG00000075230.4) and (dTet3, ENSDARG00000062646.6).  
 
I then injected the tet1 and tet3 morpholinos individually to WT 
embryos and examined the injected embryos both at 8hpf and also 
at 24hpf. At 8hpf, as with the former morpholinos, both tet1 and tet3 
morphants appeared normal and in-distinguishable from their 
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uninjected siblings.  Moreover, both also developed phenotypes 
identical to those observed with previously used morpholinos at 24hpf 
(Figure 7.5, A-F, Figure 7.6, A-D). 
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Figure 7.5 Targeting different sequence in tet1 gene produce 
identical phenotypes. 
(A-F) Bright field microscopy of tet1 exon7 morphants mild (A), 
moderate (C) and strong (E) phenotypes compared to their tet1 
exon10 morphants counterparts (B, D, F).  
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Figure 7.6 Targeting different sequence in tet3 gene produce 
identical phenotypes. 
(A-F) Bright field microscopy of tet3 exon3 morphants mild (A), 
moderate (C) and strong (E) phenotypes compared to their tet3 
exon4 morphants counterparts (B, D, F).  
 
 
I also repeated injecting the tet2 morpholinos at higher 
concentrations and results were similar to previous data. Injected 
embryos as in the previous experiment appeared normal until 72hpf. 
Because the severity of morpholinos was higher with tet1 splice 
acceptor 7 and tet3 splice acceptor 4, I decided to use these two 
morpholinos for all subsequent tet1 and tet3  morpholino 
experiments.  
 Reproducing the phenotypes with injecting morpholinos targeting 
non-overlapping sequences in tet1 and tet3 mRNA highly suggested 
that observed phenotypes are caused by specific targeting of tet1 and 
tet3 genes and not due to non-specific binding to other places in the 
genome.  In addition, to examine if the observed phenotypes were 
caused by activation of the p53 mediated apoptosis, I co-injected the 
tet1 and tet3 morpholinos with p53 morpholinos in the ratio of 2:1 
(Robu et al., 2007), and examined the embryos at 8hpf and then at 
24hpf for the phenotypes. Even though addition of the p53 
morpholinos to the injection mix reduced the severity of observed 
phenotypes, their persistence in co-injected embryos further 
eliminated the possibility of non-specific toxicity (Figure 7.7). 
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Figure 7.7: tet2 morpholino injection with high amount does 
not affect embryonic development, and addition of p53 Mo 
does not rescue tet1 or tet3 morphants. 
(A) WT embryo co-injected with tet2 exon 6 splice donor and exon 6 
acceptor morpholinos. The embryos appear normal and in-
distinguishable from uninjected controls (B). (C) WT embryo co-
injected with tet1 exon7 splice acceptor morpholino and p53 
morpholinos with persisting phenotypes. (D) WT embryo co-injected 
with tet3 exon 4 splice acceptor morpholino and p53 morpholino with 
persisting phenotypes. 
 
7.3 Injecting tet1 or tet3 leads to deletion of targeted 
exons, frame shifts and premature termination of 
tet1 and tet3 genes 
To study the effect of injecting tet1 or tet3 morpholinos on the normal 
splicing of these genes transcripts, I designed two pairs of primers, 
one to bind the exons before and after the targeted tet1 exon 7 
(DB658 and DB452; Figure 7.8, A). The other to bind the exons 
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before and after the targeted tet3 exon 4 (DB457 and DB659; Figure 
7.9, A). Next, I performed total RNA extraction and R.T. first strand 
cDNA synthesis from tet1 morphants, tet3 morphants and uninjected  
control embryos, all collected at 24hpf. Normal PCR amplification was 
then performed with the two sets of primers, followed by gel analysis 
of produced fragments (Figure 7.8, B, Figure 7.9, B respectively). 
Comparing tet1 or tet3 morphants cDNA results to their uninjected 
siblings, it is apparent that the majority of targeted transcripts were 
altered, indicated by the smaller bands with tet1 and tet3 morphants 
compared to their uninjected siblings. Comparing these bands to the 
molecular ladder, it is likely that the entire targeted exons were 
skipped in both tet1 and tet3 morphants during the splicing process, 
as predicted (Figure 7.8, A and Figure 7.9, A respectively). To further 
confirm gel results, and to rule out the possibility of splicing to cryptic 
splice sites in the area around targeted exons, which might result in 
partial insertion or deletion in-frame with the targeted tet1 or tet3 
genes. For this, I extracted the fragments with altered sizes from the 
gel, and then submitted these fragments for sequencing, utilizing the 
same primer pairs for sequencing from both directions. Sequencing 
results showed no cryptic splicing with either tet1 or tet3 morphants, 
and so confirmed the complete deletion of targeted exons, and 
splicing between the outside (5' and 3') neighbouring exons and 
introduction of  frame shifts and premature termination of the tet1 
and tet3 genes as predicted (Figure 7.8, C-E and Figure 7.9, C-E 
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respectively). On the other hand,  gel results for tet3 morpholinos 
showed a  significant remaining normally spliced tet3 transcript in 
tet3 morphants (the * in Figure 7.9 B), however this may be resulting 
from the difficulty associated with injecting low doses of morpholino, 
and pooling the morphants with some that might have less efficient 
tet3 knock down.  
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Figure 7.8 tet1 exon 7 splice acceptor morpholino leads to 
deletion of exon 7, frame-shift and premature termination of 
Tet1 protein translation.   
(A) Annealing of exon 7 splice acceptor antisense morpholino to 
exon7 splice acceptor site in the tet1 pre-mRNA is intended to prevent 
the normal spliceosomal recognition of targeted exon (top), skipping 
exon 7 and splicing between exon 6 and exon 8. Blue arrows show 
locations of primers used to validate morpholino efficiency (DB658 
and DB452) and for mRNA quantification with RT-PCR (DB450 and 
DB452). Black lines depict expected fragment sizes in uninjected 
control (top) and tet1 exon 7 splice acceptor morphants (below). (B) 
The gel result showed fragments of expected sizes (as indicated with 
the green arrows) after performing normal PCR with the primers 
depicted in (A) with cDNA templates prepared from tet1 morphants 
total RNA isolated at 24hpf, and uninjected controls siblings. The gel 
results showed almost complete loss of normally spliced tet1 
transcript in tet1 morphants (the top 435bp) and a strong band with 
expected (284bp) fragment. (C) Screenshot of sequencing result 
(viewed in BioEdit software) of the tet1 morphants cDNA PCR 
fragment (the 284bp in B) after excision from gel. Sequencing result 
confirmed the complete deletion of exon 7 and splicing of exon 6 with 
exon 8 in tet1 morphants (as depicted in A). (D) Schematic 
presentation of tet1 morphants transcript with skipping exon 7 that 
leads to frame-shift (indicated by the yellow line). Premature 
termination of the transcript, and production of truncated protein that 
lack the functioning deoxygenase domain. This is compared to the 
uninjected control transcript and protein product with the active 
deoxygenase domain (the green box). (E) Magnification of the boxed 
area in (D) showing the frameshift caused by deletion of exon 7 and 
the changes in amino acid sequence caused by this frame-shift. The 
grey line indicates the in-frame translation, whereas the yellow line 
indicates the out-of-frame translation. 
223 | P a g e  
 
 
Figure 7.9 tet3 exon 4 splice acceptor morpholino leads 
deletion of exon 4, frame-shift and premature termination of 
Tet3 protein translation.  
(A) Annealing of exon 4 splice acceptor antisense morpholino to exon 
4 splice acceptor site in the tet3 pre-mRNA is intended to prevent the 
normal spliceosomal recognition of targeted exon (top), skipping 
exon 4 and splicing between exon 3 and exon5. Blue arrows show 
locations of primers used to validate morpholino efficiency (DB457 
and DB659) and for mRNA quantification with RT-PCR (DB457 and 
DB458). Black lines depict expected fragment sizes in uninjected 
control (top) and tet3 exon 4 splice acceptor morphants (below). (B) 
The gel result showed fragments of expected sizes (as indicated with 
the green arrows) after performing normal PCR with the primers 
depicted in (A) with cDNA templates prepared from tet3 morphants 
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total RNA isolated at 24hpf and uninjected siblings cDNA. The gel 
results showed significant reduction of normally spliced tet3 
transcript in tet3 morphants (the top 258bp) and a strong band with 
expected (167bp) fragment. (C) Screenshot of sequencing result 
(viewed in BioEdit software) for the tet3 morphants cDNA PCR 
fragment (the 167bp in B) after excision from gel. Sequencing result 
confirmed the complete deletion of exon 4 and splicing of exon 3 to 
exon5 in tet3 morphants (as depicted in A). (D) Schematic 
presentation of tet3 morphants transcript with skipping exon 4 that 
leads to frame-shift (indicated by the yellow line) and premature 
termination of the transcript, and production of truncated protein that 
lacks the functioning deoxygenase domain. This is compared to the 
uninjected control transcript and protein product with the active 
deoxygenase domain (the green box). (E) Magnification of the boxed 
area in (D) showing the frame-shift caused by deletion of exon 4 and 
the changes in amino acid sequence caused by this frame-shift. The 
grey line indicates the in-frame translation, whereas the yellow line 
indicates the out-of-frame translation. * The remaining normally 
spliced transcript in tet3 morphants cDNA PCR that may be resulting 
from the low injected dose that may have reduced the efficiency in 
some injected embryos.   
 
7.4 Quantitative RT-PCR shows significant reduction in tet1 
transcript in tet1 morphants and significant reduction in both tet1 
and tet3 transcripts in tet3 morphants 
Due to the similarity of phenotypes observed in tet1 or tet3 
morphants, we wanted to know if the two proteins act together to 
mediate the 5mC oxidation, or whether one of the genes regulates 
the other. To achieve this, I measured the level of the two transcripts 
in tet1 and tet3 morphants then compared their levels to their 
uninjected controls. In this process total RNA was firstly isolated at 
24hpf, reversed transcribed, then quantified by RT-PCR with primers 
(DB450 and DB452; Figure 7.8, A) for tet1 quantification, and 
(DB457 and DB458 Figure 7.9, A) for tet3 quantification. In tet1 
morphants, real time quantification showed a significant reduction in 
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tet1 transcript but no effect on tet3 transcripts (Figure 7.10, A). On 
the other hand, I noticed significant reduction in the two transcripts 
in tet3 morphants (Figure 7.10, B). Even though the result suggests 
dependency of tet1 on presence of tet3, we found it difficult to 
exclude the possibility that the reduction in tet1 transcript was a 
complication associated with the failure in organogenesis. 
 
Figure 7.10 tet1 mRNA significantly reduced in both tet1 and 
tet3 morphants whereas tet3 transcript only reduced in tet3 
morphants.   
(A-B) Histograms showing quantitative real time PCR results of tet1 
and tet3 transcripts in uninjected, tet1 morphants and tet3 
morphants. Blocking tet1 expression only reduced tet1 mRNA level 
(middle bar in A and B), while blocking tet3 expression reduced both 
tet1 mRNA and tet3 mRNA (right bar in A-B) (Mean and SEM; 
***p<0.001; ****p<0.0001; t test). 
 
 
 
7.5 Notch signalling is altered in tet1 and tet3 
morphants 
Given the severe developmental phenotypes observed in tet1 and 
tet3 morphants, which included malformation of the head structure 
and improper somitogenesis added to the abnormality in multiple 
organs, we wanted to test whether the Notch signalling pathway was 
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affected in these morphants. Notch signalling is a key regulator 
controlling cell specification and tissue patterning, and plays an 
essential role in the development of various organs, including 
neurogenesis, somitogenesis,  cardiovascular and haematopoiesis 
(Koch et al., 2013). To study the effects of blocking tet genes on 
Notch signalling, we injected the tet1/2/3 morpholinos into our in-
house Notch reporter transgenic line Tg(csl:venus)qmc61  then 
monitored expression of the reporter fluorescent protein (Venus) by 
fluorescent microscopy in these injected embryos, compared to their 
uninjected siblings. While expression of the Notch reporter gene in 
tet2 morphants was almost identical in the level and expression 
pattern to their uninjected siblings, when examined at 24hpf and 
48hpf, tet3 morphants showed a strong reduction in the reporter 
gene expression when examined at 24hpf (Figure 7.11, A-E').  
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Figure 7.11 Notch activity severely reduced in tet3 morphants 
and not affected in tet2 morphants. 
(A-E') Bright field and fluorescent microscopy of uninjected and 
tet2/3 injected Tg(csl:venus)qmc61 embryos at 24hpf (A-C') and 48hpf 
(D-E'). Expression of the Notch reporter gene (venus) in tet2 
morphants appeared identical to uninjected controls both at 24hpf 
(A-B') and at 48hpf (D-E'). tet3 depletion in tet3 morphants leads to 
severe reduction in Notch reporter gene expression at 24hpf (C-C'). 
 
Interestingly, when we examined the moderately affected tet1 
morphants, we found that Notch reporter expression was still 
maintained in these embryos, but with different distribution among 
tissues with known Notch activity. For instance, whereas Notch 
reporter fluorescent protein was reduced throughout the notochord 
in uninjected controls at 23hpf, its expression was maintained at high 
level in tet1 morphants (yellow arrow in Figure 7.12 B). On the other 
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hand, expression of the reporter gene was much lower in the 
hindbrain and axial vessels in these tet1 morphants compared to their 
uninjected controls (red arrows in Figure 7.12 A).   
 
Figure 7.12 Notch activity is altered in tet1 morphants.  
(A-F') Fluorescent microscopy and in situ hybridization images of 
uninjected and tet1 morpholino injected Tg(csl:venus)qmc61 embryos 
at 23hpf (A-D,E-F) and 21hpf (E-E'). (A) Expression of the Notch 
reporter gene venus in tet1 morphants is maintained at a high level 
in the notochord (yellow arrow) at 23hpf compared to the uninjected 
controls. The normal venus expression in the DA and hindbrain (red 
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arrows in B) is either un detectable or severely reduced in tet1 
morphants. (C-D) Fluorescent microscopy results are recapitulated 
by venus mRNA. (E-F) venus mRNA distribution tet1 morphants at 
23hpf (D) does not match the venus mRNA distribution in younger 
uninjected controls. (C', E', F') are magnifications of the boxed areas 
in (C, E, F). 
 
 Because fluorescent microscopy only reports the fluorescent protein 
accumulated in the tissues over the period before examination, rather 
than the time point of examination, we decided to stop and fix tet1 
morphants for in situ hybridization to test for the venus mRNA 
expression pattern and so Notch activity at 23hpf. 
Our in situ results further confirmed the fluorescent microscopy 
findings, as in situ also showed strong up-regulation of the Notch 
reporter mRNA in the notochord and its absence in the DA region. It 
is also evident that Notch activity in the hindbrain is much lower than 
that of uninjected siblings (Figure 7.12 C-D). We then wanted to know 
if the observed alteration in Notch activity was due a general 
developmental delay, so we compared the 23hpf mRNA expression of 
the tet1 morphants to uninjected controls stopped 2 hours earlier 
(21hpf). Even though, the younger uninjected controls appeared 
morphologically similar to the 23 hpf tet1 morphants, the expression 
pattern was completely different in the two groups.  Unlike in the 
uninjected controls, where Notch was highly active in the hypochord 
and barely detectable in the notochord area, no clear Notch activity 
was reported in the tet1 morphants' hypochord, and high activity was 
observed in the notochord (Figure 7.12, E-F, black arrows in E'-F'), 
230 | P a g e  
 
which suggests a tet1 depletion dependent mis-regulation of the 
Notch signalling pathway. 
tet1 morphants, appear normal and in-distinguishable from their 
uninjected controls when examined under bright field microscopy 
until early somitogenesis. This time point corresponds with the time 
when tet1 gene is expressed in the developing embryo. Therefore, 
we wanted to see if the alteration in Notch activity is also happening 
at the time point when Tet1 protein is required in these morphants. 
For this, we examined the expression pattern of the venus gene 
mRNA in our Notch reporter line Tg(csl:venus)qmc61. We also 
examined expression of the Notch downstream target her4.1 by in 
situ hybridization at the 1-3 somite stage in tet1 morphants and 
compared them to their uninjected controls, and also to mib mutants 
homozygous or heterozygous embryos (Figure 7.13, A-D).  In 
agreement with bright field microscopy findings, and unlike the mib 
homozygous or heterozygous, Notch reporter mRNA and the Notch 
downstream target her4.1 were both normally expressed in these 
tissues in tet1 morphants, and their expression was indistinguishable 
from uninjected controls (Figure 7.13, A-D). Moreover, when 
examining the expression pattern of the Notch components notch1b 
and dla at 10 somite stage, their expression in tet1 morphants were 
similar to uninjected controls (Figure 7.13, E-F). Interestingly, when 
examining expression of the Notch components notch1b and dla at 
23hpf in tet1 morphants, we noticed persistence of their transcripts 
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in the neural tube (Figure 7.13 G-H), which further suggests an 
epigenetic control on Notch activity in this tissue.    
 
 
Figure 7.13 Notch signalling persists in tet1 morphants 
despite alteration in its expression pattern in late 
somitogenesis. 
(A-H) Whole mount in situ hybridization for her4.1 expression in 
uninjected and tet1 injected embryos at 1-3 somite stage (A), 
compared to its expression in mib mutants (C). Expression of venus 
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reporter gene in uninjected and tet1 injected Tg(csl:venus)qmc61 
embryos at 1-3 somite stage (B), compared to its expression in mib 
homozygous with the same transgene in the background  (D). (E-H) 
Whole mount in situ hybridization for notch1b and dla expression in 
uninjected and tet1 injected embryos at 10 somite stage (E-F) and 
23hpf (G-H). Unlike in mib mutants, her4.1 and venus mRNAs are 
maintained in the neural tube progenitors (red arrows in A-D) 
hypochord progenitors (black arrows in A-D). Notch components  
notch1b and dla expression persistsed in tet1 morphants and were 
comparable to their uninjected siblings both at 10 somite stage (E-F) 
and 23hph (G-H). 
 
 
Taken together, the normal development of embryos until the time 
point when tet1 gene expression appears in the embryo at early 
somitogenesis, and the persistence of Notch activity but with altered 
pattern and defective organogenesis thereafter, collectively suggest 
a global role for tet genes in tissue patterning and organogenesis, 
and that this role may  include implementing the Notch pathway. 
 
7.6 tet1 knockdown alter neurologic program in 
zebrafish embryos 
Notch signalling is known to play key role in embryonic neural 
development, and its mis-regulation is known to disrupt the normal 
patterning and differentiation of the neurological tissues. To analyse 
the effect of knocking down tet1 on the neurological development, 
we examined the expression of neuronal lineage markers in tet1 
morphants both at 1-3 and 10 somite stages. In agreement with our 
previous findings, in situ analysis of the tet1 morphants revealed no 
significant changes in the expression of either proneural marker 
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neurog1 (neurogenin) or the early post-mitotic neuronal marker 
elavl3 (embryonic lethal abnormal vision; Elavl3/HuC) (Figure 7.14 
A-B). However, by 23 hpf, tet1 morphants showed a markedly 
increased expression of elavl3 in several regions of the neural tube, 
suggesting an alteration of neurogenesis program occurring in these 
embryos (Figure 7.14 C-D). Even though these results strongly 
suggest a tet1 depletion dependent alteration in the neurogenesis 
program, it is still not identified whether Tet1 protein is interacting 
directly with the examined neurological markers through altering 
their methylome marks or through altering the epigenetic marks of 
components involved in Notch signalling pathway in order to regulate 
and co-ordinate neurogenesis.  
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Figure 7.14 tet1 knockdown leads to atypical neurogenesis in 
zebrafish embryos. 
(A-D) Whole mount in situ hybridization for neurog1 expression in 
tet1 morphants, compared to their uninjected controls at 1-3 somites 
stage (A) and for elavl3 expression at 1-3 somites,  10 somites (B) 
and at 23hpf (C-D). Dorsal (top) and anterior (bottom) views in  (A-
B) show identical expression pattern of neurog1 and  elavl3 in 
uninjected embryos and tet1 morphants at early somitogenesis. 
235 | P a g e  
 
Anterior, dorsal and lateral views of elavl3 expression in tet1 
morphants compared to their uninjected controls showing an 
increased expression of elavl3 mRNA in several regions of the neural 
tube (indicated by black arrows in C and D). 
 
 
7.7 5hmC levels decrease in the elavl3 promoter in 
both tet1 and tet3 morphants 
DNA methylation was proven to be critical  in regulating gene 
expression and tissue patterning. tet genes through their oxygenase 
domains have also been shown to promote the conversion of  the 
5mC to 5hmC and then to the more oxidized forms 5-formylcytosine 
and 5-carboxylcytosine that play   passive and active demethylation 
roles (Tahiliani et al., 2009, Ito et al., 2010, He et al., 2011, Gu et 
al., 2011, Zhang et al., 2013). To determine whether injecting tet1 
or tet3 alters the methylation levels of Notch components, the 
neurological marker elavl3 or the tet genes themselves, we utilised 
antibodies specific for the 5mC and 5hmC to enrich for these cytosine 
modifications and carried out DNA immune-precipitation (DIP) on 
DNA from tet1 morpholino injected, tet3 morpholino injected and 
uninjected controls. 
Enrichment was then quantified using quantitative PCR (qPCR) at 12 
candidate loci whose selection was based on their CpG enrichment 
and always upstream or within the first introns of selected genes. 
Most of the qPCR results were difficult to interpret, which may be 
resulted from the ambiguity associated with the heterogeneity of cell 
236 | P a g e  
 
types in 24hpf embryos (Figure 7.15). However, we noticed a 
significant decrease in the 5hmC levels in the elavl3 promoter region 
both in the tet1 and tet3 morphants, which may indicate a functional 
relationship between the status of methylation in elavl3 promoter 
region and the abnormal expression pattern observed in tet1 
morphants.  
 
Figure 7.15 Real time PCR quantification results of 5hmC DNA 
immunoprecipitation (DIP) of indicated genomic regions in 
tet1, tet3 morphants compared to their uninjected controls, 
all examined at 24 hpf. 
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Histograms showing relative enrichment values normalised to the DIP 
reactions without 5hmC antibodies. Significance was determined 
using student t test, **** p<0.0001; *** p<0.001; ** p< 0.01; * 
p< 0.05; ns – not significant. 
 
 
7.8 Global 5hmC level dramatically decrease in tet1 
morphants 
The very oxidized forms of the tet mediated 5mC modifications are 
the 5fC, and 5caC which are known targets for DNA repair enzymes 
such as the thymine-DNA glycosylase (Tdg) (Shen et al., 2013).  The 
repair process is known as the base excision repair (Ber), and leads 
to excision 5fC or the 5caC and replacing them with un-methylated 
ones, as part of the active DNA demethylation. Based on tet 
dependence on presence of the Ber enzymes for active de-
methylation, we expected the Tet and Ber enzymes to have a similar 
expression profile. When analysed, the zebrafish transcriptome data, 
we identified a number of Ber enzymes related transcripts (gadd45g, 
lig3, pcna and tdg) that showed expression profiles similar to that of 
tet1/2/3 mRNAs, with their mRNA levels peaking during 
organogenesis stages between 24-48 hpf (Appendix 12, A).  
We then wanted to investigate if individual or combined ablation of 
tet1/tet3 in tet morphants can alter the global levels of the oxidized 
forms of 5mC in zebrafish embryos. For this, we examined fixed 
sections from these morphants by immuno-staining, and compared 
the results to uninjected control sections. The anti-5hmC, anti-5fC 
and anti-5caC antibodies used in the sensitive version of 
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immunochemistry, were the antibodies we previously used for 
detection of 5hmC in fish and mammalian tissues (Ruzov et al., 
2011). Interestingly, unlike in human and mouse ESCs which showed 
decent staining for 5fC and 5caC (Appendix 13, B). Expression of 
these 5mC derivatives were un-detectable in zebrafish embryo 
sections taken at 24 hpf (Appendix 13: B).  On the other hand, our 
immunostaining has shown a strong staining for the 5hmC mark and 
this mark is strongly reduced not only in combined tet1/tet3 or tet3 
morphants that leads to reduction of tet1 and tet3 transcripts, but 
even individual tet1 morphants show strong reduction in staining 
(Appendix 13: B). 
To verify the immunostaining results and also to quantify the levels 
of 5hmC and 5mC in tet1/tet3 morphants and compare them to those 
of uninjected controls, we submitted samples of the three groups for 
mass spectrometry. Consistent with our previous immunostaining 
findings, the 5hmC/5mC ratio was 6-7 times lower in both tet1 and 
tet3 morphants' DNA compared to their uninjected control, while no 
difference was reported in the 5mC levels between injected and 
uninjected embryos (Appendix 13, C-E). Surprisingly, despite the 
similarity in 5fC/5hmC ratios between the zebrafish embryonic DNA 
and mouse ESCs (mESCs) DNA, our results showed that the 5hmC 
and 5fC levels were approximately 10 times lower in  zebrafish 
embryonic DNA compared to mESCs (Appendix 13, F).   
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7.9 Discussion of results 
This chapter showed that injecting zebrafish embryos with 
morpholinos designed to block expression of tet1 or tet3 genes, but 
not tet2, leads to severe developmental defects soon after 
somitogenesis. Reproducing the same phenotypes with different 
morpholinos targeting non-overlapping sequences in the same genes 
strongly suggested that observed phenotypes were due to loss of tet1 
or tet3 genes and not due to off-target effect. Observed phenotypes 
are also unlikely to be an apoptotic effect caused by injected 
morpholinos, as these phenotypes were maintained even with co-
injecting the p53 morpholinos.  
RT-PCR, gel analysis and sequencing all demonstrated that injecting 
tet1 and tet3 morpholinos lead to complete deletions of targeted 
exons, frame-shifts and the introduction of premature termination 
and production of truncated proteins that lack the functional 
Dioxygenase domain. To investigate if Tet1 and Tet3 enzymes act 
together or regulate one another, we quantified tet1 and tet3 mRNA 
both in tet1 and tet3 morphants and compared it to their uninjected 
siblings. Quantification RT-PCR results suggest that injecting tet1 
morpholino leads to reduction of tet1 mRNA level and no effect on 
tet3, whereas injecting tet3 morpholino leads to reduction of both 
tet1 and tet3 transcripts. While these findings suggest that tet3 acts 
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upstream of tet1, it is essential to consider the possibility that mRNA 
alteration has resulted from the severely defected organogenesis  
Utilizing our in-house Notch reporter, we presented both fluorescent 
microscopy and in situ hybridization data showing that blocking tet1 
gene expression alters Notch activity in the developing embryo. This 
alteration appeared to be tet1 depletion-specific and did not result 
from developmental delays, as the expression pattern of the reporter 
gene does not match that of younger uninjected siblings. Unlike with 
tet1 morphants, expression of the reporter gene was 
indistinguishable from uninjected siblings in tet2 morphants, and 
completely lost in tet3 morphants.  
To investigate if blocking tet1 affects normal embryonic 
neurogenesis, we performed in situ hybridization on tet1 depleted 
embryos and the results showed an up-regulation of the neural 
marker elavl3 when examined at 23hpf. Quantification of the 5hmC 
levels of selected Notch components, elavl3, tet1 and tet3 promoters 
in tet1 and tet3 morphants compared to their uninjected siblings was 
generally difficult to interpret, likely due to the abnormal 
development of tet1 and tet3 morphants. Interestingly, these data 
imply that loss of Tet1 or Tet3 led to a reduction in the 5hmC in elavl3 
promoter.  
Analysing the zebrafish transcriptome data showed that tet genes and 
several BER related enzymes have similar expression profiles, thus 
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cytosine de-methylation is likely to occur through a repair mechanism 
involving BER enzymes. Immunostaining and mass-spectrometry 
done on WT and tet1/tet3 morphants both showed clear 5hmC mark 
at 24hpf in WT embryos, and this mark sharply reduced with the 
combined or individual knock-down of tet1 or tet3 genes.  
Together, our morpholino data showed an important rule for Tet 
proteins in zebrafish organogenesis. Our results also suggest that the 
proposed redundancy between different Tet enzymes in mice is not 
conserved in zebrafish. While our morpholino validation results and 
the dramatic decrease in 5hmC levels in these morphants suggest 
that observed phenotypes were specific to depletion of Tet1 or Tet3 
enzymes, the possibility that observed phenotypes were resulting 
from morpholino non-specific toxicity cannot be excluded. Supporting 
mutants data is still necessary to assign observed findings to loss of 
tet1 and tet3 genes.  
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CHAPTER 8  
8 Discussion 
8.1 Analysing Notch activity during zebrafish early 
development 
To improve our understanding of Notch requirement in 
haematopoietic stem cells development, we previously generated 
three transgenic lines that are identical in their structures but with 
different reporting fluorescent proteins, Tg(csl:venus)qmc61 
Tg(csl:cerulean)qmc63 and Tg(csl:mCherry)qmc97. Our careful analysis 
of fluorescent protein expression in these three lines showed that the 
reporter proteins in these three lines truly recapitulates tissues with 
Notch activities. This was based on the reporter genes reproducible 
expression in specific tissues such as the telencephalon, heart, dorsal 
aorta, neural tube and medial fin fold (Figure 3.3), some of which 
with previously known Notch activities, such as the developing central 
nervous system (Scheer et al., 2001). Moreover, the expression 
patterns seen in these lines were also identical to those in the Notch 
reporter lines developed and verified independently at the same 
period of time (Parsons et al., 2009).  
We then utilised our in-house generated Notch reporter lines to profile 
Notch activities during zebrafish early development with the focus on 
the time point and the region where HSCs first appear in the embryo. 
Our analysis showed that the earliest zygotic Notch reporter mRNA 
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was detected in the neural tube at 8hpf, while the fluorescent protein 
become detectable three and a half hours later both in the hypochord 
and the developing somites.    This delay in detecting the fluorescent 
protein can be attributed to the time required for accumulation and 
maturation of the synthesised protein to detectable levels. It was 
previously reporter that at least one hour is required for Gfp 
maturation at 37°C (Sniegowski et al., 2005). However, as zebrafish 
embryos are usually raised at 28.5°C, fluorescent protein maturation 
may take a longer period of time to become detectable in these 
embryos. 
By 18hpf, we reported Notch activity in the arterial progenitor cells 
at the time of their arrival to the midline to form the dorsal aorta. 
Notch activity then appeared to increase in these cells   after their 
gain of the arterial fate and continues to 26hpf  (the time point at 
which haematopoietic stem cell precursors are starting to emerge 
from the dorsal aorta). On day 2 post fertilization, Notch activity 
sharply decreased in the arterial vasculatures to hardly detectable 
levels.  Persistence of Notch signalling and its expansion after arterial 
fate determination further supports the concept of an additional role 
for Notch signalling in vascular maturation and haematopoietic stem 
cell development. Our data confirmed that the previously reported 
expression of Notch receptors and ligands in the DA principally leads 
to functioning Notch signalling.  
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Recently, a study published by the Lawson lab (Quillien et al., 2014), 
utilising a similar Notch reporter line also showed that Notch is active 
in the progenitor cells forming the developing DA, and that Notch 
activity increases after the time point of arterial specification. Quillien 
et al. (2014) also suggested persistence of Notch activity in the DA 
and arterial ISV based on persistence of the reporter Gfp fluorescent 
protein in these tissues. Unlike in the data of Quillien et al. (2014), 
our in situ hybridization data showed a sharp reduction in Notch 
activity in the DA and arterial ISV (Figure 3.7). The observed 
difference between our findings and those of Quillien et al. (2014) 
data may be resulting from the fact that in our in situ data, we 
examined the mRNA, which is less stable and appears earlier than 
the reporter fluorescent protein. 
On the other hand, Quillien et al. (2014), examined the persistence 
of the highly stable reporter fluorescent protein on day 7 post 
fertilisation. This makes it unsurprising to detect the accumulated 
stable fluorescent protein from the basal level expression and its 
detection with normal or confocal microscopy. The authors also 
suggested that arterial and haematopoietic progenitor cells have 
Notch activity well before their arrival to the midline to form the DA. 
They provided a double in situ data showing an overlap between the 
Notch reporter mRNA and the endothelial marker etv2 mRNA at early 
somitogenesis. Their findings also were supported by the proposed 
expression of dlc in these migrating progenitor cells (Smithers et al., 
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2000). Consistent with Quillien et al. (2014) data, our ability to detect 
the Notch reporter protein in the cells forming the developing DA at 
18hpf also indirectly suggests that Notch activity must have initiated 
in these progenitor cells at least 3-4 hours earlier, i.e. around 14hpf. 
However, our indirect observation and the double in situ data from 
Quillien et al. (2014) do not conclusively show co-localization within 
single cells, leaving the possibility that Notch activation is occurring 
in adjacent cells. 
Therefore, a more conclusive experiment may be desirable to clearly 
determine when Notch signalling becomes active in these progenitor 
cells. Recent advances in single cell transcriptome analysis enabled a 
higher degree of resolution that make it possible to study individual 
cell fates as soon as they are acquired. Applying these techniques on 
individual cells sorted with the help of an endothelial reporter 
fluorescent protein at early somitogenesis. Analysing these cells for 
the Notch reporter gene mRNA, could provide a direct and powerful 
evidence for Notch activity in these progenitor cells during early 
somitogenesis.  
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8.2 High level of Notch is required for flt4 
suppression and HSCs formation in the DA whereas 
low level is sufficient for arterial specification 
 Previously, it was suggested by Lawson et al. (2001) that a major 
role of Notch signalling in the DA at the time point of HSC formation, 
is to repress the venous fate of the developing DA by repressing flt4 
expression. We, and others, have also shown that the whole embryo 
Notch over-activation with the Gal4-Uas system, suppress flt4 
expression in the CV and expands both arterial and haematopoietic 
markers such as efnb2a, runx1 and c-myb in these tissues 
(Rowlinson, 2010, Lawson et al., 2001, Lawson et al., 2002). In 
agreement with these findings, we reported in Chapter 3 an up-
regulation in Notch signalling in the DA after arterial fate 
determination. In Chapter 4 we also showed that the venous marker 
flt4 is expressed in the developing DA at 18-20hpf at high level. 
This high  flt4 coincides with low Notch activity as indicated by low 
level of the reporter fluorescent protein in our reporter lines. As the 
Notch activity become higher in the DA at 24h, we found that flt4 
expression become much weaker and completely disappears from the 
DA by 26hpf. This up-regulation was also confirmed in our lab at the 
mRNA level by RT-PCR experiments performed on FAC-sorted 
flk1:gfp positive trunk endothelial cells (Modhara, 2014). These data 
strongly suggest that high levels of Notch are required to suppress 
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flt4 expression in the DA to allow HSC development. In addition, the 
fact that residual Notch signalling in DAPM-treated embryos was 
sufficient to support the arterial fate as determined by efnb2a 
expression, but was not adequate to suppress flt4 expression in the 
DA further support this hypothesis. 
 On the other hand, we found that with the more efficient Notch 
blocking approaches, such as mib mutation and rbpja/b morpholinos, 
even arterial specification was blocked. In line with this, a former PhD 
student in our lab also reported a morpholino study showing that 
blocking individual Notch receptors that are dominantly expressed in 
the DA (notch1a, notch1b and notch3) lead either to severe reduction 
or complete loss of the haematopoietic program in the embryo, with 
intact or minimally reduced arterial specification. On the other hand, 
complete deletion of the three Notch receptors blocked both arterial 
and haematopoietic programs (Rowlinson, 2010). 
Recently, a similar study was carried out, but with the main focus on 
arterial specification (Quillien et al., 2014), which showed no 
significant reduction in Notch activity in developing DA with individual 
morpholino knockdown of notch1a and notch1b or minimal and 
temporary reduction with notch3 knockdown (that was mostly 
restored by 24hpf). Quillien et al. (2014) also reported a severe 
reduction in the arterial marker efnb2a expression when injected the 
notch3 mutants with the notch1b morpholinos, and less severe 
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reduction with injecting the combined notch1a and notch1b 
morpholinos. The Quillien et al. (2014) data, despite its slight 
discrepancy with our findings, does not exclude the possibility that a 
low level of Notch is sufficient to support arterial specification.   This 
slight discrepancy, possibly due to blocking notch1b in notch3 mutant 
background, that is expected to be more efficient than our injection 
of notch1b and notch3 morpholinos, and there is also a possibility of 
injecting slightly different dosages of the combined notch1a/notch1b 
morpholinos in the Quillien et al. (2014) work.  
Together our findings provide a possible explanation to one of the 
fundamental questions in the field about how Notch signalling 
pathway differently affects arterial specification and haematopoietic 
stem cells development. In the mouse animal model, it was 
hypothesised that specific Notch receptors and ligands are required 
for HSCs development. This hypothesis was mainly based on the 
jagged1 loss of function experiment reported by Robert-Moreno et al. 
(2008). In this experiment, the authors showed a complete or severe 
reduction gata2 and runx1 expression following deletion of jagged1 
ligands, without affecting the arterial program.  They also found that 
this loss can be rescued by co-culturing these cells with jagged1 
expressing stromal cells. 
A similar loss of function experiment was also recently reproduced in 
zebrafish by the Traver Lab (Espin-Palazon et al., 2014). In this 
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study, it was also shown that loss of jag1a leads to decrease in HSC 
numbers as determined by the reduction in the runx1 expressing cells 
in the DA. The other interpretation of the data provided by Robert-
Moreno et al. (2008) and Espin-Palazon et al. (2014) in light of our 
work is that the residual Notch signalling provided by the remaining 
Notch components after deleting jagged1 in the mouse or jag1a in 
the zebrafish was sufficient to support arterial specification. However, 
this low remaining signalling was below the level required for 
initiating the definitive haematopoietic program in the embryo.  
Furthermore, to our knowledge  there are no published studies 
demonstrating that Jagged1 is an obligate ligand  for any of the Notch 
receptors. Conversely, in mammalian cell culture, it was  shown that 
Delta and Jagged ligands can bind Notch1 and Notch3 receptors 
interchangeably, and thus suggesting that binding between Notch 
receptors and ligands is promiscuous (Shimizu et al., 2000).  
 
8.3 Studying the cell autonomous requirements for 
Notch in zebrafish definitive haematopoiesis 
Notch signalling was demonstrated to be absolutely required for HSC 
formation in all studied vertebrates (Burns et al., 2005, Hadland et 
al., 2004, Krebs et al., 2000, Kumano et al., 2003, Robert-Moreno et 
al., 2008, Robert-Moreno et al., 2005, Yoon et al., 2008), but whether 
this requirement was cell autonomous or non-cell-autonomous 
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initially remained unclear. To determine the source of this Notch 
signal Hadland et al. (2004) generated mouse chimera with        
notch1 -/- cells and found that notch deficient cells lack the ability to 
contribute to HSCs. Based on these findings, it was presumed that 
the requirements for Notch are solely cell autonomous.  Because this 
study did not show at which developmental stage Notch is required, 
or whether signalling from other tissues are also involved in the 
process. For this, several other endothelial specific Notch loss/gain of 
function studies were carried out to further confirm the findings of  
Hadland et al. (2004) and to determine when Notch is required in this 
tissues. 
Nonetheless, these studies were hampered by the severe 
complications on blood circulation after mis-expressing Notch 
pathway in the endothelium. Unlike in mouse, zebrafish embryos can 
survive for days with non-functioning blood circulation, which makes 
them an attractive complement animal model to study  HSCs 
development. However, several molecular tools available in the 
mouse model were still not established for zebrafish.  One of the 
issues with the zebrafish model is the lack of a ubiquitous promoter 
comparable to the mouse rosa26 (Mosimann et al., 2011). 
In Chapter 5, we tried to optimise the currently available molecular 
tools to enable efficient and reliable endothelial specific over-
activation/blocking of Notch signalling in stable transgenic lines. The 
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main obstacles faced in developing these tools were firstly, the 
complications associated with the polyA transcription termination 
signal read-through, and consequently the early death of embryos in 
which the constructs were integrated in supportive genomic regions. 
Read-through the polyA transcription termination signal has been 
previously reported (Maxwell et al., 1989). One strategy to overcome 
the previously reported read-trough the pA problem is to add multiple 
SV40 polyA  repeats at the 3´ end of the floxed cassettes. This 
provided tighter spatial and temporal controls, and enabled 
generating transgenic lines with incorporated toxic or oncogenes. 
Utilising this approach Jackson et al. (2001) generated a floxed 
super-stop cassette made of four SV40 polyA signals, and were able 
to study involvement of the oncogene k-ras in lung tumour initiation 
and progression. We utilised the Jackson et al. (2001) cassette to 
over-come the read-through and generated effector transgenic lines 
floxed super-stop cassettes. 
The other complication we faced was the weak activity of the ef1α 
promoter in driving the nicd or the dnRbpj expression in the 
endothelium after recombination.  Mosimann et al. (2011) reported 
isolation and characterisation of the zebrafish ubiquitin promoter 
(ubi), which they showed to be constitutively expressed in all 
developmental stages, including all blood lineages. To further 
enhance our effector lines, we also replaced the ef1α promoters in 
our constructs with the ubi promoter then generated new effector 
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lines with these modified constructs. Our data suggests that even 
with the ubi promoter the expression of nicd or dnRbpj were still 
tolerated by the embryos, as the embryos appeared completely 
normal and in distinguishable from their WT siblings. 
Mosimann et al. (2013) showed that ubi promoter driven expression 
pattern can vary significantly due to the location in which it is inserted 
in the genome. They even showed that in two lines generated by the 
same construct, a complete silencing for gfp expression in 
haematopoietic cells at adulthood in one line, while gfp expression 
was maintained in the haematopoietic cells in the other. We and 
others, have previously shown that implementing the binary Gal4-
Uas system efficiently amplifys the amount of over-expressed nicd in 
the whole embryo to a level sufficient to expand the HSCs markers 
runx1 and c-myb (Rowlinson and Gering, 2010, Burns et al., 2005). 
In this thesis, we demonstrated that combining the Gal4-Uas system 
with the Cre/LoxP system provided a powerful tool to mis-express 
Notch signalling in targeted tissue. 
In our generated quadruple transgenic embryos we showed that by 
expressing the cre recombinase gene under control of the flk1 
promoter, we were able to excise  the floxed super stop cassette, and 
so limit activation of the Gal4-Uas system and accompanied Notch 
over-activation to the endothelium, which was confirmed by the 
significant up-regulation of the reporter fluorescent protein 
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expression. Consistent with Siekmann and Lawson (2007), we found 
that over-activating Notch in the endothelium does block tip cell 
formation, indicated by cell failure in forming the DLAV, and instead 
arterial endothelial cells were preferentially located in the dorsal aorta 
or the base cell of the developing arterial ISV. Unlike with whole 
embryo over-activation, previously shown to repress flt4 expression 
in the CV (Lawson et al., 2001), flt4 expression in the CV was not 
affected. This is likely due to the lower flk1 activity in the endothelial 
cells forming the CV, compared to cells forming the DA (Sumoy et al., 
1997, Kohli et al., 2013). 
One of the issues we also reported in this work was the likely toxic 
effect resulting from the Gal4-vp16 accumulation in the endothelium, 
which we found to lead to late vascular defects and lack of blood 
circulation. It was previously proposed that accumulating high 
intercellular levels of the Gal4-vp16 can interfere with the cellular 
transcriptional machinery in yeast and mammalian cell culture 
(Gilbert and Glynias, 1993, Sadowski et al., 1988, Triezenberg et al., 
1988). Consistent with that, we hypothesised that the observed late 
defect in blood circulation, and also lack of HSCs markers runx1 and 
c-myb, were due to the accumulation of high levels of Gal4-vp16 in 
these cells. Our data also suggest that endothelial Notch over-
activation partially rescues the hematopoietic defects in these 
embryos. Moreover, we found that truncating the last 20 amino acids 
of the VP16 activating domain as previously employed (Davison et 
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al., 2007, Inbal et al., 2006, Koster and Fraser, 2001, Sagasti et al., 
2005, Scott et al., 2007) 
Addition of temporal control, by replacing the ubi promoter with the 
heat shock promoter in the effector line, significantly delays the 
transcriptional interference resulting from Gal4-vp16 protein 
accumulation in the cells. This contributed to developing a strategy 
by which we over-activated Notch in the endothelium and moderately 
enhanced runx1 and c-myb expression in the DA aorta and the CHT. 
The fact that gfi1.1 expression persisted until day 2 in the DA also 
suggests that these cells failed to differentiate and leave the DA. In 
recent work done by the Jafferdo lab, it was shown in chicken embryo, 
that temporally restricted decrease in Notch signalling is critical for 
HSCs emergence from the haemogenic endothelium (Drevon and 
Jaffredo, 2014). 
We also showed that transient gene expression under control of the 
minimal flk1 or fli1 promoters, due to the high copy number of 
injected plasmids led to a strong endothelial specific Notch induction, 
indicated by the strong expression of the fused gfp. This strong up-
regulation appeared to be essential for the endothelial to 
haematopoietic transition, whereas the sharp decrease in later time 
points indicated by loss of the gfp expression, due to rapid cell 
division and foreign DNA degradation, allowed the fated HSCs to 
differentiate into mature HSCs that are able to leave the vDA and 
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seed the CHT. Together, we demonstrated for the first time in the 
zebrafish animal model that cell autonomous Notch induction is 
sufficient to expand HSCs markers expression in the DA and the CHT. 
Collectively, our data demonstrate that endothelial specific Notch 
induction is sufficient to expand haematopoietic stem cell markers in 
the DA and the CHT. We also showed that a high transient Notch 
signal is required to initiate the HSCs fate, followed by a low Notch 
signal to enable HSC differentiation into mature cells that are able to 
leave the DA and seed the CHT. These data represent the first 
demonstration, to our knowledge, that cell autonomous Notch 
signalling in vivo is sufficient to expand HSC formation in vertebrates. 
In the last four years, an intensive work was carried out in several 
labs to analyse the non-cell autonomous requirements for Notch in 
definitive haematopoiesis proposed by (Clements et al., 2011). These 
efforts have not only confirmed existence of such requirements, but 
also suggested several pathways and intermediate factors to transmit 
or facilitate transmission of these signals to the developing DA 
(reviewed in chapter 1). In our study, we showed that up-regulation 
of the cell autonomous Notch in the context of normal non-cell 
autonomous Notch signalling is sufficient to expand the zebrafish 
haematopoietic stem cells both in the DA and the CHT. What is still 
to be shown is whether up-regulation of the cell autonomous Notch 
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in absence of non-cell autonomous signalling is still sufficient to lead 
to the same expansion.  
It is still not clear if up-regulation of the somatic Notch signalling will 
lead to similar expansion in absence of normal cell autonomous Notch 
signal. Several molecular tools are currently available to address 
these questions, like the phldb1 and pax3a promoters that were 
shown to drive expression of downstream genes, specifically in 
zebrafish somites (Kim et al., 2014, Nguyen et al., 2014). Somitic 
contribution to the zebrafish DA endothelium suggested by (Nguyen 
et al., 2014) and shown to be essential to HSCs development added 
another layer of non-cell autonomous requirement for Notch, in which 
Notch signalling contributes to maturation and specification of these 
migrating endothelial cells. Even though these cells do not directly 
contribute to formed HSCs, in light of our findings, it is still to be 
determined if the Notch activity in somite derived endothelial cells 
contributes to overall Notch level in the DA.  
Fgf signalling was also recently shown to act upstream of the Bmp 
signalling in the mesenchyme beneath the DA and shown to be 
essential for polarizing HSCs formation (Wilkinson et al., 2009, 
Pouget et al., 2014). Fgf also mediates the signalling between the 
somitic Wnt16 and the Dlc to regulate HSCs specification in the non-
cell autonomous Wnt16/Dlc;Dld pathway (Wilkinson et al., 2009, 
Pouget et al., 2014, Lee et al., 2014). Because proper somitic Fgf 
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signalling requires correctly differentiated somites, which are also 
Notch dependent, it is still not clear to what extent the Notch 
dependent somitic maturation affects HSCs specification. Putting our 
findings in the context of recently gained knowledge about the non-
cell autonomous rules for Notch in definitive haematopoiesis, it is 
possible that proper somitic Notch signalling is a pre-requisite for the 
observed HSCs expansion in our study. More advanced experiments, 
utilizing currently available somite and endothelial specific promoters, 
may provide further insight into the degree of cooperation and 
coordination between the two signalling pathways to instruct HSCs 
program.  
8.4 tet1 and tet3 deletion abolishes organogenesis 
and leads to decrease in global 5-
hydroxymethylcytosine content in zebrafish 
From previous work performed by the Ruzov lab with collaboration 
from our lab, we showed that the 5hmC enrichment of non-
committed cells is not a universal feature in vertebrate development 
(Almeida et al., 2012). Unlike in mammals, 5hmC enrichment in chick 
and zebrafish only take place later in development in a stage 
coinciding with the onset of organogenesis. We also showed that 
whereas Tet genes are highly expressed in the mammalian zygotic 
stage, they are undetectable in in the zebrafish or chick zygotes. 
Interestingly, both Tet1/2/3 mRNAs and 5hmC peak during zebrafish 
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organogenesis at 24-48 hpf, which suggests that Tet-dependent 5mC 
oxidation may be important for cell lineage specification and 
differentiation occurring at these developmental time points.  
Other indications of methylation mark involvement in zebrafish 
organogenesis came the fact that blocking the enzymes required for 
maintaining DNA methylation, such as the DNA methyltransferase 
Dnmt1 or Dnmt3, interferes with the normal organ specification of 
various tissues.  This includes defects in eye development, intestinal 
development and brain development (Rai et al., 2006; Anderson et 
al., 2009; Tittle et al., 2011; Rai et al., 2010; Seritrakul et al., 2014).  
In consistence with the findings of the Ruzov lab, several other 
studies also reported a strong DNA demethylation taking place in the 
developmental window corresponding to organogenesis and Tet 
genes expression (Collas 1998, Rai et al., 2008). To test whether the 
Tet dependent DNA demethylation is essential for proper 
organogenesis, former student in our lab (Sabrina Boudon) blocked 
expression of the Tet genes during early development with anti-sense 
morpholinos. 
Because the morpholinos were designed to target the catalytic C-
terminal of the dioxygenase domain in the three tet genes, they are 
expected to lead to frame-shifts and premature termination of their 
transcripts. In consistence with this, we observed severe defects in 
organogenesis and developmental arrest after somitogenesis 
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initiation in tet1 and tet3 morphants, whereas Tet2 morphants 
appeared normal until day3. These phenotypes were associated with 
deletion of tet genes targeted exons, as demonstrated by the shift in 
PCR amplified fragments with primers targeting the sequences 
outside these exons. Sequencing results of these fragments also 
confirmed the complete deletion of targeted tet1 and tet3 exons and 
the introduction of frame shifts and premature translation  
terminations, as predicted. We also showed that targeting different 
exons in tet1 and tet3 transcripts also produced phenotypes identical 
to those observed in the preliminary data, and that these phenotypes 
persist even with p53 morpholino co-injection. Together these 
findings strongly suggest that observed phenotypes were specific to 
morpholino injections and not were due to non-specific complication 
resulting from morpholino toxicity. 
The immune-staining and mass spectrometry results also showed a 
dramatic decrease in global 5hmC levels in both tet1 and tet3 
morphants compared to uninjected controls when examined at 24hpf, 
which strongly suggests that cell lineage fates determination during 
organogenesis were controlled by Tet dependent DNA demethylation. 
In mouse, it was reported that blocking tet1 expression alters the 
normal neurogenesis (Zhang et al., 2013). This tet1 induced 
alteration in neurogenesis was also found to be accompanied by 
failure in demethylating number of promoters involved in the 
proliferation of neural progenitor cells. Correspondingly, we observed 
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severe neurological abnormalities in tet1 morphant embryos. These 
abnormalities include alteration in Notch signalling as reflected by 
alteration in Notch activity in these morphants.  We also found that 
expression of the neural marker elavl3 was significantly altered when 
examined at 23 hpf. Interestingly, these neurological alterations were 
found to coincide with the time point when tet1 become highly active 
in WT, thus suggesting tet1 dependent demethylation, and activation 
of these promoters, in similar manner to that reported in mouse.  
In a recent methylome study of different human tissues, it was also 
suggested that DNA methylation may provide an additional layer of 
control on Notch signalling. The newly proposed Notch control is 
thought to be Tet dependent, and take place through alteration of the 
methylation marks within or near the Notch receptors and ligands 
promoters, which eventually alters the expression pattern of the 
targeted gene (Terragni et al., 2014, Tsumagari et al., 2013). To 
investigate the regulatory roles for the Tet genes on Notch activity 
during early development, we injected the tet1 morpholinos to our 
in-house generated Notch reporter line Tg(csl:venus)qmc61, and 
examined the expression pattern of the reporter gene and also the 
expression pattern of several Notch components and downstream 
targets at different time points in these injected morphants.  
In agreement with our microscopic observations, in which we 
reported normal embryonic development until early somitogenesis, 
the expression pattern of the Notch reporter and examined Notch 
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components and downstream targets appeared indistinguishable 
from their uninjected siblings. However, we found significant changes 
in the expression pattern of these genes when examined at 23hpf, 
which strongly suggests a Tet1 depletion dependent mis-regulation 
of the Notch signalling pathway. Despite this, caution must be taken 
in interpreting these data, as it is still possible that observed 
alteration in Notch activity was a complication associated with failure 
in tissue formation in these embryos rather than being caused by an 
alteration in Notch activity downstream of Tet1.  The low levels of 
5fC/5caC in zebrafish embryos at 24 hpf relative to mouse ESC also 
suggests that unlike in mouse, the early zebrafish development may 
be mainly dependent on  passive DNA demethylation, as Dnmt1 
poorly recognise and bind 5hmC (Valinluck and Sowers, 2007). This 
in turn prohibits the maintenance of existing DNA methylation 
patterns in the zebrafish actively dividing cells at early stages of 
development.  
Unlike in the mouse where a high degree of redundancy between the 
three Tet proteins was demonstrated (Dawlaty et al., 2013), in this 
study we reported a low redundancy between Tet1 and Tet3 in 
zebrafish. Interestingly, zebrafish Tet3 protein also lacks the CXXC 
domain present in mammalian and Xenopus Tet3 proteins, which was 
shown to play critical role in specific Tet3 targeting (Xu et al., 2012). 
It can therefore be assumed that the zebrafish Tet3 utilises a different 
targeting mechanism from those in frogs and mammals, which may 
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account for the absence of redundancy between Tet1 and Tet3 in 
zebrafish.  
In a recent work from the Goll Lab, zebrafish mutants for the three 
tet genes were generated and examined in single, double and triple 
mutant genotypes. Unlike in our study, organogenesis appeared 
unaffected in individual or combined homozygous mutation of tet1, 
tet2, or tet3 (Li et al., 2015). The discrepancy between our tet1 and 
tet3 morpholino knock-down results and those of Li et al. (2015) is 
possibly due to the fact that the targeted loci in their mutants were 
at the ends of tet1 and tet3 genes, which leaves most of these genes 
unaffected. Even though the authors predicted that deletion of the 
Dioxygenase arginine c-terminal residue compromised their 
Dioxygenase activity, it is possible that the produced terminally 
truncated Tet1 and Tet3 proteins were still partially active. Moreover, 
it has been recently reported that zebrafish mutants generated by 
any of the currently available genome editing tools, such as TALENs 
and CRISPRs, can compensate for mutated genes, by fine-tuning 
their transcriptomes (Rossi et al., 2015).  
To demonstrate this compensation and its contribution to the 
inconsistency between the egfl7 mutants and egfl7 morphants, Rossi 
et al. (2015) generated a mutant for egfl7 with the use of TALENs 
technology and also designed morpholinos for the same gene 
through. They then injected similar amounts of egfl7 morpholinos to 
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a batch of egfl7 mutants and a batch of WT embryos and found that 
while egfl7 has no effect on egfl7 mutants, a clear vascular phenotype 
was observed in WT embryos. Tracing possible mechanisms of 
compensation in these mutants, the authors identified a clear 
upregulation of several members of the emilin gene family, which 
shares an important functional domain with the egfl7, which may be 
responsible for this compensation. 
On the other hand, the possibility of an off-target effect caused by 
the morpholinos used in our study cannot be excluded. Toxicity due 
to off-target effects can be resulting from morpholinos activation or 
blocking of other genes, such as those resulting from activation of 
the apoptotic p53 gene, induction of Interferon response, activation 
of Toll-like receptors and compromising the RNA interference 
machinery (Anon, 2006, Robu et al., 2007). In a study performed by 
the Lawson Lab that involved generating a megamind mutant that 
appeared normal despite of deletion of most of the megamind 
genomic sequence, including a target sequence of previously 
published morpholinos shown to lead to clearly distinct phenotypes 
when used to block the same gene (Ulitsky et al., 2011). Surprisingly, 
injecting same morpholino to the generated megamind mutant 
embryos was shown to produce the same phenotypes in the mutants, 
despite the absence of the morpholino target site in their genomic 
sequences (Kok et al., 2015).  
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In summary, gene knock-down by mutating targeted genes or 
silencing their expression with anti-sense morpholinos both have 
inherent limitations that sometimes lead to inconsistencies between 
the gene knock-down results obtained by the two strategies. 
Therefore, it is desirable to reproduce morpholinos results in mutants 
that lack the same morpholino targeted genes, whenever possible, 
before assigning specific functions for that gene.  
 
8.5 Future perspectives 
In this project we presented data suggesting that Notch activity 
initiates in the migrating hECs progenitors before their arrival to the 
midline to form the DA. Based on these data it would be of great 
value to confirm these findings at a single cell level by FACS sorting 
trunk endothelial cells of Notch reporter embryos at early 
somitogenesis, then quantifying the Notch reporter mRNA in these 
cells compared to their controls. We have also generated several 
transgenic lines and constructs to mis-express Notch signalling in the 
endothelium and showed expansion of HSCs markers in the DA and 
the CHT, yet it would be of great value to examine their ability to 
seed the kidney and the thymus, and also to see if they can 
reconstitute the zebrafish haematopoietic system. 
Our tet morpholino studies showed an essential role for Tet1 and Tet3 
in organogenesis. To confirm these morpholino data, Dr. Martin 
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Gering and the summer student working in our Lab designed  
CRISPRs guide RNA which targets the same exons we targeted in the 
morpholino injections. Deleting these exons in F0 embryos or in 
stable mutant lines and carefully analysing them and also comparing 
their phenotypes to the morpholino phenotypes will greatly expand 
our understanding of tet genes involvement in organogenesis.  
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APPENDICES 
           
 
Appendix 1: Tol2 plasmids generated and injected to 
generate the Notch reporter lines. 
Diagrams of the three plasmid constructs generated and injected to 
establish the three Notch reporter lines. The three constructs are 
identical in their tol2 back bone structure and regulatory elements 
but with different fluorescent protein gene downstream of the 
regulatory elements, with venus gene in the first, cerulean gene in 
the second and mCherry in the third.  
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Appendix 2: GFP expression driven by the flk1 promoter in 
Tg(ﬂk1:EGFP)s843 line recapitulates endogenous ﬂk1 
expression.  
(A) Diagram showing the injected construct in which the 6.5 kb 
upstream sequence of zebraﬁsh ﬂk1 was used to drive GFP 
fluorescent protein expression in the Tg(ﬂk1:EGFP)s843 line. (B-C) 
Same embryo imaged at 60hpf under bright-ﬁeld (B) and fluorescent 
microscopy, in which head and trunk vasculature were specifically 
highlighted by the GFP fluorescent protein (C). (D-G) Show head 
vasculature (D) and trunk vasculature (F) at 60 hpf embryos stained 
by endogenous alkaline phosphatase (AP) activity compared to 
fluorescently labelled head (E) and trunk (G) vasculature of similar 
areas in a Tg(ﬂk1:EGFP)s843 embryo. (H,J) endogenous ﬂk1 
expression detected by In situ hybridization at 16hpf (H) and 36hpf 
(J) compared to GFP expression in Tg(ﬂk1:EGFP)s843 embryos at 
similar stages and similar areas (I,K) visualized by fluorescent 
microscopy. Source: adapted from Jin et al. (2005). 
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Appendix3: Cre expression driven by the flk1 promoter in 
Tg(ﬂk1:cre) s898 line recapitulates endogenous ﬂk1 
expression.  
Whole mount in situ hybridization of endogenous flk1 expression 
(A,C,E)compared to cre recombinase expression in Tg(ﬂk1:cre) s898 
line (B,D,F). (A-B) Expression of both transcripts are visible in rostral 
tissues (Ro), in the area where primitive macrophages first appear in 
the embryo, and also in the caudal tissues (Ca), in the area where 
primitive erythrocytes, HSCs, and EMPs first appear in the embryo. 
(C-F) Both endogenous flk1 and flk1:cre are similar in their 
expression in cells of the developing vasculature. Source: (adapted 
from Bertrand et al., 2010). 
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Appendix 4: Identification of the minimal flk1 promoter.  
(A) Diagram showing structures of generated deletion constructs of 
flk1:GFP and summary of their ability to drive endothelial specific GFP 
expression as indicated by the + and – signs (* marks the 
transcription initiation site of flk1). (B-G) fluorescent microscopy 
images of 1-day-old WT embryos injected with the linearized DNA of 
constructs as described in each image. A strong endothelial restricted 
GFP expression was observed with the full flk1(−6.5)-GFP (B), 
flk1(−5.0)-GFP (C) and flk1(−5.0,−3.5/−1.5)-GFP (F). A weaker but 
endothelial specific GFP expression was also observed with the 
construct flk1(−4.3)-GFP (D), and also with the 
flk1(−4.3,−3.5/−1.5)-GFP (G). While no GFP expression was 
observed with the flk1(−5.0,−4.3/−1.5)-GFP (E). The highlighted 
parts of the figure are the minimal flk1 promoter construct and its 
expression pattern. Source: (adapted from Choi et al., 2007). 
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Appendix 5: Minimal and full flk1 promoters drives identical 
expression pattern in stable reporter transgenic lines. 
(A, C) gfp expression driven by the minimal flk1 promoter in our in-
house Tg(flk:gfp)qmc67 is identical to expression driven by the full 
(6.5kb) flk1 promoter fragment in Jin et al. (2005) line, 
Tg(flk1:gfp)s843 (B, D). (A-B) gfp expression become detectable in 
the migrating endothelial progenitors migrating to the mid-line to 
form the main axial vessels. (C-D) gfp expression persists in the 
endothelium of axial and ISVs till late developmental stages. Source 
(images (B,D) adapted from (Jin et al., 2005), images (A,C) from 
Gering lab, unpublished data). 
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Appendix 6: Cloning steps followed to replace ef1α promoter 
with the ubi promoter in the constructs P311 and P312.  
 (A-B) Schematics of the constructs P311 (A) and P312 (B) with the 
red arrows indicating where the promoter replacement step. (C-J) 
shows the cloning steps followed to replace the ef1α promoter with 
the ubi promoter in P311 and P312 plasmids. (C,G) we firstly 
amplified the ubi promoter from the containing plasmid with addition 
of ApaI and SbfI restriction sites, then cut and cleaned amplified 
fragments, preparing them for ligation. (D,H) P311 and P312 were 
also cut with the same enzymes ApaI and SbfI then cleaned. (E,I) 
amplified ApaI and SbfI cut ubi promoter was then ligated to the cut, 
cleaned P311 plasmid (E) and also ligated to the cut cleaned P312 
plasmid (I). (F,J) show the final constructs P323 and P325 with the 
ubi promoter replacing the ef1α promoter.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
273 | P a g e  
 
 
 
274 | P a g e  
 
Appendix 7: Cloning steps followed to replace the cerulean pA 
fragment in P323 and P325 with the mCherry-s.stop cassette 
fragment.  
Schematic showing the cloning steps followed to generate the P351 
and P352 plasmids. (A) mCherry gene was PCR amplified from P292 
with the DB377 and DB378 that also add SacII and AflII at the 
mCherry 5' and the 3' sites respectively. (B) Both amplified fragment 
and the s.stop plasmid P330 were cut with the SacII and AflII 
enzymes, then the removed fragment upstream of the s.stop cassette 
was replaced with the mCherry fragment. This has led to generation 
of the mCherry-s.stop plasmid P349 (C). Both P349 (F) and P300 (E) 
were cut with SacII and XmnI to enable addition of the loxP site 
upstream of the mCherry and generation of the loxP-mCherry-s.stop 
cassette P345 (D). P345 and the backbone plasmids P323 and P325 
were then cut with BamHI and SbfI (G,H,I,L) to remove the cerulean-
pA fragment and replace it with the loxP-mCherry-s.stop fragment 
(J-K). This led to generation of the plasmids P351 and P352.  
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Appendix 8: Cloning steps followed to generate the Tol2-ubi-
loxP-mCherry-s.stop-loxP-gal4-vp16 construct P356.   
(A) Diagram showing the main components of the P356 construct. 
(B-E) construction steps followed to generate the P356 plasmid in 
which the gal4-vp16 gene was PCR amplified from the plasmid P346 
with the primers DB414 and DB415 that add the restriction site SalI 
followed by the kozak sequence (GCCACC) at the 5′ and ClaI at the 
3′ end (B). The plasmid P353 (C) was cut with the same enzymes 
(SalI and ClaI) to replace the EGFP gene with the gal4-vp16 gene 
(D), thus generating the final Tol2-ubi-loxP-mCherry-s.stop-loxP-
gal4-vp16 plasmid (P356). 
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Appendix 9: Cloning steps followed to generate the P385 
construct HSP-loxP-mCherry-pA-loxP-Tgal4-vp16.   
(A) Restriction map of plasmid P363 that was modified to generate 
P385 by firstly removing the GFP gene with the restriction enzymes 
XmaI and ClaI. (B) PCR amplification of the 624bp truncated gal4-
vp16 (tgal4-vp16) with the primers DB542 and DB543 from plasmid 
P355. DB542 is a forward primer that includes the XmaI and the 
kozak sequence whereas DB543 is a reverse primer that exclude the 
last 60 bp of the VP16 and add a stop codon followed by the restriction 
site ClaI.  (C) The final P385 map after cloning the amplified, XmaI 
and ClaI cut fragment to the prepared HSP-loxP-mCherry-pA 
backbone thus generating the final construct  HSP-loxP-mCherry-pA-
loxP-tgal4-vp16 (P385). (D) The main components of the generated 
plasmid. 
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Appendix 10: Diagram showing GIBSON assembly steps 
followed to generate the tol2-m.flk1:NICD-GFP plasmid P405. 
(A) NICD gene was firstly amplified from P312 with the primers 
DB608 and DB609 which add a kozak sequence preceded by an 
overlap sequence to the linearized tol2-m.flk1 plasmid at the 5' end 
and exclude the NICD stop codon and also add an overlap to the no-
start GFP in-frame with the NICD at the 3' end. No-ATG GFP was also 
amplified with DB610 and DB611 from P252 with exclusion of the ATG 
and addition of an overlap sequence to NICD at the 5' end and overlap 
sequence to the backbone plasmid at the 3' end. (B) The two 
amplified fragments were firstly fused with GIBSON assembly method 
then PCR amplified as one fragment with DB 608 and DB610 (C). A 
second GIBSON assembly was then done to ligate the NICD-GFP 
fusion gene to the tol2-m.flk1 backbone plasmid (D). This led to 
generation of the final plasmid tol2-m.flk1:NICD-GFP plasmid P405 
(E).   
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Appendix 11: Diagram showing GIBSON assembly steps 
followed to generate the tol2-fli1:NICD-GFP plasmid P409. 
(A) fli1 promoter was firstly amplified from P377 with the primers 
DB612 and DB613 that add an overlap sequence to the linearized tol2 
plasmid at the 5' end NICD-GFP fusion at the 3' end. NICD-GFP fusion 
was also amplified with the primers DB628 and DB611 from P405. 
The two amplified fragments were then firstly ligated together with 
GIBSON assembly method then PCR amplified as one fragment with 
DB 612 and DB611 (C). A second GIBSON assembly was then done 
to ligate the fli1-NICD-GFP fragment to the tol2 backbone plasmid 
(D). This led to generation of the final plasmid tol2-fli:NICD-GFP 
plasmid (P409;E). 
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Appendix 12: 5fC and 5caC are detectable by 
immunochemistry in mESCs.  
(A) The expression of Tet1, Tet3 and BER-related genes (GADD45G, 
LIG3, PCNA and TDG) at indicated zebrafish developmental stages. 
The Y axes show RPKM (Reads Per Kilobase of exon model per Million 
mapped reads) values. The analysis was performed using zebrafish 
time course data set provided by the zebrafish genome sequencing 
group at the Wellcome Trust Sanger Institute. (B) The results of 
5hmC, 5fC and 5caC immunostaining of mESCs colonies. 
5hmC/5fC/5caC, DAPI and merged views are shown. Scale bars are 
10 μm (The figure was courtesy of  Dr. Alexey Ruzov). 
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Appendix 13: Global 5hmC levels are dramatically decreased 
in both Tet1 and Tet3 morphants.  
(A) 5hmC co-localization with 5caC in hESCs. Scale bars are 10 μm. 
(B) Immunostaining of uninjected control, MOTet1/3, MOTet1 and 
MOTet3 embryos for 5hmC and 5caC. Representative views of 
sections through the axial embryonic tissues are shown. The slides 
were processed in parallel and imaged using identical settings. 
Identical dilutions of the antibodies and times of incubation with 
amplification reagent were used in (A) and in (B). 5hmC, 5caC, DAPI 
and merged views are shown. (C, D) Overlays of total ion 
chromatograms of global dC, dmC, (C) and dhmC (D) content 
recorded in Dynamic Multiple Reaction Monitoring (DMRM) mode in 
the DNA derived from MOTet1, MOTet3 and wild type (WT) zebrafish 
embryos at 24 hpf. (E) dmC/dC and dhmC/dmC ratios obtained from 
the quantification of mass spec peaks in the DNA derived from 
MOTet1, MOTet3 and wild type embryos at 24 hpf. (F) dmC/dC, 
dhmC/dmC and dfC/dhmC ratios obtained from the quantification of 
mass spec peaks in the DNA samples derived from 24 hpf zebrafish 
embryos and mESCs. (The figure was courtesy of  Dr. Alexey Ruzov). 
 
 
 
 
 
 
 
 
 
 
 
 
 
283 | P a g e  
 
REFERENCES 
Al-Adhami, M. A. & Kunz, Y. W. 1977. Ontogenesis of Haematopoietic Sites in Brachydanio 
rerio (Hamilton-Buchanan) (Teleostei)*. Development, Growth & Differentiation, 19, 
171-179. 
Almeida, R. D., Loose, M., Sottile, V., Matsa, E., Denning, C., Young, L., Johnson, A. D., Gering, 
M. & Ruzov, A. 2012. 5-hydroxymethyl-cytosine enrichment of non-committed cells is 
not a universal feature of vertebrate development. Epigenetics, 7, 383-9. 
Alvarez-Silva, M., Belo-Diabangouaya, P., Salaun, J. & Dieterlen-Lievre, F. 2003. Mouse 
placenta is a major hematopoietic organ. Development, 130, 5437-44. 
Amatruda, J. F. & Zon, L. I. 1999. Dissecting hematopoiesis and disease using the zebrafish. 
Dev Biol, 216, 1-15. 
Anderson, R. M., Bosch, J. A., Goll, M. G., Hesselson, D., Dong, P. D., Shin, D., Chi, N. C., Shin, 
C. H., Schlegel, A., Halpern, M. & Stainier, D. Y. 2009. Loss of Dnmt1 catalytic activity 
reveals multiple roles for DNA methylation during pancreas development and 
regeneration. Dev Biol, 334, 213-23. 
Anon 2006. RNA interference on target. Nat Meth, 3, 659-659. 
Bahary, N., Goishi, K., Stuckenholz, C., Weber, G., Leblanc, J., Schafer, C. A., Berman, S. S., 
Klagsbrun, M. & Zon, L. I. 2007. Duplicate VegfA genes and orthologues of the KDR 
receptor tyrosine kinase family mediate vascular development in the zebrafish. Blood, 
110, 3627-36. 
Baron, M. H., Isern, J. & Fraser, S. T. 2012. The embryonic origins of erythropoiesis in 
mammals. Blood, 119, 4828-37. 
Bedell, V. M., Westcot, S. E. & Ekker, S. C. 2011. Lessons from morpholino-based screening in 
zebrafish. Brief Funct Genomics, 10, 181-8. 
Beis, D., Bartman, T., Jin, S. W., Scott, I. C., D'amico, L. A., Ober, E. A., Verkade, H., Frantsve, J., 
Field, H. A., Wehman, A., Baier, H., Tallafuss, A., Bally-Cuif, L., Chen, J. N., Stainier, D. 
Y. & Jungblut, B. 2005. Genetic and cellular analyses of zebrafish atrioventricular 
cushion and valve development. Development, 132, 4193-204. 
Bertrand, J. Y., Chi, N. C., Santoso, B., Teng, S., Stainier, D. Y. R. & Traver, D. 2010a. 
Hematopoietic stem cells derive directly from aortic endothelium during 
development. Nature, 464, 108-11. 
Bertrand, J. Y., Chi, N. C., Santoso, B. & Traver, D. 2009. primitive  and  definitive  
hematopoiesis  arise  from  hemogenic  endothelial  cells  in  the zebrafish embryo. 
Poster presented at 6 th  European Zebrafish Genetics and Development Meeting. 
Bertrand, J. Y., Cisson, J. L., Stachura, D. L. & Traver, D. 2010b. Notch signaling distinguishes 2 
waves of definitive hematopoiesis in the zebrafish embryo. Blood, 115, 2777-83. 
Bertrand, J. Y., Kim, A. D., Violette, E. P., Stachura, D. L., Cisson, J. L. & Traver, D. 2007. 
Definitive hematopoiesis initiates through a committed erythromyeloid progenitor in 
the zebrafish embryo. Development, 134, 4147-56. 
Bierkamp, C. & Campos-Ortega, J. A. 1993. A zebrafish homologue of the Drosophila 
neurogenic gene Notch and its pattern of transcription during early embryogenesis. 
Mech Dev, 43, 87-100. 
Bigas, A., Guiu, J. & Gama-Norton, L. 2013. Notch and Wnt signaling in the emergence of 
hematopoietic stem cells. Blood Cells Mol Dis, 51, 264-70. 
Burns, C. E., Traver, D., Mayhall, E., Shepard, J. L. & Zon, L. I. 2005. Hematopoietic stem cell 
fate is established by the Notch-Runx pathway. Genes Dev, 19, 2331-42. 
Bussmann, J., Lawson, N., Zon, L. & Schulte-Merker, S. 2008. Zebrafish VEGF receptors: a 
guideline to nomenclature. PLoS Genet, 4, e1000064. 
Butko, E., Distel, M., Pouget, C., Weijts, B., Kobayashi, I., Ng, K., Mosimann, C., Poulain, F. E., 
Mcpherson, A., Ni, C. W., Stachura, D. L., Del Cid, N., Espin-Palazon, R., Lawson, N. D., 
284 | P a g e  
 
Dorsky, R., Clements, W. K. & Traver, D. 2015. Gata2b is a restricted early regulator of 
hemogenic endothelium in the zebrafish embryo. Development, 142, 1050-61. 
Cambier, T., Honegger, T., Vanneaux, V., Berthier, J., Peyrade, D., Blanchoin, L., Larghero, J. & 
Thery, M. 2015. Design of a 2D no-flow chamber to monitor hematopoietic stem cells. 
Lab Chip, 15, 77-85. 
Chen, M. J., Yokomizo, T., Zeigler, B. M., Dzierzak, E. & Speck, N. A. 2009. Runx1 is required for 
the endothelial to haematopoietic cell transition but not thereafter. Nature, 457, 887-
91. 
Choi, J., Dong, L., Ahn, J., Dao, D., Hammerschmidt, M. & Chen, J. N. 2007. FoxH1 negatively 
modulates flk1 gene expression and vascular formation in zebrafish. Dev Biol, 304, 
735-44. 
Clements, W. K., Kim, A. D., Ong, K. G., Moore, J. C., Lawson, N. D. & Traver, D. 2011. A somitic 
Wnt16/Notch pathway specifies haematopoietic stem cells. Nature, 474, 220-4. 
Clements, W. K. & Traver, D. 2013. Signalling pathways that control vertebrate haematopoietic 
stem cell specification. Nat Rev Immunol, 13, 336-48. 
Collas, P. 1998. Modulation of plasmid DNA methylation and expression in zebrafish embryos. 
Nucleic Acids Res, 26, 4454-61. 
Coultas, L., Chawengsaksophak, K. & Rossant, J. 2005. Endothelial cells and VEGF in vascular 
development. Nature, 438, 937-45. 
Covassin, L. D., Villefranc, J. A., Kacergis, M. C., Weinstein, B. M. & Lawson, N. D. 2006. Distinct 
genetic interactions between multiple Vegf receptors are required for development 
of different blood vessel types in zebrafish. Proc Natl Acad Sci U S A, 103, 6554-9. 
Cross, L. M., Cook, M. A., Lin, S., Chen, J. N. & Rubinstein, A. L. 2003. Rapid analysis of 
angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscler Thromb Vasc Biol, 
23, 911-2. 
Davison, J. M., Akitake, C. M., Goll, M. G., Rhee, J. M., Gosse, N., Baier, H., Halpern, M. E., 
Leach, S. D. & Parsons, M. J. 2007. Transactivation from Gal4-VP16 transgenic 
insertions for tissue-specific cell labeling and ablation in zebrafish. Dev Biol, 304, 811-
24. 
Dawlaty, M. M., Breiling, A., Le, T., Barrasa, M. I., Raddatz, G., Gao, Q., Powell, B. E., Cheng, A. 
W., Faull, K. F., Lyko, F. & Jaenisch, R. 2014. Loss of Tet enzymes compromises proper 
differentiation of embryonic stem cells. Dev Cell, 29, 102-11. 
Dawlaty, M. M., Breiling, A., Le, T., Raddatz, G., Barrasa, M. I., Cheng, A. W., Gao, Q., Powell, 
B. E., Li, Z., Xu, M., Faull, K. F., Lyko, F. & Jaenisch, R. 2013. Combined deficiency of 
Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal 
development. Dev Cell, 24, 310-23. 
De Bruijn, M. F., Ma, X., Robin, C., Ottersbach, K., Sanchez, M. J. & Dzierzak, E. 2002. 
Hematopoietic stem cells localize to the endothelial cell layer in the midgestation 
mouse aorta. Immunity, 16, 673-83. 
Deaton, A. M. & Bird, A. 2011. CpG islands and the regulation of transcription. Genes Dev, 25, 
1010-22. 
Detrich, H. W., 3rd, Kieran, M. W., Chan, F. Y., Barone, L. M., Yee, K., Rundstadler, J. A., Pratt, 
S., Ransom, D. & Zon, L. I. 1995. Intraembryonic hematopoietic cell migration during 
vertebrate development. Proc Natl Acad Sci U S A, 92, 10713-7. 
Detrich, H. W., Westerfield, M. & Zon, L. I. 2011. The zebrafish: disease models and chemical 
screens, Academic Press. 
Dieterlen-Lievre, F. 1975. On the origin of haemopoietic stem cells in the avian embryo: an 
experimental approach. J Embryol Exp Morphol, 33, 607-19. 
Drevon, C. & Jaffredo, T. 2014. Cell interactions and cell signaling during hematopoietic 
development. Exp Cell Res, 329, 200-6. 
285 | P a g e  
 
Drew, E. 2010. The Role of the PI3K/AKT Pathway in HSC Formation in the Zebrafish Embryo. 
Master, University of Nottingham. 
Eilken, H. M., Nishikawa, S. & Schroeder, T. 2009. Continuous single-cell imaging of blood 
generation from haemogenic endothelium. Nature, 457, 896-900. 
Eisen, J. S. & Smith, J. C. 2008. Controlling morpholino experiments: don't stop making 
antisense. Development, 135, 1735-43. 
Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D. & Sklar, J. 1991. 
TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal 
translocations in T lymphoblastic neoplasms. Cell, 66, 649-61. 
Espin-Palazon, R., Stachura, D. L., Campbell, C. A., Garcia-Moreno, D., Del Cid, N., Kim, A. D., 
Candel, S., Meseguer, J., Mulero, V. & Traver, D. 2014. Proinflammatory signaling 
regulates hematopoietic stem cell emergence. Cell, 159, 1070-85. 
Ford, C. E., Hamerton, J. L., Barnes, D. W. & Loutit, J. F. 1956. Cytological identification of 
radiation-chimaeras. Nature, 177, 452-4. 
Fouquet, B., Weinstein, B. M., Serluca, F. C. & Fishman, M. C. 1997. Vessel patterning in the 
embryo of the zebrafish: guidance by notochord. Dev Biol, 183, 37-48. 
Gekas, C., Dieterlen-Lievre, F., Orkin, S. H. & Mikkola, H. K. 2005. The placenta is a niche for 
hematopoietic stem cells. Dev Cell, 8, 365-75. 
Gering, M. & Patient, R. 2005. Hedgehog signaling is required for adult blood stem cell 
formation in zebrafish embryos. Dev Cell, 8, 389-400. 
Gering, M., Rodaway, A. R., Gottgens, B., Patient, R. K. & Green, A. R. 1998. The SCL gene 
specifies haemangioblast development from early mesoderm. Embo j, 17, 4029-45. 
Gibson, D. G., Glass, J. I., Lartigue, C., Noskov, V. N., Chuang, R. Y., Algire, M. A., Benders, G. 
A., Montague, M. G., Ma, L., Moodie, M. M., Merryman, C., Vashee, S., Krishnakumar, 
R., Assad-Garcia, N., Andrews-Pfannkoch, C., Denisova, E. A., Young, L., Qi, Z. Q., 
Segall-Shapiro, T. H., Calvey, C. H., Parmar, P. P., Hutchison, C. A., 3rd, Smith, H. O. & 
Venter, J. C. 2010. Creation of a bacterial cell controlled by a chemically synthesized 
genome. Science, 329, 52-6. 
Gibson, D. G., Young, L., Chuang, R. Y., Venter, J. C., Hutchison, C. A., 3rd & Smith, H. O. 2009. 
Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods, 
6, 343-5. 
Gilbert, W. & Glynias, M. 1993. On the ancient nature of introns. Gene, 135, 137-44. 
Goll, M. G., Anderson, R., Stainier, D. Y., Spradling, A. C. & Halpern, M. E. 2009. Transcriptional 
silencing and reactivation in transgenic zebrafish. Genetics, 182, 747-55. 
Golub, R. & Cumano, A. 2013. Embryonic hematopoiesis. Blood Cells Mol Dis, 51, 226-31. 
Gross, J. B., Hanken, J., Oglesby, E. & Marsh-Armstrong, N. 2006. Use of a ROSA26:GFP 
transgenic line for long-term Xenopus fate-mapping studies. J Anat, 209, 401-13. 
Gu, T. P., Guo, F., Yang, H., Wu, H. P., Xu, G. F., Liu, W., Xie, Z. G., Shi, L., He, X., Jin, S. G., Iqbal, 
K., Shi, Y. G., Deng, Z., Szabo, P. E., Pfeifer, G. P., Li, J. & Xu, G. L. 2011. The role of Tet3 
DNA dioxygenase in epigenetic reprogramming by oocytes. Nature, 477, 606-10. 
Gupta-Rossi, N., Le Bail, O., Gonen, H., Brou, C., Logeat, F., Six, E., Ciechanover, A. & Israel, A. 
2001. Functional interaction between SEL-10, an F-box protein, and the nuclear form 
of activated Notch1 receptor. J Biol Chem, 276, 34371-8. 
Habeck, H., Odenthal, J., Walderich, B., Maischein, H. & Schulte-Merker, S. 2002. Analysis of a 
zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis. Curr Biol, 
12, 1405-12. 
Haddon, C., Jiang, Y. J., Smithers, L. & Lewis, J. 1998. Delta-Notch signalling and the patterning 
of sensory cell differentiation in the zebrafish ear: evidence from the mind bomb 
mutant. Development, 125, 4637-44. 
286 | P a g e  
 
Hadland, B. K., Huppert, S. S., Kanungo, J., Xue, Y., Jiang, R., Gridley, T., Conlon, R. A., Cheng, 
A. M., Kopan, R. & Longmore, G. D. 2004. A requirement for Notch1 distinguishes 2 
phases of definitive hematopoiesis during development. Blood, 104, 3097-105. 
Haffter, P., Granato, M., Brand, M., Mullins, M. C., Hammerschmidt, M., Kane, D. A., Odenthal, 
J., Van Eeden, F. J., Jiang, Y. J., Heisenberg, C. P., Kelsh, R. N., Furutani-Seiki, M., 
Vogelsang, E., Beuchle, D., Schach, U., Fabian, C. & Nusslein-Volhard, C. 1996. The 
identification of genes with unique and essential functions in the development of the 
zebrafish, Danio rerio. Development, 123, 1-36. 
Hans, S., Kaslin, J., Freudenreich, D. & Brand, M. 2009. Temporally-controlled site-specific 
recombination in zebrafish. PLoS One, 4, e4640. 
He, Y. F., Li, B. Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., Sun, Y., Li, X., 
Dai, Q., Song, C. X., Zhang, K., He, C. & Xu, G. L. 2011. Tet-mediated formation of 5-
carboxylcytosine and its excision by TDG in mammalian DNA. Science, 333, 1303-7. 
Henkel, T., Ling, P. D., Hayward, S. D. & Peterson, M. G. 1994. Mediation of Epstein-Barr virus 
EBNA2 transactivation by recombination signal-binding protein J kappa. Science, 265, 
92-5. 
Herbert, S. P., Huisken, J., Kim, T. N., Feldman, M. E., Houseman, B. T., Wang, R. A., Shokat, K. 
M. & Stainier, D. Y. 2009. Arterial-venous segregation by selective cell sprouting: an 
alternative mode of blood vessel formation. Science, 326, 294-8. 
Hirai, H., Samokhvalov, I. M., Fujimoto, T., Nishikawa, S., Imanishi, J. & Nishikawa, S. 2005. 
Involvement of Runx1 in the down-regulation of fetal liver kinase-1 expression during 
transition of endothelial cells to hematopoietic cells. Blood, 106, 1948-55. 
Hsieh, J. J., Henkel, T., Salmon, P., Robey, E., Peterson, M. G. & Hayward, S. D. 1996. Truncated 
mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism 
resembling that of Epstein-Barr virus EBNA2. Molecular and Cellular Biology, 16, 952-
959. 
Inbal, A., Topczewski, J. & Solnica-Krezel, L. 2006. Targeted gene expression in the zebrafish 
prechordal plate. Genesis, 44, 584-8. 
Ishitobi, H., Matsumoto, K., Azami, T., Itoh, F., Itoh, S., Takahashi, S. & Ema, M. 2010. Flk1-GFP 
BAC Tg mice: an animal model for the study of blood vessel development. Exp Anim, 
59, 615-22. 
Isogai, S., Lawson, N. D., Torrealday, S., Horiguchi, M. & Weinstein, B. M. 2003. Angiogenic 
network formation in the developing vertebrate trunk. Development, 130, 5281-5290. 
Ito, S., D'alessio, A. C., Taranova, O. V., Hong, K., Sowers, L. C. & Zhang, Y. 2010. Role of Tet 
proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass 
specification. Nature, 466, 1129-33. 
Itoh, M., Kim, C. H., Palardy, G., Oda, T., Jiang, Y. J., Maust, D., Yeo, S. Y., Lorick, K., Wright, G. 
J., Ariza-Mcnaughton, L., Weissman, A. M., Lewis, J., Chandrasekharappa, S. C. & 
Chitnis, A. B. 2003. Mind bomb is a ubiquitin ligase that is essential for efficient 
activation of Notch signaling by Delta. Dev Cell, 4, 67-82. 
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T. & 
Tuveson, D. A. 2001. Analysis of lung tumor initiation and progression using 
conditional expression of oncogenic K-ras. Genes Dev, 15, 3243-8. 
Jaffredo, T., Gautier, R., Eichmann, A. & Dieterlen-Lievre, F. 1998. Intraaortic hemopoietic cells 
are derived from endothelial cells during ontogeny. Development, 125, 4575-83. 
Jalali, M. 2012. Using the Cre/LoxP recombination system to study the role of the PI3K/AKT 
signalling transduction pathway and the embryonic cellular origin of adult 
haematopoietic stem cells in the zebrafish. Master, University of Nottingham. 
Janicke, M., Carney, T. J. & Hammerschmidt, M. 2007. Foxi3 transcription factors and Notch 
signaling control the formation of skin ionocytes from epidermal precursors of the 
zebrafish embryo. Dev Biol, 307, 258-71. 
287 | P a g e  
 
Jiang, Y. J., Brand, M., Heisenberg, C. P., Beuchle, D., Furutani-Seiki, M., Kelsh, R. N., Warga, R. 
M., Granato, M., Haffter, P., Hammerschmidt, M., Kane, D. A., Mullins, M. C., 
Odenthal, J., Van Eeden, F. J. & Nusslein-Volhard, C. 1996. Mutations affecting 
neurogenesis and brain morphology in the zebrafish, Danio rerio. Development, 123, 
205-16. 
Jin, H., Sood, R., Xu, J., Zhen, F., English, M. A., Liu, P. P. & Wen, Z. 2009. Definitive 
hematopoietic stem/progenitor cells manifest distinct differentiation output in the 
zebrafish VDA and PBI. Development, 136, 647-54. 
Jin, H., Xu, J. & Wen, Z. 2007. Migratory path of definitive hematopoietic stem/progenitor cells 
during zebrafish development. Blood, 109, 5208-14. 
Jin, S. W., Beis, D., Mitchell, T., Chen, J. N. & Stainier, D. Y. 2005. Cellular and molecular 
analyses of vascular tube and lumen formation in zebrafish. Development, 132, 5199-
209. 
Jones, R. J., Celano, P., Sharkis, S. J. & Sensenbrenner, L. L. 1989. Two phases of engraftment 
established by serial bone marrow transplantation in mice. Blood, 73, 397-401. 
Joutel, A., Monet, M., Domenga, V., Riant, F. & Tournier-Lasserve, E. 2004. Pathogenic 
mutations associated with cerebral autosomal dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 
activity via the RBP/JK signaling Pathway. Am J Hum Genet, 74, 338-47. 
Kataoka, H., Takakura, N., Nishikawa, S., Tsuchida, K., Kodama, H., Kunisada, T., Risau, W., Kita, 
T. & Nishikawa, S. I. 1997. Expressions of PDGF receptor alpha, c-Kit and Flk1 genes 
clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal 
cells. Dev Growth Differ, 39, 729-40. 
Kato, H., Taniguchi, Y., Kurooka, H., Minoguchi, S., Sakai, T., Nomura-Okazaki, S., Tamura, K. & 
Honjo, T. 1997. Involvement of RBP-J in biological functions of mouse Notch1 and its 
derivatives. Development, 124, 4133-41. 
Kawakami, K., Takeda, H., Kawakami, N., Kobayashi, M., Matsuda, N. & Mishina, M. 2004. A 
transposon-mediated gene trap approach identifies developmentally regulated genes 
in zebrafish. Dev Cell, 7, 133-44. 
Kawamata, S., Du, C., Li, K. & Lavau, C. 2002. Overexpression of the Notch target genes Hes in 
vivo induces lymphoid and myeloid alterations. Oncogene, 21, 3855-63. 
Kim, A. D., Melick, C. H., Clements, W. K., Stachura, D. L., Distel, M., Panakova, D., Macrae, C., 
Mork, L. A., Crump, J. G. & Traver, D. 2014. Discrete Notch signaling requirements in 
the specification of hematopoietic stem cells. Embo j, 33, 2363-73. 
Kim, Y. H., Hu, H., Guevara-Gallardo, S., Lam, M. T., Fong, S. Y. & Wang, R. A. 2008. Artery and 
vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis. 
Development, 135, 3755-64. 
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. & Schilling, T. F. 1995. Stages of 
embryonic development of the zebrafish. Dev. Dyn. Developmental Dynamics, 203, 
253-310. 
Kissa, K. & Herbomel, P. 2010. Blood stem cells emerge from aortic endothelium by a novel 
type of cell transition. Nature, 464, 112-5. 
Kissa, K., Murayama, E., Zapata, A., Cortes, A., Perret, E., Machu, C. & Herbomel, P. 2008. Live 
imaging of emerging hematopoietic stem cells and early thymus colonization. Blood, 
111, 1147-56. 
Kobayashi, I., Kobayashi-Sun, J., Kim, A. D., Pouget, C., Fujita, N., Suda, T. & Traver, D. 2014. 
Jam1a-Jam2a interactions regulate haematopoietic stem cell fate through Notch 
signalling. Nature, 512, 319-23. 
Koch, U., Lehal, R. & Radtke, F. 2013. Stem cells living with a Notch. Development, 140, 689-
704. 
288 | P a g e  
 
Koh, K. P., Yabuuchi, A., Rao, S., Huang, Y., Cunniff, K., Nardone, J., Laiho, A., Tahiliani, M., 
Sommer, C. A., Mostoslavsky, G., Lahesmaa, R., Orkin, S. H., Rodig, S. J., Daley, G. Q. & 
Rao, A. 2011. Tet1 and Tet2 Regulate 5-Hydroxymethylcytosine Production and Cell 
Lineage Specification in Mouse Embryonic Stem Cells. Cell Stem Cell, 8, 200-213. 
Kohli, V., Schumacher, J. A., Desai, S. P., Rehn, K. & Sumanas, S. 2013. Arterial and venous 
progenitors of the major axial vessels originate at distinct locations. Dev Cell, 25, 196-
206. 
Kohyama, J., Tokunaga, A., Fujita, Y., Miyoshi, H., Nagai, T., Miyawaki, A., Nakao, K., Matsuzaki, 
Y. & Okano, H. 2005. Visualization of spatiotemporal activation of Notch signaling: live 
monitoring and significance in neural development. Dev Biol, 286, 311-25. 
Kok, F. O., Shin, M., Ni, C. W., Gupta, A., Grosse, A. S., Van Impel, A., Kirchmaier, B. C., Peterson-
Maduro, J., Kourkoulis, G., Male, I., Desantis, D. F., Sheppard-Tindell, S., Ebarasi, L., 
Betsholtz, C., Schulte-Merker, S., Wolfe, S. A. & Lawson, N. D. 2015. Reverse genetic 
screening reveals poor correlation between morpholino-induced and mutant 
phenotypes in zebrafish. Dev Cell, 32, 97-108. 
Kopan, R. & Ilagan, M. X. 2009. The canonical Notch signaling pathway: unfolding the 
activation mechanism. Cell, 137, 216-33. 
Koster, R. W. & Fraser, S. E. 2001. Tracing transgene expression in living zebrafish embryos. 
Dev Biol, 233, 329-46. 
Krebs, L. T., Shutter, J. R., Tanigaki, K., Honjo, T., Stark, K. L. & Gridley, T. 2004. 
Haploinsufficient lethality and formation of arteriovenous malformations in Notch 
pathway mutants. Genes Dev, 18, 2469-73. 
Krebs, L. T., Xue, Y., Norton, C. R., Shutter, J. R., Maguire, M., Sundberg, J. P., Gallahan, D., 
Closson, V., Kitajewski, J., Callahan, R., Smith, G. H., Stark, K. L. & Gridley, T. 2000. 
Notch signaling is essential for vascular morphogenesis in mice. Genes Dev, 14, 1343-
52. 
Kriaucionis, S. & Heintz, N. 2009. The nuclear DNA base 5-hydroxymethylcytosine is present in 
Purkinje neurons and the brain. Science, 324, 929-30. 
Kumano, K., Chiba, S., Kunisato, A., Sata, M., Saito, T., Nakagami-Yamaguchi, E., Yamaguchi, 
T., Masuda, S., Shimizu, K., Takahashi, T., Ogawa, S., Hamada, Y. & Hirai, H. 2003. 
Notch1 but not Notch2 is essential for generating hematopoietic stem cells from 
endothelial cells. Immunity, 18, 699-711. 
Kumaravelu, P., Hook, L., Morrison, A. M., Ure, J., Zhao, S., Zuyev, S., Ansell, J. & Medvinsky, 
A. 2002. Quantitative developmental anatomy of definitive haematopoietic stem 
cells/long-term repopulating units (HSC/RUs): role of the aorta-gonad-mesonephros 
(AGM) region and the yolk sac in colonisation of the mouse embryonic liver. 
Development, 129, 4891-9. 
Lam, E. Y., Hall, C. J., Crosier, P. S., Crosier, K. E. & Flores, M. V. 2010. Live imaging of Runx1 
expression in the dorsal aorta tracks the emergence of blood progenitors from 
endothelial cells. Blood, 116, 909-14. 
Lancrin, C., Sroczynska, P., Stephenson, C., Allen, T., Kouskoff, V. & Lacaud, G. 2009. The 
haemangioblast generates haematopoietic cells through a haemogenic endothelium 
stage. Nature, 457, 892-5. 
Latimer, A. J., Dong, X., Markov, Y. & Appel, B. 2002. Delta-Notch signaling induces hypochord 
development in zebrafish. Development, 129, 2555-63. 
Lawson, N. D., Mugford, J. W., Diamond, B. A. & Weinstein, B. M. 2003. phospholipase C 
gamma-1 is required downstream of vascular endothelial growth factor during arterial 
development. Genes Dev, 17, 1346-51. 
Lawson, N. D., Scheer, N., Pham, V. N., Kim, C. H., Chitnis, A. B., Campos-Ortega, J. A. & 
Weinstein, B. M. 2001. Notch signaling is required for arterial-venous differentiation 
during embryonic vascular development. Development, 128, 3675-83. 
289 | P a g e  
 
Lawson, N. D., Vogel, A. M. & Weinstein, B. M. 2002. sonic hedgehog and vascular endothelial 
growth factor act upstream of the Notch pathway during arterial endothelial 
differentiation. Dev Cell, 3, 127-36. 
Lee, Y., Manegold, J. E., Kim, A. D., Pouget, C., Stachura, D. L., Clements, W. K. & Traver, D. 
2014. FGF signalling specifies haematopoietic stem cells through its regulation of 
somitic Notch signalling. Nat Commun, 5, 5583. 
Leslie, J. D., Ariza-Mcnaughton, L., Bermange, A. L., Mcadow, R., Johnson, S. L. & Lewis, J. 2007. 
Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. 
Development, 134, 839-44. 
Li, C., Lan, Y., Schwartz-Orbach, L., Korol, E., Tahiliani, M., Evans, T. & Goll, M. G. 2015. 
Overlapping Requirements for Tet2 and Tet3 in Normal Development and 
Hematopoietic Stem Cell Emergence. Cell Rep, 12, 1133-43. 
Li, Z., Cai, X., Cai, C. L., Wang, J., Zhang, W., Petersen, B. E., Yang, F. C. & Xu, M. 2011. Deletion 
of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent 
development of myeloid malignancies. Blood, 118, 4509-18. 
Liao, W., Bisgrove, B. W., Sawyer, H., Hug, B., Bell, B., Peters, K., Grunwald, D. J. & Stainier, D. 
Y. 1997. The zebrafish gene cloche acts upstream of a flk-1 homologue to regulate 
endothelial cell differentiation. Development, 124, 381-9. 
Lichanska, A. M. & Hume, D. A. 2000. Origins and functions of phagocytes in the embryo. Exp 
Hematol, 28, 601-11. 
Lorenz, E., Uphoff, D., Reid, T. R. & Shelton, E. 1951. Modification of irradiation injury in mice 
and guinea pigs by bone marrow injections. J Natl Cancer Inst, 12, 197-201. 
Makinodan, T. 1956. Circulating rat cells in lethally irradiated mice protected with rat bone 
marrow. Proc Soc Exp Biol Med, 92, 174-9. 
Maximow, A. 1908. Untersuchungen über Blut und Bindegewebe. Archiv für mikroskopische 
Anatomie, 73, 444-561. 
Maxwell, I. H., Harrison, G. S., Wood, W. M. & Maxwell, F. 1989. A DNA cassette containing a 
trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-
initiated transcription. Biotechniques, 7, 276-80. 
Medvinsky, A. & Dzierzak, E. 1996. Definitive hematopoiesis is autonomously initiated by the 
AGM region. Cell, 86, 897-906. 
Medvinsky, A., Rybtsov, S. & Taoudi, S. 2011. Embryonic origin of the adult hematopoietic 
system: advances and questions. Development, 138, 1017-31. 
Modhara, S. 2014. Mathematical modelling of vascular development in zebraﬁsh. PhD, 
University of Nottingham. 
Moore, M. A. & Metcalf, D. 1970. Ontogeny of the haemopoietic system: yolk sac origin of in 
vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol, 
18, 279-96. 
Morgan, T. H. 1917. The Theory of the Gene. The American Naturalist, 51, 513-544. 
Mosimann, C., Kaufman, C. K., Li, P., Pugach, E. K., Tamplin, O. J. & Zon, L. I. 2011. Ubiquitous 
transgene expression and Cre-based recombination driven by the ubiquitin promoter 
in zebrafish. Development, 138, 169-77. 
Mosimann, C., Puller, A. C., Lawson, K. L., Tschopp, P., Amsterdam, A. & Zon, L. I. 2013. Site-
directed zebrafish transgenesis into single landing sites with the phiC31 integrase 
system. Dev Dyn, 242, 949-63. 
Motoike, T., Markham, D. W., Rossant, J. & Sato, T. N. 2003. Evidence for novel fate of Flk1+ 
progenitor: contribution to muscle lineage. Genesis, 35, 153-9. 
Murayama, E., Kissa, K., Zapata, A., Mordelet, E., Briolat, V., Lin, H. F., Handin, R. I. & Herbomel, 
P. 2006. Tracing hematopoietic precursor migration to successive hematopoietic 
organs during zebrafish development. Immunity, 25, 963-75. 
290 | P a g e  
 
Nasevicius, A. & Ekker, S. C. 2000. Effective targeted gene 'knockdown' in zebrafish. Nat Genet, 
26, 216-20. 
Nguyen, P. D., Hollway, G. E., Sonntag, C., Miles, L. B., Hall, T. E., Berger, S., Fernandez, K. J., 
Gurevich, D. B., Cole, N. J., Alaei, S., Ramialison, M., Sutherland, R. L., Polo, J. M., 
Lieschke, G. J. & Currie, P. D. 2014. Haematopoietic stem cell induction by somite-
derived endothelial cells controlled by meox1. Nature, 512, 314-8. 
North, T. E., De Bruijn, M. F., Stacy, T., Talebian, L., Lind, E., Robin, C., Binder, M., Dzierzak, E. 
& Speck, N. A. 2002. Runx1 expression marks long-term repopulating hematopoietic 
stem cells in the midgestation mouse embryo. Immunity, 16, 661-72. 
Nowell, P. C., Cole, L. J., Habermeyer, J. G. & Roan, P. L. 1956. Growth and continued function 
of rat marrow cells in x-radiated mice. Cancer Res, 16, 258-61. 
Nowotschin, S., Xenopoulos, P., Schrode, N. & Hadjantonakis, A. K. 2013. A bright single-cell 
resolution live imaging reporter of Notch signaling in the mouse. BMC Dev Biol, 13, 
15. 
Oberlin, E., Tavian, M., Blazsek, I. & Peault, B. 2002. Blood-forming potential of vascular 
endothelium in the human embryo. Development, 129, 4147-57. 
Orkin, S. H. & Zon, L. I. 2008. Hematopoiesis: an evolving paradigm for stem cell biology. Cell, 
132, 631-44. 
Ottersbach, K. & Dzierzak, E. 2005. The murine placenta contains hematopoietic stem cells 
within the vascular labyrinth region. Dev Cell, 8, 377-87. 
Palis, J. & Yoder, M. C. 2001. Yolk-sac hematopoiesis: the first blood cells of mouse and man. 
Exp Hematol, 29, 927-36. 
Paranjpe, S. S. & Veenstra, G. J. 2015. Establishing pluripotency in early development. Biochim 
Biophys Acta, 1849, 626-36. 
Pardanaud, L., Luton, D., Prigent, M., Bourcheix, L. M., Catala, M. & Dieterlen-Lievre, F. 1996. 
Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. 
Development, 122, 1363-71. 
Parsons, M. J., Pisharath, H., Yusuff, S., Moore, J. C., Siekmann, A. F., Lawson, N. & Leach, S. D. 
2009. Notch-responsive cells initiate the secondary transition in larval zebrafish 
pancreas. Mech Dev, 126, 898-912. 
Pastor, W. A., Aravind, L. & Rao, A. 2013. TETonic shift: biological roles of TET proteins in DNA 
demethylation and transcription. Nat Rev Mol Cell Biol, 14, 341-56. 
Paw, B. H. & Zon, L. I. 2000. Zebrafish: a genetic approach in studying hematopoiesis. Curr 
Opin Hematol, 7, 79-84. 
Pelster, B. & Burggren, W. W. 1996. Disruption of hemoglobin oxygen transport does not 
impact oxygen-dependent physiological processes in developing embryos of zebra 
fish (Danio rerio). Circ Res, 79, 358-62. 
Penton, A. L., Leonard, L. D. & Spinner, N. B. 2012. Notch signaling in human development and 
disease. Semin Cell Dev Biol, 23, 450-7. 
Pouget, C., Gautier, R., Teillet, M. A. & Jaffredo, T. 2006. Somite-derived cells replace ventral 
aortic hemangioblasts and provide aortic smooth muscle cells of the trunk. 
Development, 133, 1013-22. 
Pouget, C., Peterkin, T., Simoes, F. C., Lee, Y., Traver, D. & Patient, R. 2014. FGF signalling 
restricts haematopoietic stem cell specification via modulation of the BMP pathway. 
Nat Commun, 5, 5588. 
Quillien, A., Moore, J. C., Shin, M., Siekmann, A. F., Smith, T., Pan, L., Moens, C. B., Parsons, M. 
J. & Lawson, N. D. 2014. Distinct Notch signaling outputs pattern the developing 
arterial system. Development, 141, 1544-52. 
Rai, K., Huggins, I. J., James, S. R., Karpf, A. R., Jones, D. A. & Cairns, B. R. 2008. DNA 
demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and 
gadd45. Cell, 135, 1201-12. 
291 | P a g e  
 
Rai, K., Jafri, I. F., Chidester, S., James, S. R., Karpf, A. R., Cairns, B. R. & Jones, D. A. 2010. 
Dnmt3 and G9a cooperate for tissue-specific development in zebrafish. J Biol Chem, 
285, 4110-21. 
Rai, K., Nadauld, L. D., Chidester, S., Manos, E. J., James, S. R., Karpf, A. R., Cairns, B. R. & Jones, 
D. A. 2006. Zebra fish Dnmt1 and Suv39h1 regulate organ-specific terminal 
differentiation during development. Mol Cell Biol, 26, 7077-85. 
Robert-Moreno, A., Espinosa, L., De La Pompa, J. L. & Bigas, A. 2005. RBPjkappa-dependent 
Notch function regulates Gata2 and is essential for the formation of intra-embryonic 
hematopoietic cells. Development, 132, 1117-26. 
Robert-Moreno, A., Guiu, J., Ruiz-Herguido, C., Lopez, M. E., Ingles-Esteve, J., Riera, L., Tipping, 
A., Enver, T., Dzierzak, E., Gridley, T., Espinosa, L. & Bigas, A. 2008. Impaired embryonic 
haematopoiesis yet normal arterial development in the absence of the Notch ligand 
Jagged1. Embo j, 27, 1886-95. 
Robu, M. E., Larson, J. D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber, S. A. & Ekker, S. C. 
2007. p53 activation by knockdown technologies. PLoS Genet, 3, e78. 
Rossi, A., Kontarakis, Z., Gerri, C., Nolte, H., Holper, S., Kruger, M. & Stainier, D. Y. R. 2015. 
Genetic compensation induced by deleterious mutations but not gene knockdowns. 
Nature, 524, 230-233. 
Rowlinson, J. 2010. defining the role of Notch in Definitive Hematopoiesis. PhD, University of 
Nottingham. 
Rowlinson, J. M. & Gering, M. 2010. Hey2 acts upstream of Notch in hematopoietic stem cell 
specification in zebrafish embryos. Blood, 116, 2046-56. 
Rudenko, A., Dawlaty, M. M., Seo, J., Cheng, A. W., Meng, J., Le, T., Faull, K. F., Jaenisch, R. & 
Tsai, L. H. 2013. Tet1 is critical for neuronal activity-regulated gene expression and 
memory extinction. Neuron, 79, 1109-22. 
Ruzov, A., Tsenkina, Y., Serio, A., Dudnakova, T., Fletcher, J., Bai, Y., Chebotareva, T., Pells, S., 
Hannoun, Z., Sullivan, G., Chandran, S., Hay, D. C., Bradley, M., Wilmut, I. & De Sousa, 
P. 2011. Lineage-specific distribution of high levels of genomic 5-
hydroxymethylcytosine in mammalian development. Cell Res, 21, 1332-42. 
Sadowski, I., Ma, J., Triezenberg, S. & Ptashne, M. 1988. GAL4-VP16 is an unusually potent 
transcriptional activator. Nature, 335, 563-4. 
Sagasti, A., Guido, M. R., Raible, D. W. & Schier, A. F. 2005. Repulsive interactions shape the 
morphologies and functional arrangement of zebrafish peripheral sensory arbors. 
Curr Biol, 15, 804-14. 
Scheer, N. & Campos-Ortega, J. A. 1999. Use of the Gal4-UAS technique for targeted gene 
expression in the zebrafish. Mech Dev, 80, 153-8. 
Scheer, N., Groth, A., Hans, S. & Campos-Ortega, J. A. 2001. An instructive function for Notch 
in promoting gliogenesis in the zebrafish retina. Development, 128, 1099-107. 
Schier, A. F., Neuhauss, S. C., Harvey, M., Malicki, J., Solnica-Krezel, L., Stainier, D. Y., 
Zwartkruis, F., Abdelilah, S., Stemple, D. L., Rangini, Z., Yang, H. & Driever, W. 1996. 
Mutations affecting the development of the embryonic zebrafish brain. Development, 
123, 165-78. 
Scott, E. K., Mason, L., Arrenberg, A. B., Ziv, L., Gosse, N. J., Xiao, T., Chi, N. C., Asakawa, K., 
Kawakami, K. & Baier, H. 2007. Targeting neural circuitry in zebrafish using GAL4 
enhancer trapping. Nat Methods, 4, 323-6. 
Seritrakul, P. & Gross, J. M. 2014. Expression of the de novo DNA methyltransferases (dnmt3 
- dnmt8) during zebrafish lens development. Dev Dyn, 243, 350-6. 
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L. & Schuh, 
A. C. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient 
mice. Nature, 376, 62-6. 
292 | P a g e  
 
Shen, L., Wu, H., Diep, D., Yamaguchi, S., D'alessio, A. C., Fung, H. L., Zhang, K. & Zhang, Y. 
2013. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine 
oxidation dynamics. Cell, 153, 692-706. 
Shimizu, K., Chiba, S., Hosoya, N., Kumano, K., Saito, T., Kurokawa, M., Kanda, Y., Hamada, Y. 
& Hirai, H. 2000. Binding of Delta1, Jagged1, and Jagged2 to Notch2 rapidly induces 
cleavage, nuclear translocation, and hyperphosphorylation of Notch2. Mol Cell Biol, 
20, 6913-22. 
Sieger, D., Tautz, D. & Gajewski, M. 2003. The role of Suppressor of Hairless in Notch mediated 
signalling during zebrafish somitogenesis. Mech Dev, 120, 1083-94. 
Siekmann, A. F. & Lawson, N. D. 2007. Notch signalling limits angiogenic cell behaviour in 
developing zebrafish arteries. Nature, 445, 781-4. 
Sinha, D. K., Neveu, P., Gagey, N., Aujard, I., Benbrahim-Bouzidi, C., Le Saux, T., Rampon, C., 
Gauron, C., Goetz, B., Dubruille, S., Baaden, M., Volovitch, M., Bensimon, D., Vriz, S. & 
Jullien, L. 2010. Photocontrol of protein activity in cultured cells and zebrafish with 
one- and two-photon illumination. Chembiochem, 11, 653-63. 
Siridechadilok, B., Gomutsukhavadee, M., Sawaengpol, T., Sangiambut, S., Puttikhunt, C., 
Chin-Inmanu, K., Suriyaphol, P., Malasit, P., Screaton, G. & Mongkolsapaya, J. 2013. A 
simplified positive-sense-RNA virus construction approach that enhances analysis 
throughput. J Virol, 87, 12667-74. 
Slukvin, Ii 2013. Hematopoietic specification from human pluripotent stem cells: current 
advances and challenges toward de novo generation of hematopoietic stem cells. 
Blood, 122, 4035-46. 
Smithers, L., Haddon, C., Jiang, Y. J. & Lewis, J. 2000. Sequence and embryonic expression of 
deltaC in the zebrafish. Mech Dev, 90, 119-23. 
Sniegowski, J. A., Lappe, J. W., Patel, H. N., Huffman, H. A. & Wachter, R. M. 2005. Base 
catalysis of chromophore formation in Arg96 and Glu222 variants of green fluorescent 
protein. J Biol Chem, 280, 26248-55. 
Souilhol, C., Cormier, S., Monet, M., Vandormael-Pournin, S., Joutel, A., Babinet, C. & Cohen-
Tannoudji, M. 2006. Nas transgenic mouse line allows visualization of Notch pathway 
activity in vivo. Genesis, 44, 277-86. 
Stone, H. 2010. How Notch signalling varies to differentially regulate arterial endothelial gene 
expression and Haematopoietic Stem cell emergence in Danio rerio Master, University 
of Nottingham. 
Sumoy, L., Keasey, J. B., Dittman, T. D. & Kimelman, D. 1997. A role for notochord in axial 
vascular development revealed by analysis of phenotype and the expression of VEGR-
2 in zebrafish flh and ntl mutant embryos. Mech Dev, 63, 15-27. 
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, 
L. M., Liu, D. R., Aravind, L. & Rao, A. 2009. Conversion of 5-methylcytosine to 5-
hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 324, 930-5. 
Takke, C. & Campos-Ortega, J. A. 1999. her1, a zebrafish pair-rule like gene, acts downstream 
of notch signalling to control somite development. Development, 126, 3005-14. 
Takke, C., Dornseifer, P., V Weizsacker, E. & Campos-Ortega, J. A. 1999. her4, a zebrafish 
homologue of the Drosophila neurogenic gene E(spl), is a target of NOTCH signalling. 
Development, 126, 1811-21. 
Terragni, J., Zhang, G., Sun, Z., Pradhan, S., Song, L., Crawford, G. E., Lacey, M. & Ehrlich, M. 
2014. Notch signaling genes: myogenic DNA hypomethylation and 5-
hydroxymethylcytosine. Epigenetics, 9, 842-50. 
Thompson, M. A., Ransom, D. G., Pratt, S. J., Maclennan, H., Kieran, M. W., Detrich, H. W., 3rd, 
Vail, B., Huber, T. L., Paw, B., Brownlie, A. J., Oates, A. C., Fritz, A., Gates, M. A., 
Amores, A., Bahary, N., Talbot, W. S., Her, H., Beier, D. R., Postlethwait, J. H. & Zon, L. 
293 | P a g e  
 
I. 1998. The cloche and spadetail genes differentially affect hematopoiesis and 
vasculogenesis. Dev Biol, 197, 248-69. 
Thummel, R., Bai, S., Sarras, M. P., Jr., Song, P., Mcdermott, J., Brewer, J., Perry, M., Zhang, X., 
Hyde, D. R. & Godwin, A. R. 2006. Inhibition of zebrafish fin regeneration using in vivo 
electroporation of morpholinos against fgfr1 and msxb. Dev Dyn, 235, 336-46. 
Till, J. E. & Mcculloch, E. A. 1961. A Direct Measurement of the Radiation Sensitivity of Normal 
Mouse Bone Marrow Cells. Radiation Research, 14, 213-222. 
Tittle, R. K., Sze, R., Ng, A., Nuckels, R. J., Swartz, M. E., Anderson, R. M., Bosch, J., Stainier, D. 
Y., Eberhart, J. K. & Gross, J. M. 2011. Uhrf1 and Dnmt1 are required for development 
and maintenance of the zebrafish lens. Dev Biol, 350, 50-63. 
Triezenberg, S. J., Lamarco, K. L. & Mcknight, S. L. 1988. Evidence of DNA: protein interactions 
that mediate HSV-1 immediate early gene activation by VP16. Genes Dev, 2, 730-42. 
Tsumagari, K., Baribault, C., Terragni, J., Varley, K. E., Gertz, J., Pradhan, S., Badoo, M., Crain, 
C. M., Song, L., Crawford, G. E., Myers, R. M., Lacey, M. & Ehrlich, M. 2013. Early de 
novo DNA methylation and prolonged demethylation in the muscle lineage. 
Epigenetics, 8, 317-32. 
Ulitsky, I., Shkumatava, A., Jan, C. H., Sive, H. & Bartel, D. P. 2011. Conserved function of 
lincRNAs in vertebrate embryonic development despite rapid sequence evolution. 
Cell, 147, 1537-50. 
Uyttendaele, H., Ho, J., Rossant, J. & Kitajewski, J. 2001. Vascular patterning defects associated 
with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci U 
S A, 98, 5643-8. 
Valinluck, V. & Sowers, L. C. 2007. Endogenous cytosine damage products alter the site 
selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res, 67, 
946-50. 
Varnum-Finney, B., Xu, L., Brashem-Stein, C., Nourigat, C., Flowers, D., Bakkour, S., Pear, W. S. 
& Bernstein, I. D. 2000. Pluripotent, cytokine-dependent, hematopoietic stem cells 
are immortalized by constitutive Notch1 signaling. Nat Med, 6, 1278-81. 
Venkatesh, D. A., Park, K. S., Harrington, A., Miceli-Libby, L., Yoon, J. K. & Liaw, L. 2008. 
Cardiovascular and hematopoietic defects associated with Notch1 activation in 
embryonic Tie2-expressing populations. Circ Res, 103, 423-31. 
Walls, J. R., Coultas, L., Rossant, J. & Henkelman, R. M. 2008. Three-dimensional analysis of 
vascular development in the mouse embryo. PLoS One, 3, e2853. 
Weber, J. M. & Calvi, L. M. 2010. Notch signaling and the bone marrow hematopoietic stem 
cell niche. Bone, 46, 281-5. 
Westerfield, M. & Zfin. 2000. The zebrafish book a guide for the laboratory use of zebrafish 
Danio (Brachydanio) rerio [Online]. [Eugene, Or.]: ZFIN. Available: 
http://zfin.org/zf_info/zfbook/zfbk.html. 
Westin, J. & Lardelli, M. 1997. Three novel Notch genes in zebrafish: implications for 
vertebrate Notch gene evolution and function. Dev Genes Evol, 207, 51-63. 
Wilkinson, R. N., Pouget, C., Gering, M., Russell, A. J., Davies, S. G., Kimelman, D. & Patient, R. 
2009. Hedgehog and Bmp polarize hematopoietic stem cell emergence in the 
zebrafish dorsal aorta. Dev Cell, 16, 909-16. 
Wu, H. & Zhang, Y. 2011. Mechanisms and functions of Tet protein-mediated 5-
methylcytosine oxidation. Genes Dev, 25, 2436-52. 
Xu, M. J., Matsuoka, S., Yang, F. C., Ebihara, Y., Manabe, A., Tanaka, R., Eguchi, M., Asano, S., 
Nakahata, T. & Tsuji, K. 2001. Evidence for the presence of murine primitive 
megakaryocytopoiesis in the early yolk sac. Blood, 97, 2016-22. 
Xu, Y., Xu, C., Kato, A., Tempel, W., Abreu, J. G., Bian, C., Hu, Y., Hu, D., Zhao, B., Cerovina, T., 
Diao, J., Wu, F., He, H. H., Cui, Q., Clark, E., Ma, C., Barbara, A., Veenstra, G. J. C., Xu, 
G., Kaiser, U. B., Liu, X. S., Sugrue, S. P., He, X., Min, J., Kato, Y. & Shi, Y. G. 2012. Tet3 
294 | P a g e  
 
CXXC Domain and Dioxygenase Activity Cooperatively Regulate Key Genes for 
Xenopus Eye and Neural Development. Cell, 151, 1200-13. 
Yamaguchi, T. P., Dumont, D. J., Conlon, R. A., Breitman, M. L. & Rossant, J. 1993. flk-1, an flt-
related receptor tyrosine kinase is an early marker for endothelial cell precursors. 
Development, 118, 489-98. 
Yoon, K. J., Koo, B. K., Im, S. K., Jeong, H. W., Ghim, J., Kwon, M. C., Moon, J. S., Miyata, T. & 
Kong, Y. Y. 2008. Mind bomb 1-expressing intermediate progenitors generate notch 
signaling to maintain radial glial cells. Neuron, 58, 519-31. 
Zecchin, E., Conigliaro, A., Tiso, N., Argenton, F. & Bortolussi, M. 2005. Expression analysis of 
jagged genes in zebrafish embryos. Developmental Dynamics, 233, 638-645. 
Zhang, R. R., Cui, Q. Y., Murai, K., Lim, Y. C., Smith, Z. D., Jin, S., Ye, P., Rosa, L., Lee, Y. K., Wu, 
H. P., Liu, W., Xu, Z. M., Yang, L., Ding, Y. Q., Tang, F., Meissner, A., Ding, C., Shi, Y. & 
Xu, G. L. 2013. Tet1 regulates adult hippocampal neurogenesis and cognition. Cell 
Stem Cell, 13, 237-45. 
Zovein, A. C., Hofmann, J. J., Lynch, M., French, W. J., Turlo, K. A., Yang, Y., Becker, M. S., 
Zanetta, L., Dejana, E., Gasson, J. C., Tallquist, M. D. & Iruela-Arispe, M. L. 2008. Fate 
tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell, 3, 
625-36. 
 
 
 
 
 
 
